研究者基本情報

研究者

• 氏名

  鈴木　和浩, スズキ　カズヒロ

基本情報

• 研究者氏名（日本語）

  鈴木, 和浩

• 研究者氏名（カナ）

  スズキ, カズヒロ

使用外国語

• 発表に使用する外国語

  英語

• 執筆に使用する外国語

  英語

所属

• 群馬大学, 教授
• 群馬大学, 教授

学歴

• 1996年, 群馬大学, 医学研究科, 泌尿器科
• 1988年, 群馬大学, 医学部
• 1996年, 群馬大学

学位

• 医学博士
• 医学博士

所属学協会

• International Society of Urology
• American Association for Cancer Research
• American Urological Association
• 北関東医学会
• 日本透析医学会
• 日本がん検診・診断学会
• 日本アンドロロジー学会
• 日本癌治療学会
• 日本泌尿器科学会
• 日本家族性腫瘍学会
• 日本ステロイドホルモン学会
• 日本内分泌学会
• Europen Society of Medical Oncology
• American Society of Clinical Oncoogy

経歴

• 1997年, 1999年
• 1997年, 1999年, オハイオ州立大学血液腫瘍学 研究員

研究活動情報

研究分野

• ライフサイエンス, 泌尿器科学

研究キーワード

• 前立腺癌

論文

• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa Y, Nakamura T, Takezawa Y, Shimizu N, Matsuo Y, Ogura H, Takei T, Sekine Y, Arai S, Suzuki K., 2023年, Prostate, 83, 8, 759, 764, 研究論文（学術雑誌）
• Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Y, Shimizu T, Sekine Y, Arai S, Ohtsu A, Fujizuka Y, Nomura M, Koike H, Matsui H, Suzuki K., 2022年, IJU Case Rep, 6, 1, 37, 40, 研究論文（学術雑誌）
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama H, Kawaguchi O, Seto T, Suzuki K, Matsuyama H, Matsubara N, Tajima Y, Fukao T., 2022年, BMC Cancer., 22, 1, 470
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu A, Arai S, Sawada T, Kato M, Maeno Y, Miyazawa Y, Fujizuka Y, Sekine Y, Koike H, Matsui H, Suzuki K., 2022年, Biochem Biophys Res Commun., 628, 76, 83, 研究論文（学術雑誌）
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S., Int J Clin Oncol, 27, 10, 1632, 1643, 研究論文（学術雑誌）
• Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Kurihara S, Matsui H, Ohtake N, Aoki M, Sekine Y, Arai S, Koike H, Suzuki K, Miyazawa Y, 2022年, Cancer Diagn Progn, 2, 5, 542, 548, 学位論文（博士）
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami T, Kawamura H, Kubo N, Sato H, Kawahara M, Adachi A, Matsui H, Suzuki K, Saitoh JI, Nakano T, Ohno T., 2023年, Asia Pac J Clin Oncol, Apr 23. doi: 10.1111/ajco.13960., 研究論文（学術雑誌）
• Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Miyazawa Y, Sekine Y, Arai S, Nomura M, Koike H, Matsui H, Suzuki K., 2022年, Cancer Diagn Progn., 2, 6, 686, 690, 研究論文（学術雑誌）
• Summary of the clinical practice manual for late-onset hypogonadism, de H, Akehi Y, Fukuhara S, Ohira S, Ogawa S, Kataoka T, Kumagai H, Kobayashi K, Komiya A, Shigehara K, Syuto T, Soh J, Tanabe M, Taniguchi H, Chiba K, Matsushita K, Mitsui Y, Yoneyama T, Shirakawa T, Fujii Y, Kumano H, Ueshiba H, Amano T, Sasaki H, Maeda S, Mizokami A, Suzuki K, Horie S, 2023年, Int J Urol, Feb 9. doi: 10.1111/iju.15160., 研究論文（学術雑誌）
• Combination therapy with novel androgen recetptor antagonists and statin for castration- resistant prostate cancer, Nakayama H, Sekine Y, Oka D, Miyazawa Y, Arai S, Koike H, Matsui H, Shibata Y, Suzuki K, 2022年, Prostate, 82, 3, 314, 322, 学位論文（博士）
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO ／ YUASA HISAKO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, 2003年09月, Tohoku Journal of Experimental Medicine
• Estrogen treatment of prostate cancer increases tyiglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, USUI SHINICHI ／ SUZUKI KAZUHIRO ／ YAMANAKA HIDETOSHI ／ NAKANO TAKAMITSU ／ NAKAJIMA KATSUYUKI ／ HARA YUKICHI ／ OKAZAKI MITSUYO, 2002年03月, Clin Chem Acta
• A novel immunosuppressive drug,FTY720,prevents the cancer progerssion indudced by cyclosporine, TANAKA TOSHIYUKI ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ WANG J-D ／ ICHIMARU NAOTSUGU ／ SUZUKI SEIICHI ／ MOROZUMI KUNIO ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, 2002年07月, Cancer Letters
• Tumor-associated tissue eosinophilia of penile cancer, ONO YOSHIHIRO ／ OZAWA MASASHI ／ TAMURA YOSHIMI ／ suzuki takanori ／ SUZUKI KAZUHIRO ／ KUROKAWA KOHEI ／ FUKABORI YOSHITATSU ／ YAMANAKA HIDETOSHI, 2002年09月, Int J Urol
• Incidence of Bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males., Okazaki H / suzuki takanori / KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2004年05月, Tohoku J Exp Med
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2002年06月, Int J Urol
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, SUZUKI KAZUHIRO / ITO KAZUTO / YAMAMOTO TAKUMI / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / KOIKE HIDEKAZU / MATSUI HIROSHI / ONO YOSHIHIRO / HASUMI MASARU / NAKAZATO HARUKI / OKUGI HIRONOBU / SEKINE YOSHITAKA / OOKI KAZUNARI, 2002年06月, Int J Cancer
• Prognostic significance of plasma placental growth factor levels in renal cell cancer:An association with clinical characteristics and vascular endothelial growth factor levels, MATSUMOTO KAZUHISA ／ SUZUKI KAZUHIRO ／ KOIKE HIDEKAZU ／ OKAMURA KEIGO ／ TSUCHIYA KIYOTAKA ／ UCHIDA TATSUYA ／ TAKEZAWA YUTAKA ／ kobayashi mikio ／ YAMANAKA HIDETOSHI, 2003年, ANTICANCER RESEARCH
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2002年07月, J Urol
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population., NAKAZATO HARUKI ／ SUZUKI KAZUHIRO ／ MATSUI HIROSHI ／ OHTAKE NOBUAKI ／ NAKATA SEIJI ／ YAMANAKA HIDETOSHI, 2003年, Br J Cancer
• Gene expression profiles of human BPH(II):Optimization of laser-capture microdissection and utilization of cDNA microarray., MATSUI HIROSHI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ KOIKE HIDEKAZU ／ OKUGI HIRONOBU ／ NAKAZATO HARUKI ／ YAMANAKA HIDETOSHI, 2003年, Anticancer Research
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, KUROKAWA KOHEI / SUZUKI KAZUHIRO / OKAZAKI HIROSHI / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2002年05月, Int J Urol
• Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR, SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / HASUMI MASARU / ONO YOSHIHIRO / NAKAZATO HARUKI / KOIKE HIDEKAZU / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI, 2001年11月, Anticancer Res
• 前立腺腫瘍マーカーの進歩と問題点：２．前立腺がんスクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 伊藤 一人 / 鈴木 和浩 / 山中 英寿, 2001年05月, 泌尿器外科, 14（臨増）: 441-443
• 前立腺集団検診受診者における国際前立腺症状スコアー(I-PSS)の傾向とQOL indexとの関係, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, 2001年08月, 泌尿器外科, 14(8): 868-871
• 前立腺特異抗原値(PSA)が6.1～10.0ng/mlにおける生検陽性率に関係する因子の臨床的検討, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, 2001年03月, 腎泌予防医誌, 9(1): 66-68
• 前立腺特異抗原(PSA)値別および年齢別の遊離型PSA(fPSA)・総PSA(tPSA)比の基準値設定に関する研究, 山本 巧 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, 2001年03月, 腎泌予防医誌, 9(1): 69-70
• 群馬県における前立腺がん検診の変遷・現況・将来展望, 武智浩之 / 伊藤 一人 / 山本 巧 / 鈴木 和浩, 2003年09月, 泌尿器外科, 16(9),1005-1010
• Comparative study on the prevalence of clinically detectable prostate cancer in cases with and without bladder cancer, KUROKAWA KOHEI / ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2004年02月, Urology
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, OHI MASARU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / YAMANAKA HIDETOSHI, 2004年01月, Eur Urol
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2004年01月, Int J Androl
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, MATSUMOTO KAZUHISA / SUZUKI KAZUHIRO / KOIKE HIDEKAZU / HASUMI MASARU / MATSUI HIROSHI / OKUGI HIRONOBU / SHIBATA YASUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI, 2003年09月, Anticancer Res
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / YAMAMOTO TAKUMI / ITO KAZUTO / KUROKAWA KOHEI / AOKI JUN / ENDO KEIGO / YAMANAKA HIDETOSHI, 2003年09月, Anticancer Res
• Association of genetic polymorphisms of Glutathione-S-transpherase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, NAKAZATO HARUKI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / TAKEI TOMOYUKI / NAKATA SEIJI / HASUMI MASARU, 2003年05月, Anticancer Res
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / NAKAZATO HARUKI / OKUGI HIRONOBU / KOIKE HIDEKAZU / ONO YOSHIHIRO, 2003年07月, J Biomed Sci
• 初回ホルモン療法後の再燃における放射線療法の適応　PSAdoubling time(PSADT)による判定は可能か, 黒川 公平 / 伊藤 一人 / 鈴木 和浩 / 深堀 能立 / 秋元 哲夫 / 三橋紀夫 / 山中 英寿, 2001年, 泌尿器外科, 14,No.臨時増刊(451-453)
• An evaluation of the Banff 97 classification after kidney transplantation, TANAKA TOSHIYUKI ／ KYO MASAHIRO ／ KOKADO YUKITO ／ TAKAHARA SHIRO ／ HATORI MOTOAKI ／ SUZUKI KAZUHIRO ／ HASUMI MASARU ／ TOKI KIYOHIDE ／ ICHIMARU NAOTSUGU ／ OKUYAMA AKIHIKO ／ YAMANAKA HIDETOSHI, 2003年, Transplantation Proceedings
• Hands-free hook for endourological procedures, ONO YOSHIHIRO ／ SUZUKI KAZUHIRO, 2003年10月, Int J Urol
• Malignant fibrous histiocytoma of the right spermatic cord: a case report., Sekine Y / Saruki K / Morita T / NAKAZATO HARUKI / YOKOO HIDEAKI / Yamanaka H / Ohki K / Okamoto K / Nomura M / Tomita H / Ohtake N / SUZUKI KAZUHIRO / KUROKAWA KOHEI / Mashimo M, 2001年, Int J Urol
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / YAMANAKA HIDETOSHI / NAKAZATO HARUKI / MATSUI HIROSHI / KOIKE HIDEKAZU / OKUGI HIRONOBU / KASHIWAGI BUNZOU / NISHII MASAHIRO / OHTAKE NIBUAKI / NAKATA SEIJI, 2003年10月, Cancer
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, HASUMI MASARU / SUZUKI KAZUHIRO / MATSUI HIROSHI / KOIKE HIDEKAZU / ITO KAZUTO / YAMANAKA HIDETOSHI, 2003年10月, Cancer Lett
• Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2003年09月, Prostate
• Natural history of PSA increase with and without prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2003年07月, Urology
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, SUZUKI KAZUHIRO / HATORI MOTOAKI / ITO KAZUTO / YAMANAKA HIDETOSHI / MATSUI HIROSHI / NAKAZATO HARUKI / KOIKE HIDEKAZU / OKUGI HIRONOBU / HASUMI MASARU / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI, 2003年06月, Cancer Lett
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/mL., ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2003年04月, Urology
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / TERADA N / ITO KAZUTO / YAMANAKA HIDETOSHI, 2003年03月, Int J Urol
• Cumulative probability of PSA increase above 4.0 ng/ml in population based screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / TAKECHI HIROYUKI / KUROKAWA KOHEI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2004年04月, Int J Cancer
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA]n repeat with familial prostate cancer risk in a Japanese population., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSI / KOIKE HIDEKAZU / OKUGI HIRONOBU / OHTAKE NOBUAKI / NAKATA SEIJI / HASUMI MASARU / YAMANAKA HIDETOSHI, 2003年, Anticancer Research
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, SUZUKI KAZUHIRO / ITO KAZUTO / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / MATSUI HIROSHI / ONO YOSHIHIRO / NAKAZATO HARUKI / HASUMI MASARU / KOIKE HIDEKAZU, 2002年11月, Anticancer Res
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with PSA levels of 4.1 to 10.0 ng/ml, ITO KAZUTO / YAMAMOTO TAKUMI / KUROKAWA KOHEI / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2002年11月, Cancer
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, HASUMI MASARU / SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2002年04月, Anticancer Res
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/ml or less, YAMAMOTO TAKUMI / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2001年12月, Urology
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis:A case report, MATSUMOTO KAZUHISA / HAYASHI MASAMICHI / KOSAKU NOZOMU / YAMAMOTO TAKUMI / HATORI MOTOAKI / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / ONO YASUHIRO, 2003年, Kitakanto Med J
• 前立腺生検の適応, 鈴木 和浩 / 伊藤 一人 / 山中 英寿, 2004年, 臨床泌尿器科, 58,No.7(455-459)
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: is it possible to identify patients likely to have good treatment outcomes?, KUROKAWA KOHEI / ITO KAZUTO / SUZUKI KAZUHIRO / YAMAMOTO TAKUMI / AKIMOTO TETSUO / YAMANAKA HIDETOSHI, 2002年11月, Jpn J Clin Oncol
• 前立腺癌　男性ホルモン依存性と非依存性, 鈴木 和浩 / 山中 英寿, 2002年01月, ホルモンと臨床, 50,No.1(83-87)
• 酢酸クロルマジノン(プロスタール)を用いた症例, 鈴木 和浩 / 黒川 公平 / 山中 英寿, 2002年03月, 排尿障害プラクティス, 10,No.3(245-248)
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population., SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI / MATSUI HIROSHI / OHTAKE NOBUAKI / NAKATA SEIJI / TAKEI TOMOYUKI / KOIKE HIDEKAZU / NAKAZATO HARUKI / OKUGI HIRONOBU / HASUMI MASARU, 2003年05月, Int J Urol
• 進行性前立腺癌におけるFlutamideによる副腎性アンドロゲン抑制効果の臨床的検討, 中里 晴樹 / 鈴木 和浩 / 伊藤 一人 / 深堀 能立 / 黒川 公平 / 山中 英寿, 2001年01月, 日本泌尿器科学会雑誌, 92,No.(6-12）
• Role of androgen on blood flow and capillary structure in rat seminal vesicle, ONO YOSHIHIRO / SUZUKI KAZUHIRO / KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2004年02月, Tohoku J Exp Med
• 慢性腎不全に腎盂腫瘍を合併し、血液透析導入、外科手術を行った血友病Ｂの１例, 曲 友弘 / 羽鳥 基明 / 小野芳啓 / 塩野昭彦 / 清水信明 / 黒川 公平 / 深堀 能立 / 鈴木 和浩 / 山中 英寿, 2003年12月, 日本透析医学会雑誌, 36,No.12(1731-1736)
• CAPD導入5年後に陰嚢浮腫、陰茎浮腫を認めた1例, 上井崇智 / 曲 友弘 / 川口拓也 / 羽鳥 基明 / 鈴木 和浩 / 山中 英寿, 2004年03月, 日本透析医学会雑誌, 37,No.3(249-252)
• 網膜多発血栓を合併し、ヘパリン起因性血小板減少症(HIT)が強く疑われた1例, 曲 友弘 / 羽鳥 基明 / 蓮見　勝 / 田中俊之 / 松井　博 / 森田崇弘 / 小野芳啓 / 鈴木 和浩 / 山中 英寿, 2004年06月, 日本透析医学会雑誌, 37,No.6(1437-1442)
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Shigehito Miyamoto / ITO KAZUTO / KUROKAWA KOHEI / SUZUKI KAZUHIRO / 鈴木慶二 / YAMANAKA HIDETOSHI, 2006年06月, Int J Urol
• 前立腺疾患のトピックス　前立腺癌家族内発生, 鈴木 和浩 / 大竹伸明 / 中田誠司 / 山中 英寿, 2003年04月, 臨床泌尿器科, 57,No.4(310-315)
• 前立腺癌の早期診断と治療をめぐって, 荒井陽一 / 鈴木 和浩 / 頴川　晋, 2004年, カレントテラピー, 22,No.9(88-94)
• 前立腺癌の症状、治療の基礎知識, 鈴木 和浩 / 村椿茂里 / 諸田了子, 2004年10月, ウロ・ナーシング, 9,No.10(908-915)
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2004年02月, J Urol
• PSAスクリーニング導入後10年間の検診発見前立腺癌症例の臨床病理学的特徴の変化, 山本 巧 / 伊藤 一人 / 武智 浩之 / 河野真意 / 坂西理恵 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2005年, 泌尿器外科, 18(8):1000-1002
• 前立腺がん検診暴露率と発見がん症例の臨床的特徴の関係, 武智 浩之 / 伊藤 一人 / 山本 巧 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2005年, 泌尿器外科, 18(8): 997-999
• 新しい前立腺がん診断法と将来の方向性について, 伊藤 一人 / 山本 巧 / 鈴木 和浩 / 山中 英寿, 2004年, 日本がん検診・診断学会誌, 11: 50-53
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / ARAI SEIJI, 2005年08月, Urology
• 前立腺特異抗原(PSA)による前立腺がん検診と精度管理, 山本 巧 / 伊藤 一人 / 武智 浩之 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2004年, 日本がん検診・診断学会誌, 11(2): 37-39
• 前立腺癌における新しい画像診断：MR-Spectroscopy(MRS), 鈴木 和浩, 2004年, 日本がん検診・診断学会誌, 11,No.2(62-64)
• 前立腺生検法, 鈴木 和浩 / 伊藤 一人, 2005年, 日本臨床, 63,No.2(253-259)
• 家族性・遺伝性前立腺がん, 鈴木 和浩 / 大竹伸明 / 松井　博 / 中田誠司, 2004年09月, 泌尿器外科, 17,No.9(971-976)
• Fatal leukemia in interleukin-15 transgenic mice., Fehniger T.A. / SUZUKI KAZUHIRO / VanDeusen J.B. / Cooper M.A. / Freud A.G. / Caligiuri M.A., 2001年, Blood Cells, Molecules, and Disease
• BODY MASS INDEX（BMI）の前立腺がん罹患および血清PSA値に与える影響, 山本 巧 / 伊藤 一人 / 武智 浩之 / 鈴木 和浩, 2006年03月, 腎泌予防医誌, 14(1): 43-45
• 前立腺がん集団検診における年齢階層別発見がんの臨床病理学的検討―受診年齢上限の設定について―, 山本 巧 / 伊藤 一人 / 武智 浩之 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2003年01月, 日本がん検診・診断学会誌, 10(2):118-122
• 年齢階層別PSAを基準とした前立腺がん検診の展開―前立腺がん集団検診における導入の意義―, 山本 巧 / 黒川 公平 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, 2003年01月, 日本がん検診・診断学会誌, 10(2):87-90
• 前立腺がん集団検診における年齢階層別ＰＳＡ基準値の有用性―69歳以下のＰＳＡ基準値引き下げによる効果―, 武智 浩之 / 山本 巧 / 伊藤 一人 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2003年01月, 日本がん検診・診断学会誌, 10(2)：126-129
• 群馬県における前立腺癌の罹患率、臨床病期、組織学的分化度の推移, 中田誠司 / 大竹伸明 / 久保田裕 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿, 2004年, 泌尿紀要, 50:165-170
• A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States, Oyama T / Allsbrook WC / Kurokawa K / Matsuda H / SEGAWA ATSUKI / SANO TAKAAKI / SUZUKI KAZUHIRO / Epstein LI, 2005年08月, Arch Pathol Lab Med
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, SHIBATA YASUHIRO / KASHIWAGI BUNZOU / ONO YOSHIHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / HONMA SEIJIRO / YAMANAKA HIDETOSHI, 2004年02月, Urological Research
• 膀胱重量算出ノモグラムを使用した下部尿路閉塞の評価, 曲 友弘 / 深堀 能立 / 鈴木 和浩 / 山中 英寿 / 小倉治之, 2004年01月, 泌尿器科紀要, 50,No.1(7-14)
• 前立腺癌検診の効用, 鈴木 和浩 / 山中 英寿, 2004年, 綜合臨牀, 53,No.10(2741-2742)
• ガイドラインに基づく腎尿路疾患診療　前立腺癌, 鈴木 和浩 / 羽鳥 基明, 2004年, 腎と透析, 56,No.5(758-762）
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., SHIBATA YASUHIRO / FUKABORI YOSHITATSU / SUZUKI KAZUHIRO / 本間誠次郎, 2004年, Endocrinology
• 生下時より認めていたと思われる小児精巣腫瘍の１例, 上井崇智 / 加藤雄一 / 三木正也 / 鈴木 和浩 / 山中 英寿, 2002年11月, 泌尿器外科, 15,No.11(1237-1240)
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer., KOIKE HIDEKAZU / ITO KAZUTO / OYAMA TETSUNARI / YAMANAKA HIDETOSHI / SUZUKI KAZUHIRO, 2005年04月, Br J Cancer.
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity., AKIMOTO TETSUO / ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / NAKANO TAKASHI, 2005年10月, Int J Radiat Oncol Biol Phys.
• 本邦における家族性前立腺癌の最新知見, 大竹伸明 / 中田誠司 / 深堀 能立 / 鈴木 和浩 / 山中 英寿, 2002年, 日本臨牀, 60,No.11(469-473)
• 古作クリニックにおけるブラッドアクセスの現状と初回内シャントと2回目内シャントの比較検討, 小野芳啓 / 羽鳥 基明 / 伊藤 一人 / 鈴木 和浩 / 山中 英寿 / 古作　望 / 松本和久 / 林　雅道 / 内田達也 / 竹澤　豊 / 小林 幹男 / 中里 晴樹 / 山本 巧, 2002年10月, 臨牀透析, 18,No.10(1377-1381)
• 原発性陰嚢内硬化性脂肪肉芽腫―手術的摘除例と自然消退例, 小野芳啓 / 古作　望 / 矢嶋久徳 / 高橋　修 / 深堀 能立 / 鈴木 和浩 / 山中 英寿 / 真下正道 / 関原哲夫 / 猿木和久 / 松本和久 / 林　雅道, 2002年07月, Kitakanto Med J, 52,No.4(271-277)
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous andorgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / ONO YOSHIHIRO / SUZUKI RYOTA / HONMA SEIJIRO / SUZUKI KAZUHIRO, 2005年10月, Journal of Andrology
• Effect of androgen concentration on seminal vesicle blood flow in rat-establishment of new highly sensitive simultaneous androgen measurement method, KASHIWAGI BUNZOU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / HONMA SEIJIRO / ONO YOSHIHIRO / YAMANAKA HIDETOSHI, 2005年06月, Urology
• 未治療進行性前立腺癌における初回LH-RH agonist投与時のflare-up予防：Diethylstilbestrol-Diphosphate, Estramustine Phosphate, Chlormadinone Acetateによる比較検討, 松井　博 / 鈴木 和浩 / 中里 晴樹 / 黒川 公平 / 柴田 康博 / 蓮見　勝 / 伊藤 一人 / 深堀 能立 / 山中 英寿, 2001年10月, 癌の臨床, 47,No.10(861-866）
• 多数箇所生検で発見された前立腺癌の前立腺領域別分布, 武智 浩之 / 伊藤 一人 / 山本 巧 / 黒川 公平 / 鈴木 和浩, 2005年, 日本がん検診・診断学会誌, 12: 148-150
• 私の行っている縫合と吻合の手技―膀胱･尿道吻合, 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2002年12月, 臨床泌尿器科, 56,No.13(1119-1123)
• 集合管癌(Bellini管癌)の一例, 小池 秀和 / 武井智幸 / 大竹伸明 / 真下正道 / 鈴木 和浩 / 山中 英寿, 2002年07月, Kitakannto Med J, 52,No.4(267-270)
• 後腹膜原発性腺外胚細胞腫瘍の一例, 河野真意 / 鈴木光一 / 鈴木 孝憲 / 富田　光 / 岡本亘平 / 松井　博 / 山本 巧 / 中里 晴樹 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2002年05月, Kitakanto Med J, 52,No.3(203-206)
• 膀胱平滑筋肉腫の一例, 河野真意 / 松井　博 / 山本 巧 / 小野芳啓 / 深堀 能立 / 黒川 公平 / 鈴木 和浩 / 山中 英寿 / 鈴木慶二, 2002年07月, Kitakanto Med J, 52,No.4(279-282)
• 日本における前立腺がん検診と予後, 鈴木 和浩, 2003年, 日本がん検診・診断学会誌, 10,No.2(192-194)
• 男性維持透析患者における前立腺癌のスクリーニング, 羽鳥 基明 / 鈴木 和浩 / 柴田 康博 / 伊藤 一人 / 黒川 公平, 2004年, 泌尿器科外科, 17, No.12 (1251-1254)
• 膀胱癌と前立腺癌, 羽鳥 基明 / 鈴木 和浩 / 山中英壽, 2004年, 日本臨床, 62, 増刊号6 (374-377)
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, KUROKAWA KOHEI / suzuki takanori / SUZUKI KAZUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2001年05月, Int J Urol
• 群馬大学医学部附属病院における維持透析患者の手術症例の検討, 羽鳥 基明 / 黒川 公平 / 深堀 能立 / 山中 英寿 / 林　雅道 / 塩野昭彦 / 蓮見　勝 / 武井智幸 / 松井　博 / 川口拓也 / 伊藤 一人 / 鈴木 和浩, 2002年11月, 日本透析医学会雑誌, 35,No.11(1447-1451)
• PSA4.1～10ng/mlにおける前立腺生検法の検討　年齢/前立腺体積を考慮に入れた前立腺生検法の有用性, 伊藤 一人 / 山本 巧 / 大井　勝 / 深堀 能立 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2002年08月, 泌尿器外科, 15No.8(934-937)
• NK cell-mediated anti-tumor immune response to human prostate Cancer cell, PC-3 : immunogene therapy using a highly secretable form of interleukin-15 gene transfer., SUZUKI KAZUHIRO / NAKAZATO HARUKI / MATSUI HIROSHI / HASUMI MASARU / SHIBATA YASUHIRO / ITO KAZUTO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2001年04月, Journal of Leucocyte Biology
• Fatal leukemia in inter leukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD 8 T cells, Fehniger, T.A. / Caligiuri M.A. / SUZUKI KAZUHIRO / Ponnappan A. / VanDeusen J.B. / Cooper M.A. / Florea S.M. / Freud A.G. / Robinson M.L. / Durbin J, 2001年, J Exp Med
• 前立腺集団検診における年齢階層別PSA基準値の有用性, 山本 巧 / 伊藤 一人 / 大井　勝 / 久保田裕 / 黒川 公平 / 鈴木 和浩 / 山中 英寿, 2002年, 日本腎泌尿器疾患予防医学研究会誌, 10,No.1(18-19)
• 嫌色素性腎癌の１例, 柏木 文蔵 / 栗田　晋 / 中村敏之 / 加藤宣雄 / 鈴木 和浩 / 山中 英寿, 2002年02月, 泌尿器科紀要, 48,No.2(85-87)
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Hironobu Okugi, Haruki Nakazato, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, 2006年, Cancer Detection and Prevention
• 尿路腫瘍(膀胱、腎盂・尿管癌)外来におけるPSAスクリーニング, 黒川 公平 / 松井　博 / 深堀 能立 / 山中 英寿 / 鈴木 和浩 / 岡崎　浩 / 伊藤 一人 / 塩野昭彦 / 羽鳥 基明 / 蓮見　勝 / 井上雅晴 / 川口拓也, 2002年03月, 日本腎泌尿器疾患予防医学研究会誌, 10,No.1(29-30)
• 透析患者の腎尿路系腫瘍　３前立腺癌, 鈴木和浩、羽鳥基明, 2006年, 透析フロンティア, 16, 3, 13-15
• A case of emphyematous pyelonephritis in a renal allograft, Seiji Arai, Takeaki Makino, Masaru Hasumi, Yasuhiro Shibata, Motoaki Hatori, Kazuhiro Suzuki, 2006年, Transplantation
• 前立腺肥大症治療におけるChlormadinone acetate投与によるPSA測定値への影響（他施設共同研究）, 藤本清秀、舛森直哉、塚本泰司、徳山聡、荒井陽一、谷川俊貴、高橋公太、鈴木和浩、山中英壽、宮永直人、赤座英之、加藤聡彦、石井延久、宮澤克人、鈴木孝治、小野佳成、大島伸一、平尾佳彦、CMA-PSA研究会, 2005年, 日本腎泌尿器疾患予防医学研究会誌, 13, 1, 89-91
• 前立腺癌診療ガイドラインからみた前立腺癌検診, 鈴木和浩, 2006年, 総合臨床, 55, 11, 2705
• 前立腺癌, 鈴木和浩、羽鳥基明, 2006年, 腎と透析 　臨時増刊号, 464-468
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues., Hironobu Okugi, Hidekazu Koike, Yoshitaka Sekine, Hiroshi Matsui, Kauzhiro Suzuki, 2006年, Asia-Pacific Journal of Clinical Oncology
• 前立腺癌の治療Q&A, 鈴木和浩, 2005年, 泌尿器ケア　冬季増刊, 140-153
• 内分泌外科からみた前立腺癌の臨床：前立腺癌の治療法と適応, 鈴木和浩, 2005年, 内分泌外科, 22, 4, 206-216
• 腫瘍マーカー/泌尿器系　PSA(γ-Sm), 鈴木和浩, 2005年, Medicina, 42, 12, 539-541
• 前立腺の病気になりやすい人はいるか, 鈴木和浩、松井博、大竹伸明, 2005年, からだの科学, 243
• 腎細胞癌の多発性肺転移症例に対する骨髄非破壊的同種末梢血幹細胞移植, 土岐典子、松島孝文、斉藤泰之、横浜章彦、塚本憲史、唐沢正光、村上博和、鈴木和浩、野島美久 , 2006年, kitakanto medical journal, 56, 3, 231-235
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate-specific antigen levels of 4.0ng/ml or less, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2001年02月, Cancer
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents Chlormadinone acetate and Finasteride, SHIBATA YASUHIRO / FUKABORI YOSHITATSU / ITO KAZUTO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2001年01月, J Urol
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / NAKAZATO HARUKI / HASUMI MASARU / MATSUI HIROSHI / ITO KAZUTO / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2001年06月, Int J Androl
• Positive effect of prostaglandin on regulation of prostatic blood flow., Kashiwagi B, Shibata Y, Ohki K, Arai S, Honma S, Suzuki K., 2006年, Urology
• 機能的解剖を応用した術中勃起神経温存評価の短期結果, 黒川 公平 / 小山大輔 / 山中 英寿 / 鈴木 孝憲 / 鈴木 和浩 / 伊藤 一人 / 小野芳啓 / 深堀 能立 / 武井智幸 / 寺田直樹 / 荒井陽一, 2002年08月, 泌尿器外科, 15,No.8(928-930)
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Shibata Y, Kashiwagi B, Arai S, Magari T, Suzuki K, Honma S., 2006年, Urology
• Cyclin D1 gene polymorphism and familial prostate cancer : The AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage., KOIKE HIDEKAZU / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI / TAKEI TOMOYUKI / NAKATA SEIJI / SATHO T / OHTAKE NOBUAKI, 2003年11月, Anticancer Research
• Lead time of prostate cancer detected in population-based screening for prostate cancer in Japan., Ito K, Yamamoto T, Miyakubo M, Takechi H, Ohi M, Shibata Y, Suzuki K., 2007年10月, J Urol , 178, 1258-1264
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Sekine Y, Ito K, Yamamoto T, Nakazato H, Shibata Y, Hatori M, Suzuki K., 2007年
• Editorial Comment, Kazuhiro Suzuki, 2008年02月, Int J Urol
• Editorial Comment, Kazuhiro Suzuki, 2008年02月, Int J Urol, 15
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. , Sekine Y, Koike H, Nakano T, Nakajima K, Suzuki K, 2007年08月, Clin Chim Acta
• 男性型脱毛症薬プロペシア錠（フィナステリド）の前立腺がん検診における内服症例と年齢をマッチさせた非内服症例の血清PSA値の比較, 宮久保真意、伊藤一人、山本巧、武智浩之、大井勝、鈴木和浩, 2008年01月, 日本がん検診・診断学会雑誌, 15, 2, 125-127
• 泌尿器悪性腫瘍　最近の診断と治療　増加する前立腺癌　家族性・遺伝性前立腺がん, 鈴木和浩, 2000年03月, 臨床と研究, ８４, ３, ３０９－３１４
• EBMに基づいた前立腺癌診療ガイドライン２００６年度版　要約, 守殿貞夫、大島伸一、平尾佳彦、鈴木和浩、荒井陽一、藤元博行、江川晋、赤座英之、原勲、筧善行、樋之津史朗、長谷川友紀、, 2007年03月, 日本泌尿器科学会雑誌, ９８, １－３１
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation , Kawaguchi T, Moriyama T, Suzuki K, Hatori M, Tanaka T, Takahara S, Yamanaka H., 2004年06月, Transplantation Proc
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility ot familial prostate cancer in a Japanese population, Tatsuya Hamano, Hiroshi Matsui, Nobuaki Ohtake, Seiji Nakata, Kazuhiro Suzuki, 2008年02月, Asia-Pacific Journal of Clinical Oncology
• 前立腺癌治療後のPSA再発をいかにとらえるか 放射線療法後のPSA再発に対する治療戦略　When and How+, 鈴木和浩, 2008年04月, Urological View, 6, 2, 74-80
• 前立腺癌予見因子としての血清インスリン様成長因子の意義, 山本巧、伊藤一人、武智浩之、大井勝、宮久保真意、鈴木和浩, 2007年03月, 日本がん検診・診断学会雑誌, 15, 1, 93-95
• 前立腺癌予防の可能性：脂質, 関根芳岳、小池秀和、鈴木和浩, 2007年12月, 泌尿器外科, 20, 12, 1525-1529
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　検診 前立腺癌検診における年齢階層別PSA基準値導入の意義, 大井勝、伊藤一人、山本巧、武智浩之、鈴木和浩, 2007年12月, 日本臨床, 65, 10, 203-206
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　検診　我が国における前立腺癌検診の現状と展望, 鈴木和浩, 2007年12月, 日本臨床, 65, 10, 187-293
• 前立腺癌　基礎・臨床研究のアップデート　臨床研究　疫学　我が国における家族性前立腺癌の特徴, 大竹伸明、中田誠司、鈴木和浩、深堀能立、山中英壽, 2007年12月, 日本臨床, ６５, １０, 182-186
• 排尿障害の診断と治療, 鈴木和浩, 2007年07月, 高崎医学, 57, 25-27
• 泌尿器科　疼痛対策　進行癌の疼痛対策　前立腺癌, 鈴木和浩、小池秀和, 2007年10月, Urology view, ５, ５, ７７－８２
• JUA前立腺癌診療ガイドライン　初版の読みどころと改定に向けての課題　疫学, 鈴木和浩, 2007年06月, 泌尿器外科, 20, 6, 737-741
• Effects of Aromatase Inhibitor, TZA-2209, on the Prostate of Androstenedione-treated Castrated Dogs : Changes in Prostate Volume and Histopathological Findings, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, 1996年05月, Prostate
• Endocrine Environment of Benign Prostatic Hyperplasia : Prostate Size and Volume are Correlated with Serum Estrogen Concentration, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, 1995年03月, Scand J Urol Nephrol
• Effects of New Steroidal Antiandrogen, TZP-4238(172-acetoxy-6-chloro-2-oxa-4, 6-pregnadine-3, 20-dione), on Spontaneously Developed Canine Benign Prostatic Hyperplasia, TAKEZAWA YUTAKA / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 1995年, Prostate
• 群馬県における前立腺集団検診形態の変遷-18年間の総括および現況・問題点-, 伊藤 一人 ／ 山本 巧 ／ 鈴木 和浩 ／ 山中 英寿, 2000年, 泌尿器外科, 13/8,997-1001
• Effects of new steroidal aromatase inhibitor, TZA-2237, and/or Chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, ITO KAZUTO / FUKABORI YOSHITATSU / SHIBATA YASUHIRO / SUZUKI KAZUHIRO / YAMANAKA HIDETOSHI, 2000年10月, Eur J Endocrinol
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, ITO KAZUTO / YAMAMOTO TAKUMI / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2000年08月, Urology
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathological features : Evaluation of mass screening populations, ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / KUROKAWA KOHEI / YAMANAKA HIDETOSHI, 2000年05月, Urology
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / YAMANAKA HIDETOSHI, 1998年, Int Urol Nephrol
• IL-15 costimulates the generalized shuartzman reaction and innate immune IFN-γ production in vivo, SUZUKI KAZUHIRO, 2000年, J Immunol
• Differential cytokine and chemokino gene expression by human NK cells following activation with IL-18 or IL-15 combination with IL-12 : Imprication for the innata immune response, SUZUKI KAZUHIRO, 1999年, J. Immunol
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontareously developed canine prostate hypertrophy, SUZUKI KAZUHIRO, 1998年, Prostate
• Estimation of canine prostatic volume : Nomesram based on prostatic cubic volume, SUZUKI KAZUHIRO, 1998年, 1st Urol Nephrol
• Expression and degredation of rat androgen reoptor following castration testosterone replacement and antiandrogens administration analysis by western blot and immnnohistochemishy, SUZUKI KAZUHIRO, 1997年, Tohoku J Ey Med
• Effect of aromotase inhibitor, TZA-2209, on the prostate of androsternedione-treated castrated dogs : chayes in prostate volume and histopathological findings, SUZUKI KAZUHIRO, 1996年, Prostate
• Synergistic Effects of Estrogen and Androgen on the Prostate : Effects of Estrogen on Androgen-and Estrogen-receptors, Brd V Uptake, Immunohistochemical Study of AR, and Responses to Antiandrogens, SUZUKI KAZUHIRO / ITO KAZUTO / suzuki takanori / YAMANAKA HIDETOSHI, 1995年03月, Prostate
• Expression and Degradation of Rat Androgen Receptor Following Castration, testosterone Replacement and Antiandrogens Administration : Analysis by Western Blot and Immunohistochemistry, SUZUKI KAZUHIRO / ITO KAZUTO / KUROKAWA KOHEI / suzuki takanori / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 1997年11月, Tohoku J Exp Med
• Changes in the endocrine environment of the human prostate transition zone with aging : Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, SHIBATA YASUHIRO / ITO KAZUTO / SUZUKI KAZUHIRO / FUKABORI YOSHITATSU / YAMANAKA HIDETOSHI, 2000年01月, Prostate
• 照射後の膀胱全摘・尿路変更に伴う腸管トラブル, 鈴木和浩, 2010年05月, 泌尿器外科, ２３, ５, ７１９
• 前立腺がんと前立腺肥大症の疫学, 鈴木和浩, 2009年05月, 日本医師会雑誌, 138, 2, 251
• 前立腺がん検診の有効性　死亡率減少効果について, 鈴木和浩, 2008年12月, 泌尿器外科, ２１, １２, １５８５
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009年12月, JMAJ
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals., Nakajima K, Kodaira T, Kato M, Nakazato K, Tokita Y, Kikuchi H, Sekine H, Suzuki K, Nagamine T., 2010年05月, Clin Chim Acta
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Abdulah R, Faried A, Kobayashi K, Yamazaki C, Suradji EW, Ito K, Suzuki K, Murakami M, Kuwano H, Koyama H., 2009年11月, BMC Cancer
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Arai S, Miyashiro Y, Shibata Y, Kashiwagi B, Tomaru Y, Kobayashi M, Watanabe Y, Honma S, Suzuki K., 2010年01月, Steroids
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K, Koike H, Sekine Y, Matsui H, Suzuki K., 2009年08月, Cancer Epidemiolo
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S, Suzuki K., 2009年07月, Cancer Epidemiol
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha1-adrenergic receptor antagonist work well for ureteral stones?, Ohki K, Ohno Y, Suzuki K., 2010年01月, Int Urol Nephrol
• Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K., 2009年06月, Int J Urol
• Induction of type 1 interferon receptor by zinc in U937 cells., Nagamine T, Nakajima K, Takada H, Sekine Y, Suzuki K., 2009年06月, Cytokine
• Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia., Nagai Y, Hasegawa M, Shinmi K, Kishi C, Tsushima Y, Endo K, Okabe K, Suzuki K, Ishikawa O., 2008年06月, Acta Derm Venereol
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K., 2008年07月, Biochem Biophys Res Commun.
• Changes in baseline PSA levels in Japanese men from 1988 to 2003., Ohi M, Ito K, Yamamoto T, Miyakubo M, Takechi H, Kubota Y, Suzuki K., 2008年07月, Urology
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Yamamoto T, Ito K, Miyakubo M, Takechi H, Suzuki K, Akimoto T, Ishikawa H, Nakano T., 2008年10月, Urology
• Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Hamano T, Matsui H, Sekine Y, Ohtake N, Nakata S, Suzuki K., 2010年08月, Journal of Urology
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K., 2008年12月, Urology
• 前立腺と組織内アンドロゲン　ー前立腺癌の診断・治療における応用の可能性, 鈴木和浩、柏木文蔵、新井誠二、柴田康博、本間誠次郎 , 2009年02月, 産科と婦人科, ８１, ２, ２００
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Koike H, Nakazato H, Ohtake N, Matsui H, Okugi H, Shibata Y, Nakata S, Yamanaka H, Suzuki K., 2008年04月, Int Urol Nephrol
• Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Takechi H, Ito K, Yamamoto T, Miyakubo M, Ohi M, Suzuki K., 2008年11月, Urology
• 前立腺癌検診の意義, 鈴木和浩, 2009年11月, 総合臨床, 58, 11, 2351-352
• 進行癌に対する内分泌療法, 鈴木和浩, 2009年04月, Urology View, 7, 2, 10-16
• 前立腺疾患：疫学の動向、治療のトレンド、手術のポイント, 鈴木和浩, 2009年11月, Life Support ad Anesthesia, 16, 11, 1064
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., 2012年, World J Urol
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate., 2012年, Int J Radiat Oncol Biol Phys
• Serous borderline tumor of the paratestis in a child., 2012年, BJUI.org
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme., 2012年, Prostate Cancer and Prostatic Disease
• Luteinizing horomone (LH)-releasing hormone agonist reduces serum adrenal androgen levels in prostate cancer patients: Implications for the effect of LH on the adrenal glands., 2012年, J Androl
• Lower urinary tract symptoms of neurological origin in urological practice., 2012年, Clin Auton Res
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., 2012年
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., 2012年, Biochem Biophys Res Commun
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy., 2012年, Prostate Cancer and Prostatic Disease
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 2011年, Steroids
• 腎・泌尿器疾患のインフォームドコンセントと治療選択：前立腺疾患, 2010年, 腎と透析
• ＣＲＰＣの定義と発症メカニズム, 2011年, 泌尿器外科
• 去勢抵抗性前立腺がんにおける男性ホルモンの意義, 2011年, 最新医学
• 前立腺がんの病態・診断・治療, 2011年, 泌尿器ケア
• 国内外のガイドラインからみた間歇的内分泌療法の位置付けと現状, 2011年, 泌尿器外科
• 我が国における前立腺癌検診の現状と展望, 2011年, 日本臨床
• 尿路上皮癌に対するＧＣ療法施行時におけるパロノセトロンの効果：グラニセトロンとの比較検討, 2011年, 癌の臨床
• 泌尿器科領域におけるがん検診と超音波の役割, 2011年, 泌尿器科領域におけるがん検診と超音波の役割
• 透析療法における様々な疑問に答える ー４透析患者の腎尿路悪性腫瘍-前立腺癌, 2011年, 透析フロンティア
• 腎・泌尿器疾患：ＡＬＰおよびＰＳＡの異常高値をきたした64歳の男性ー進行性前立腺癌, 2012年, 検査と技術
• 進行性・去勢抵抗性前立腺癌に対するホルモン療法の現状と今後の展望ー前立腺癌のアンドロゲン依存性に関するパラダイムシフトー, 2012年, 泌尿器外科
• 去勢抵抗性前立腺癌に対するドセタキセルの役割：効果判定とその後の治療選択, 2012年, 泌尿器外科
• シロドシンによる排尿障害の治療：Urief Dose-up Study, 2012年, 泌尿器外科
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness on human prostate cancer, 2012年, Prostate Cancer and Prostatic Disease
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 2011年, J Urol
• HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion., 2011年, The Prostate
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., 2011年, The Prostate
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010., 2010年, Int J Urol
• The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, 2010年, Int Urol Nephrol
• 泌尿器科領域ＰＳＡスクリーニング検査がもたらすもの, 2010年, Annual Review腎臓
• "泌尿器科領域におけるトラブルシューティング(第9回) 照射後の膀胱全摘・尿路変更に伴う腸管トラブル", 2010年, 泌尿器外科
• 前立腺肥大の術式, 2010年, 日本医事新報
• 臓器部位別の治療戦略　前立腺がん, 2010年, がん治療レクチャー
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Miyazawa Y, Kato H, Arai S, Furuya Y, Sekine Y, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K, 2015年, Basic and Clinical Andrology

  DOI
• Suicide attempt with an overdose of sunitinib, Arai, Seiji; Matsui, Hiroshi; Ohki, Ryo; Miyazawa, Yoshiyuki; Koike, Hidekazu; Hashita, Tadahiro; Katsuyama, Yoshihiko; Sekine, Yoshitaka; Nomura, Masashi; Shibata, Yasuhiro; Hatori, Motoaki; Ito, Kazuto; Yamamoto, Koujirou; Ohmori, Shigeru; Suzuki, Kazuhiro, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International

  DOI
• Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, Arai, S.; Shibata, Y.; Nakamura, Y.; Kashiwagi, B.; Uei, T.; Tomaru, Y.; Miyashiro, Y.; Honma, S.; Hashimoto, K.; Sekine, Y.; Ito, K.; Sasano, H.; Suzuki, K., 2013年, ANDROLOGY

  DOI
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, BMC UROLOGY

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL, Fujizuka, Yuji; Ito, Kazuto; Oki, Ryo; Suzuki, Rie; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2017年, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, ANTICANCER RESEARCH

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Kato, Haruo; Furuya, Yosuke; Koike, Hidekazu; Suzuki, Kazuhiro, 2017年, PROSTATE

  DOI
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Shibata, Yasuhiro; Kurihara, Sota; Arai, Seiji; Kato, Haruo; Suzuki, Tomomi; Miyazawa, Yoshiyuki; Koike, Hidekazu; Ito, Kazuto; Nakamura, Tetsuya; Suzuki, Kazuhiro, 2017年, JOURNAL OF INVESTIGATIVE SURGERY

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Nitta, Takashi; Koike, Hidekazu; Miyao, Takeshi; Miyazawa, Yoshiyuki; Kato, Haruo; Furuya, Yosuke; Sekine, Yoshitaka; Suzuki, Kazuhiro, 2017年, ANTICANCER RESEARCH

  DOI
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer, Kato, Haruo; Furuya, Yosuke; Miyazawa, Yoshiyuki; Miyao, Takeshi; Syuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2016年11月, ANTICANCER RESEARCH

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naive prostate cancer, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Taguri, Masataka; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, 2016年, PROSTATE

  DOI
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan, Suzuki, Kazuhiro; Namiki, Mikio; Fujimoto, Tsukasa; Takabayashi, Nobuyoshi; Kudou, Kentarou; Akaza, Hideyuki, 2015年12月, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Ishikawa, Hitoshi; Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Ito, Kazuto; Matsui, Hiroshi; Hirato, Junko; Shimizu, Nobuaki; Takezawa, Yutaka; Tsuji, Hiroshi; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi, 2015年10月, ANTICANCER RESEARCH
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Nozawa, Masahiro; Mukai, Hirofumi; Takahashi, Shunji; Uemura, Hiroji; Kosaka, Takeo; Onozawa, Yusuke; Miyazaki, Jun; Suzuki, Kazuhiro; Okihara, Koji; Arai, Yoichi; Kamba, Tomomi; Kato, Masashi; Nakai, Yasutomo; Furuse, Hiroshi; Kume, Haruki; Ide, Hisamitsu; Kitamura, Hiroshi; Yokomizo, Akira; Kimura, Takahiro; Tomita, Yoshihiko; Ohno, Keiji; Kakehi, Yoshiyuki, 2015年10月, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Kanayama, Hiro-omi; Fukumori, Tomoharu; Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Miki, Tsuneharu; Kamoi, Kazumi; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Naito, Seiji, 2015年, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor, Kato, Haruo; Sekine, Yoshitaka; Furuya, Yosuke; Miyazawa, Yoshiyuki; Koike, Hidekazu; Suzuki, Kazuhiro, 2015年, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial, Saad, Fred; Fizazi, Karim; Jinga, Viorel; Efstathiou, Eleni; Fong, Peter C.; Hart, Lowell L.; Jones, Robert; McDermott, Raymond; Wirth, Manfred; Suzuki, Kazuhiro; MacLean, David B.; Wang, Ling; Akaza, Hideyuki; Nelson, Joel; Scher, Howard I.; Dreicer, Robert; Webb, Iain J.; de Wit, Ronald, 2015年, LANCET ONCOLOGY

  DOI
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Shibata, Yasuhiro; Arai, Seiji; Miyazawa, Yoshiyuki; Shuto, Takahiro; Nomura, Masashi; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Ito, Kazuto; Suzuki, Kazuhiro, 2017年, PROSTATE

  DOI
• High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL, Miyoshi, Y.; Uemura, H.; Suzuki, K.; Shibata, Y.; Honma, S.; Harada, M.; Kubota, Y., 2017年, ANDROLOGY

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer, Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki, 2015年, CANCER CHEMOTHERAPY AND PHARMACOLOGY

  DOI
• Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Onozawa, Mizuki; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Suzuki, Kazuhiro; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Akaza, Hideyuki, 2014年10月, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer, Matsuyama, Hideyasu; Shimabukuro, Tomoyuki; Hara, Isao; Kohjimoto, Yasuo; Suzuki, Kazuhiro; Koike, Hidekazu; Uemura, Hirotsugu; Hayashi, Taiji; Ueno, Munehisa; Kodaira, Kiichiro; Tomita, Yoshihiko; Sakurai, Toshihiko; Shimizu, Nobuaki, 2014年10月, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Koike, Hidekazu; Nitta, Takashi; Sekine, Yoshitaka; Arai, Seiji; Furuya, Yosuke; Nomura, Masashi; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Oyama, Tetsunari; Suzuki, Kazuhiro, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, Miyoshi, Yasuhide; Uemura, Hiroji; Umemoto, Susumu; Sakamaki, Kentaro; Morita, Satoshi; Suzuki, Kazuhiro; Shibata, Yasuhiro; Masumori, Naoya; Ichikawa, Tomohiko; Mizokami, Atsushi; Sugimura, Yoshiki; Nonomura, Norio; Sakai, Hideki; Honma, Seijiro; Harada, Masaoki; Kubota, Yoshinobu, 2014年, BMC CANCER

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Ishizuka, Tamotsu; Hisada, Takeshi; Hatori, Motoaki; Koike, Akio; Hanabuchi, Kikuo; Matsuzaki, Shinichi; Kamide, Yosuke; Utsugi, Mitsuyoshi; Aoki, Haruka; Yoshino, Reiko; Yanagitani, Noriko; Koga, Yasuhiko; Ono, Akihiro; Kaira, Kyoichi; Sunaga, Noriaki; Dobashi, Kunio; Tsuburai, Takahiro; Akiyama, Kazuo; Yamada, Masanobu; Suzuki, Kazuhiro; Mori, Masatomo, 2014年, INFLAMMATION RESEARCH

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Miki, Tsuneharu; Kamoi, Kazumi; Fujimoto, Hiroyuki; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Mikami, Kazuya; Homma, Yukio, 2014年, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Inamoto, Teruo; Azuma, Haruhito; Hinotsu, Shiro; Tsukamoto, Taiji; Oya, Mototsugu; Ogawa, Osamu; Kitamura, Tadaichi; Kazuhiro, Suzuki; Naito, Seiji; Namiki, Mikio; Nishimura, Kazuo; Hirao, Yoshihiko; Usami, Michiyuki; Murai, Masaru; Akaza, Hideyuki, 2014年, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Seiji; Kashiwagi, Bunzo; Suzuki, Keiji; Suzuki, Kazuhiro, 2014年, ASIAN JOURNAL OF ANDROLOGY

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Fujimoto, Hiroyuki; Nakanishi, Hiroyuki; Miki, Tsuneharu; Kanayama, Hiro-omi; Ohyama, Chikara; Suzuki, Kazuhiro; Nishiyama, Hiroyuki; Eto, Masatoshi; Naito, Seiji; Fukumori, Tomoharu; Kubota, Yoshinobu; Takahashi, Satoru; Homma, Yukio; Kamoi, Kazumi, 2014年, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Mukai, Hirofumi; Takahashi, Shunji; Nozawa, Masahiro; Onozawa, Yusuke; Miyazaki, Jun; Ohno, Keiji; Suzuki, Kazuhiro, 2014年, CANCER CHEMOTHERAPY AND PHARMACOLOGY

  DOI
• Chronic expanding hematoma in the retroperitoneal space: a case report, Syuto, Takahiro; Hatori, Motoaki; Masashi, Nomura; Sekine, Yoshitaka; Suzuki, Kazuhiro, 2013年11月, BMC UROLOGY

  DOI
• High-Density Lipoprotein and Prostate Cancer: An Overview, Kotani, Kazuhiko; Sekine, Yoshitaka; Ishikawa, Shizukiyo; Ikpot, Imoh Z.; Suzuki, Kazuhiro; Remaley, Alan T., 2013年, JOURNAL OF EPIDEMIOLOGY

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Shibata, Y.; Suzuki, K.; Arai, S.; Miyoshi, Y.; Umemoto, S.; Masumori, N.; Kamiya, N.; Ichikawa, T.; Kitagawa, Y.; Mizokami, A.; Sugimura, Y.; Nonomura, N.; Sakai, H.; Honma, S.; Kubota, Y., 2013年, ANDROLOGY

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Ito, Kazuto; Miyakubo, Mai; Sekine, Yoshitaka; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Suzuki, Kazuhiro, 2013年, WORLD JOURNAL OF UROLOGY

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Magari, Tomohiro; Fukabori, Yoshitatsu; Ogura, Haruyuki; Suzuki, Kazuhiro, 2013年, CLINICAL AUTONOMIC RESEARCH

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Magari, Tomohiro; Shibata, Yasuhiro; Arai, Sew; Kashiwagi, Bunzo; Suzuki, Kazuhiro, 2013年, SCANDINAVIAN JOURNAL OF UROLOGY

  DOI
• Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial., Hiroji Uemura; Hisashi Matsushima; Kazuki Kobayashi; Hiroya Mizusawa; Hiroaki Nishimatsu; Karim Fizazi; Matthew Smith; Neal Shore; Teuvo Tammela; Ken-Ichi Tabata; Nobuaki Matsubara; Masahiro Iinuma; Hirotsugu Uemura; Mototsugu Oya; Tetsuo Momma; Mutsushi Kawakita; Satoshi Fukasawa; Tadahiro Kobayashi; Iris Kuss; Marie-Aude Le Berre; Amir Snapir; Toni Sarapohja; Kazuhiro Suzuki, 2020年11月23日, International journal of clinical oncology, 研究論文（学術雑誌）

  DOI
• Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug., Yukie Endo; Aina Oka; Akihito Uehara; Sayaka Toki; Sei-Ichiro Motegi; Osamu Ishikawa; Yoshiyuki Miyazawa; Kazuhiro Suzuki, 2020年10月, The Journal of dermatology, 47, 10, e359-e360

  DOI
• Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan., Nobuaki Matsubara; Kazuhiro Suzuki; Hirotaka Kazama; Shoko Tsukube; Takeshi Seto; Hideyasu Matsuyama, 2020年09月, Journal of geriatric oncology, 11, 7, 1067, 1073, 研究論文（学術雑誌）

  DOI
• Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial., Kazuto Ito; Mikio Kobayashi; Motokiyo Komiyama; Seiji Naito; Kazuo Nishimura; Junji Yonese; Katsuyoshi Hashine; Shiro Saito; Gaku Arai; Mitsuru Shinohara; Naoya Masumori; Nobuaki Shimizu; Takefumi Satoh; Atsushi Yamauchi; Tatsuo Tochigi; Yutaka Takezawa; Hiroyuki Fujimoto; Akira Yokomizo; Ken-Ichi Kakimoto; Iwao Fukui; Katsuyuki Karasawa; Taiji Tsukamoto; Miwako Nozaki; Masaru Hasumi; Hiromichi Ishiyama; Mikinobu Ohtani; Masaaki Kuwahara; Masaoki Harada; Yasuo Ohashi; Toshihiko Kotake; Tadao Kakizoe; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2020年09月01日, Cancer, 126, 17, 3961, 3971, 研究論文（学術雑誌）

  DOI
• YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression., Takeshi Miyao; Hidekazu Koike; Yoshitaka Sekine; Akira Ohtsu; Daisuke Oka; Kazuhiro Suzuki, 2020年09月, Anticancer research, 40, 9, 5091, 5095, 研究論文（学術雑誌）

  DOI
• Real-world efficacy and safety of two doses of cabazitaxel (20 or 25 mg/m2) in patients with castration-resistant prostate cancer: results of a Japanese post-marketing surveillance study., Hideyasu Matsuyama; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Kazuhiro Suzuki, 2020年07月13日, BMC cancer, 20, 1, 649, 649, 研究論文（学術雑誌）

  DOI
• Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer., Narisa Dewi Maulany Darwis; Takahiro Oike; Hidemasa Kawamura; Masahiro Kawahara; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroyuki Katoh; Hitoshi Ishikawa; Hiroshi Matsui; Yoshiyuki Miyazawa; Kazuto Ito; Kazuhiro Suzuki; Soehartati Gondhowiardjo; Takashi Nakano; Tatsuya Ohno, 2020年03月04日, Cancers, 12, 3, 研究論文（学術雑誌）

  DOI
• Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”, Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Tatsuji Mizukami; Hiroyuki Katoh; Hitoshi Ishikawa; Tatsuya Ohno; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Takashi Nakano, 2020年01月30日, BMC Cancer, BMC cancer, 20, 1, 75, 75, 研究論文（学術雑誌）

  DOI
• Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml., Kazuto Ito; Akira Yokomizo; Shoji Tokunaga; Gaku Arai; Mikio Sugimoto; Koichiro Akakura; Hisashi Hasumi; Hideki Sakai; Akiko Ouraji; Ryo Oki; Eiji Kashiwagi; Yoshitomo Kobori; Hiromi Hirama; Hiroki Kitoh; Hiroji Uemura; Tomoaki Hakariya; Kazuhiro Suzuki, 2020年01月, The Journal of urology, 203, 1, 83, 91, 研究論文（学術雑誌）

  DOI
• Quality of life in prostate cancer patients receiving particle radiotherapy: A review of the literature., Hidemasa Kawamura; Nobuteru Kubo; Hiro Sato; Yuhei Miyasaka; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tatsuya Ohno, 2020年01月, International journal of urology : official journal of the Japanese Urological Association, 27, 1, 24, 29, 研究論文（学術雑誌）

  DOI
• Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study., Kazuhiro Suzuki; Nobuaki Matsubara; Hirotaka Kazama; Takeshi Seto; Shoko Tsukube; Hideyasu Matsuyama, 2019年12月27日, Japanese journal of clinical oncology, 49, 12, 1157, 1163, 研究論文（学術雑誌）

  DOI
• Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening., Kazuto Ito; Ryo Oki; Yoshitaka Sekine; Seiji Arai; Yoshiyuki Miyazawa; Yasuhiro Shibata; Kazuhiro Suzuki; Isao Kurosawa, 2019年10月, International journal of urology : official journal of the Japanese Urological Association, 26, 10, 956, 970, 研究論文（学術雑誌）

  DOI
• Phase I trial of TAK-385 in hormone treatment-naïve Japanese patients with nonmetastatic prostate cancer., Hiroyoshi Suzuki; Hiroji Uemura; Atsushi Mizokami; Narihiko Hayashi; Yasuhide Miyoshi; Satoshi Nagamori; Yutaka Enomoto; Hideyuki Akaza; Takayuki Asato; Tadayuki Kitagawa; Kazuhiro Suzuki, 2019年10月, Cancer medicine, 8, 13, 5891, 5902, 研究論文（学術雑誌）

  DOI
• An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression., Yoshiyuki Miyazawa; Yoshitaka Sekine; Nobuaki Shimizu; Yutaka Takezawa; Toshiyuki Nakamura; Takeshi Miyao; Hiroshi Nakayama; Sota Kurihara; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2019年09月, The Prostate, 79, 12, 1462, 1470, 研究論文（学術雑誌）

  DOI
• Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study., Kubo N; Kawamura H; Oike T; Sato H; Iwanaga M; Mizukami T; Adachi A; Matsui H; Ito K; Suzuki K; Nakano T, 2019年07月, In vivo (Athens, Greece), In vivo (Athens, Greece), 33, 4, 1235, 1241

  DOI
• Improved Arterial Preservation Achieved by Combined Use of Indocyanine Green Angiography and Doppler Detector During Microsurgical Subinguinal Varicocelectomy., Sota Kurihara; Yasuhiro Shibata; Seiji Arai; Yoshitaka Sekine; Yoshiyuki Miyazawa; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki; Tetsuya Nakamura, 2019年05月09日, Journal of investigative surgery : the official journal of the Academy of Surgical Research, 1, 7, 研究論文（学術雑誌）

  DOI
• Prevalence and clinical characteristics of overactive bladder in systemic sclerosis., Motegi SI; Sekiguchi A; Sekine Y; Nakayama H; Suzuki K; Ishikawa O, 2019年03月, Modern rheumatology, Modern rheumatology, 1, 5

  DOI
• Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases., Shunji Takahashi; Seigo Kinuya; Norio Nonomura; Nobuo Shinohara; Kazuhiro Suzuki; Hiroyoshi Suzuki; Katsumasa Nakamura; Takefumi Satoh; Ukihide Tateishi; Toshiyuki Yoneda; Hiroyuki Horikoshi; Tsukasa Igawa; Takao Kamai; Mitsuru Koizumi; Takeo Kosaka; Nobuaki Matsubara; Hideaki Miyake; Atsushi Mizokami; Takashi Mizowaki; Naoki Nakamura; Masahiro Nozawa; Takeo Takahashi; Hiroji Uemura; Motohide Uemura; Akira Yokomizo; Mana Yoshimura; Yoshiyuki Kakehi, 2018年12月, Oncology and therapy, 6, 2, 157, 171, 研究論文（学術雑誌）

  DOI
• Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening., Ryo Oki; Kazuto Ito; Rie Suzuki; Yuji Fujizuka; Seiji Arai; Yoshiyuki Miyazawa; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2018年10月01日, International journal of cancer, 143, 7, 1611, 1619, 研究論文（学術雑誌）

  DOI
• 実践!前立腺がん検診 前立腺がん検診に潜む課題をこのように解決している, 酒井 英樹; 伊藤 一人; 鈴木 和浩; 杉元 幹史; 深貝 隆志, 2018年10月, Prostate Journal, 5, 2, 213, 218
• Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching., Mizuki Onozawa; Hideyuki Akaza; Shiro Hinotsu; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Taiji Tsukamoto, 2018年10月, Cancer medicine, 7, 10, 4893, 4902, 研究論文（学術雑誌）

  DOI
• Assessment of antimicrobiral prophylaxis in transperineal prostate biopsy: A single-center retrospective study of 485 cases., Kyoko Baba; Yoshitaka Sekine; Yoshiyuki Miyazawa; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2018年08月, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 24, 8, 637, 640, 研究論文（学術雑誌）

  DOI
• 前立腺癌診療の最新トピックス, 植村 天受; 鈴木 和浩; 上村 博司; 鈴木 啓悦, 2018年05月, Espoir, 1, 1, 07, 15
• Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism., Yoshitaka Sekine; Hiroshi Nakayama; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Seiji Arai; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2018年03月, Oncology letters, 15, 3, 3167, 3172, 研究論文（学術雑誌）

  DOI
• 【去勢抵抗性前立腺癌(CRPC)と骨転移治療の最前線[第3回]】『基礎』と『臨床』から考える去勢抵抗性前立腺癌(CRPC)の骨マネジメント, 植村 天受; 鈴木 和浩; 上村 博司, 2018年02月, Pharma Medica, 36, 2, 85, 94
• 前立腺局所所見に乏しく急速に進行した転移性前立腺癌の1 例, 金山あずさ; 宮尾武士; 小池秀和; 澤田達宏; 馬場恭子; 鈴木智美; 栗原聰太; 中山紘史; 大木亮; 宮澤慶行; 藤塚雄司; 周東孝浩; 宮久保真意; 野村昌史; 関根芳岳; 松井博; 柴田康博; 伊藤一人; 鈴木和浩; 平戸純子; 猿木和久, 2018年, Prostate journal, 5, 1, 147, 150
• Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2018年, IN VIVO, 32, 2, 409, 412

  DOI
• 当院TESE/MESA症例における精子採取予測因子の検討, 北原慈和; 柴田康博; 阿部いおり; 根岸淳江; 茂木美里; 小林未央; 飯塚円香; 中里智子; 満下淳地; 鈴木和浩; 岸裕司, 2017年10月01日, 日本生殖医学会雑誌, 日本生殖医学会雑誌, 62, 4, 404
• 去勢抵抗性前立腺癌(CRPC)の逐次療法を再考する, 鈴木 和浩; 鈴木 啓悦; 小坂 威雄; 土谷 順彦; 三宅 秀明, 2017年09月, Prostate Journal, Prostate Journal, 4, 2, 209, 217
• 【去勢抵抗性前立腺癌(CRPC)と骨転移治療の最前線[第1回]】去勢抵抗性前立腺癌(CRPC)における骨転移の治療, 植村 天受; 上村 博司; 鈴木 和浩; 絹谷 清剛, 2017年09月, Pharma Medica, 35, 9, 89, 95
• A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年08月29日, BMC Urology, 17, 1, 70, 研究論文（学術雑誌）

  DOI
• Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL., Yuji Fujizuka; Kazuto Ito; Ryo Oki; Rie Suzuki; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2017年08月, International journal of urology : official journal of the Japanese Urological Association, 24, 8, 602, 609, 研究論文（学術雑誌）

  DOI
• Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa; Yoshitaka Sekine; Takahiro Syuto; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2017年07月, ANTICANCER RESEARCH, 37, 7, 3667, 3671, 研究論文（学術雑誌）

  DOI
• Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content, Yasuhiro Shibata; Seiji Arai; Yoshiyuki Miyazawa; Takahiro Shuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Kazuhiro Suzuki, 2017年05月, PROSTATE, 77, 6, 672, 680, 研究論文（学術雑誌）

  DOI
• 日本人前立腺癌家系の生殖細胞系列変異, 松井 博; 早野 崇英; 大竹 伸明; 栗原 聰太; 関根 芳岳; 野村 昌史; 小池 秀和; 柴田 康博; 伊藤 一人; 中岡 博史; 細道 一善; 井ノ上 逸朗; 鈴木 和浩, 2017年04月, 日本泌尿器科学会総会, 105回, OP41, 3
• CRPCに対する最新治療戦略, 鈴木 和浩; 植村 天受; 大家 基嗣; 西村 和郎, 2017年04月, Prostate Journal, 4, 1, 69, 78
• LH-RHアゴニスト投与後に下垂体卒中を発症した前立腺癌症例の内分泌学的検討, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信, 2017年04月, 日本泌尿器科学会総会, 日本泌尿器科学会総会, 105回, OP71, 2
• High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL, Y. Miyoshi; H. Uemura; K. Suzuki; Y. Shibata; S. Honma; M. Harada; Y. Kubota, 2017年03月, ANDROLOGY, 5, 2, 262, 267, 研究論文（学術雑誌）

  DOI
• Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells., Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, 2017年03月, The Prostate, 77, 4, 337, 349, 研究論文（学術雑誌）

  DOI
• 去勢抵抗性前立腺癌に対するカバジタキセル療法の治療経験, 宮尾 武士; 小池 秀和; 栗原 聡太; 中山 紘史; 大木 亮; 宮澤 慶行; 周東 孝浩; 関根 芳岳; 野村 昌史; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩, 2017年, Prostate journal, 4, 2, 293, 297
• 重度精神運動発達遅滞を持つ腎移植患者に対し、服薬コンプライアンスの向上に関与した1例, 真下貴子; 飯塚 誠; 関根芳岳; 八島秀明; 阿部正樹; 荒木拓也; 鈴木和浩; 山本康次郎, 2017年, 群馬県病院薬剤師会会誌, 43, 3, 13, 16
• Efficacy of Indocyanine Green Angiography on Microsurgical Subinguinal Varicocelectomy, Yasuhiro Shibata; Sota Kurihara; Seiji Arai; Haruo Kato; Tomomi Suzuki; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuto Ito; Tetsuya Nakamura; Kazuhiro Suzuki, 2017年, JOURNAL OF INVESTIGATIVE SURGERY, 30, 4, 247, 251, 研究論文（学術雑誌）

  DOI
• YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin, Takashi Nitta; Hidekazu Koike; Takeshi Miyao; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yoshitaka Sekine; Kazuhiro Suzuki, 2017年01月, ANTICANCER RESEARCH, 37, 1, 75, 80, 研究論文（学術雑誌）

  DOI
• 前立腺癌に対するLH-RHアゴニスト投与後に下垂体卒中を認めた1例, 澤田 達宏; 宮澤 慶行; 金山 あずさ; 藤塚 雄司; 周東 孝浩; 野村 昌史; 関根 芳岳; 小池 秀和; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 堀口 和彦; 山田 正信; 冨田 健介; 秋山 恵里奈; 福間 裕二; 羽鳥 基明; 大竹 伸明; 関原 哲夫, 2016年11月, The Kitakanto Medical Journal, The Kitakanto Medical Journal, 66, 4, 309, 309
• Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer., Haruo Kato; Yosuke Furuya; Yoshiyuki Miyazawa; Takeshi Miyao; Takahiro Syuto; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2016年11月, Anticancer research, 36, 11, 6141, 6149, 研究論文（学術雑誌）

  DOI
• Asia prostate cancer study (A-CaP Study) launch symposium., Hideyuki Akaza; Yoshihiko Hirao; Choung-Soo Kim; Mototsugu Oya; Seiichiro Ozono; Dingwei Ye; Matthew Cooperberg; Shiro Hinotsu; Ji Youl Lee; Gang Zhu; Mikio Namiki; Shigeo Horie; Byung Ha Chung; Chung-Hsin Chen; Ng Chi Fai; Lukman Hakim; Edmund Chiong; Jason Letran; Rainy Umbas; Kazuhiro Suzuki; Kazuo Nishimura; Teng Aik Ong; Bannakij Lojanapiwat; Tong-Lin Wu; Wun-Jae Kim; Declan Murphy; Osamu Ogawa; Peter Carroll; Seiji Naito; Taiji Tsukamoto, 2016年09月, Prostate international, 4, 3, 88, 96, 研究論文（学術雑誌）

  DOI
• Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins., Yosuke Furuya; Yoshitaka Sekine; Haruo Kato; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, 2016年06月, Prostate international, 4, 2, 56, 60, 研究論文（学術雑誌）

  DOI
• [Perspective of basic research on prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui, 2016年05月20日, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 12, 6, 研究論文（学術雑誌）
• [Hereditary and familial prostate cancer]., Yoshitatsu Fukabori; Nobuaki Ohtake; Hiroshi Matsui; Kazuhiro Suzuki, 2016年05月20日, Nihon rinsho. Japanese journal of clinical medicine, 74 Suppl 3, 47, 51, 研究論文（学術雑誌）
• 泌尿器科と合同手術で、より安全に施行しえた左上腹部巨大後腹膜腫瘍の2切除例, 平井 圭太郎; 新木 健一郎; 久保 憲生; 渡辺 亮; 五十嵐 隆通; 塚越 真理子; 石井 範洋; 星野 弘毅; 野村 昌史; 柴田 康博; 伊藤 一人; 鈴木 和浩; 桑野 博行; 調 憲, 2016年05月, 日本外科系連合学会誌, 日本外科系連合学会誌, 41, 3, 533, 533
• Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association., Takuya Koie; Chikara Ohyama; Hiroyuki Fujimoto; Hiroyuki Nishiyama; Jun Miyazaki; Shiro Hinotsu; Eiji Kikuchi; Mizuaki Sakura; Junichi Inokuchi; Tomohiko Hara; Chikara Ohyama; Hiroyuki Nishiyama; Masato Fujisawa; Hirotsugu Uemura; Hiroyuki Fujimoto; Kazuhiro Suzuki; Masatoshi Eto; Isao Hara; Akio Matsubara; Norio Nonomura; Hiroyuki Nakanishi; Takuya Koie; Hiroomi Kanayama; Tsuneharu Miki; Tomoharu Fukumori; Seiji Naito, 2016年05月, Japanese journal of clinical oncology, 46, 5, 468, 74

  DOI
• SIMVASTATIN INHIBITS THE PROLIFERATION, MIGRATION AND INVASION OF ANDROGEN INDEPENDENT HUMAN PROSTATE CANCER CELLS VIA UP-REGULATION OF ANNEXIN A10, Yoshiyuki Miyazawa; Yoshitaka Sekine; Haruo Kato; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki, 2016年04月, JOURNAL OF UROLOGY, 195, 4, E674, E674
• LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS, Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Takashi Nitta; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2016年04月, JOURNAL OF UROLOGY, 195, 4, E675, E676
• ROLE OF ADIPONECTIN IN PROSTATE CANCER RISK AND THE PROLIFERATION OF PROSTATE CANCER., Takashi Nitta; Hidekazu Koike; Hiroshi Mastui; Takeshi Miyao; Sota Kurihara; Yoshiyuki Miyazawa; Haruo Kato; Yoshitaka Sekine; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2016年04月, JOURNAL OF UROLOGY, 195, 4, E28, E28
• [Screening for prostate cancer: clinical significance and future perspectives]., Kazuto Ito; Kazuhiro Suzuki, 2016年01月, Nihon rinsho. Japanese journal of clinical medicine, 74, 1, 72, 8, 研究論文（学術雑誌）
• Germline Variants of Prostate Cancer in Japanese Families., Takahide Hayano; Hiroshi Matsui; Hirofumi Nakaoka; Nobuaki Ohtake; Kazuyoshi Hosomichi; Kazuhiro Suzuki; Ituro Inoue, 2016年, PloS one, 11, 10, e0164233, 研究論文（学術雑誌）

  DOI
• [Heavy ion radiotherapy for prostate cancer -- the role of hormone therapy]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Tatsuya Ohno, 2015年02月, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 2, 159, 63, 研究論文（学術雑誌）
• [II. Radiotherapy for prostate cancer-the role of multi-disciplinary team]., Kazuhiro Suzuki; Hiroshi Matsui; Hidemasa Kawamura; Junko Hirado; Kei Shibuya; Naoko Taniyama; Tomomi Hashimoto; Tatsuaki Kanai; Takashi NAkano; Tatsuya Ohno, 2015年01月, Gan to kagaku ryoho. Cancer & chemotherapy, 42, 1, 32, 5, 研究論文（学術雑誌）
• [Lipid metabolism and castration resistant prostate cancer]., Kazuhiro Suzuki; Yoshitaka Sekine; Hiroshi Matsui, 2014年12月, Nihon rinsho. Japanese journal of clinical medicine, 72, 12, 2116, 20, 研究論文（学術雑誌）
• [Clinical and basic aspects of familial prostate cancer]., Kazuhiro Suzuki; Hiroshi Matsui; Nobuaki Ohtake, 2013年02月, Gan to kagaku ryoho. Cancer & chemotherapy, 40, 2, 159, 63, 研究論文（学術雑誌）
• Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score., Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Taiji Tsukamoto; Seiji Naito; Mikio Namiki; Yoshihiko Hirao; Masaru Murai, 2013年, Prostate international, 1, 2, 81, 8, 研究論文（学術雑誌）

  DOI
• [Prostate cancer-the role of docetaxel on castration-resistant prostate cancer: evaluation of efficacy and subsequent treatment]., Kazuhiro Suzuki, 2012年10月, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 10, 1467, 70, 研究論文（学術雑誌）
• [The clinical merit of anti-RANKL antibody denosumab in prostate cancer]., Hideyuki Akaza; Taiji Tsukamoto; Kazuhiro Suzuki; Mikio Namiki; Seiichiro Ozono; Seiji Naitodept, 2012年02月, Gan to kagaku ryoho. Cancer & chemotherapy, 39, 2, 207, 12, 研究論文（学術雑誌）
• Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA., Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Yoshinobu Kubota; Satoru Takahashi; Kazuhiro Suzuki; Hiro-omi Kanayama; Kazuya Mikami; Yukio Homma, 2011年12月, International journal of urology : official journal of the Japanese Urological Association, 18, 12, 876, 81, 研究論文（学術雑誌）

  DOI
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., Yoshitaka Sekine; David Osei-Hwedieh; Kant Matsuda; Nalini Raghavachari; Delong Liu; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, 2011年10月01日, The Prostate, 71, 14, 1499, 509, 研究論文（学術雑誌）

  DOI
• [Characteristics of hereditary and familial prostate cancer in Japan 2011]., Yoshitatsu Fukabori; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2011年06月, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 197, 202, 研究論文（学術雑誌）
• [Prostate cancer screening in Japan: current status and perspective]., Kazuhiro Suzuki, 2011年06月, Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 5, 203, 6, 研究論文（学術雑誌）
• HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion., Yoshitaka Sekine; Kazuhiro Suzuki; Alan T Remaley, 2011年05月15日, The Prostate, 71, 7, 690, 9, 研究論文（学術雑誌）

  DOI
• 群馬大学での限局性前立腺癌に対する重粒子線治療・初年次報告, 加藤弘之; 石川仁; 神沼拓也; 石居隆義; 小屋順一; 島田博文; 金井達明; 北田陽子; 大野達也; 中野隆史; 鈴木和浩, 2011年05月, The Kitakanto Medical Journal, The Kitakanto Medical Journal, 61, 2, 242, 研究論文（学術雑誌）
• Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats., Hideo Kobayashi; Kotaro Gotanda; Yasuhiro Shibata; Jun-ichi Watanabe; Youichi Nakano; Atsushi Shinbo; Kazuhiro Suzuki, 2011年, Arzneimittel-Forschung, 61, 9, 515, 20, 研究論文（学術雑誌）

  DOI
• High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism., Yoshitaka Sekine; Steve J Demosky; John A Stonik; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan T Remaley, 2010年09月, Molecular cancer research : MCR, 8, 9, 1284, 94, 研究論文（学術雑誌）

  DOI
• [Clinical research on prostate cancer detected in Tone central hospital--comparison of survival rates between patients diagnosed with prostate cancer in and outside screening system]., Yoshimi Tamur; Tomoko Koya; Takahiro Morita; Yutaka Kubota; Osamu Takahashi; Isao Fujiduka; Kazuto Ito; Kazuhiro Suzuki, 2009年05月, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 100, 4, 525, 33, 研究論文（学術雑誌）
• 2.前立腺癌ヨウ素125シード永久挿入時の術中・術後治療計画の比較(一般演題I,第38回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, 2008年08月, The KITAKANTO medical journal, The KITAKANTO medical journal, 58, 3, 341, 研究論文（学術雑誌）
• がん予防食品としてのセレン強化ブロッコリースプラウト 前立腺がん細胞による検討(Selenium-enriched broccoli sprouts as an anticancer nutraceutical: study in the human prostate cancer cell lines), アブドゥラ・リズキー; 小林 健司; ファリエド・アハマド; スラジ・エカ; 伊藤 一人; 鈴木 和浩; 村上 正巳; 桑野 博行; 小山 洋, 2008年06月, Biomedical Research on Trace Elements, 19, 2, 213, 213
• OP-220 ノモグラムランキングによる前立腺がん治療成績の客観的評価システム(前立腺腫瘍/放射線治療1,一般演題口演,第96回日本泌尿器科学会総会), 山本, 巧; 伊藤, 一人; 宮久保, 真意; 武智, 浩之; 大井, 勝; 鈴木, 和浩; 石川, 仁; 中野, 隆史; 秋元, 哲夫, 2008年02月, 日本泌尿器科學會雜誌, The Japanese Journal of Urology, 99, 2, 326, 研究論文（学術雑誌）
• 3 前立腺癌ヨウ素125シード永久挿入時の術前・術中治療計画の比較(一般演題I,第37回群馬放射線腫瘍研究会抄録), 工藤,滋弘; 石川,仁; 岡本,雅彦; 江原,威; 吉田,大作; 原島,浩一; 櫻井,英幸; 中野,隆史; 山本,巧; 伊藤,一人; 鈴木,和浩, 2008年02月, The KITAKANTO medical journal, The KITAKANTO medical journal, 58, 1, 104, 研究論文（学術雑誌）
• Evidence-based clinical practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition)., Sadao Kamidono; Shinichi Ohshima; Yoshihiko Hirao; Kazuhiro Suzuki; Yoichi Arai; Hiroyuki Fujimoto; Shin Egawa; Hideyuki Akaza; Isao Hara; Shiro Hinotsu; Yoshiyuki Kakehi; Tomonori Hasegawa, 2008年01月, International journal of urology : official journal of the Japanese Urological Association, 15, 1, 1, 18, 研究論文（学術雑誌）

  DOI
• Exploration of target molecules for prostate cancer gene therapy., Kazuhiro Suzuki; Kiminori Nakamura; Kazunori Kato; Hirofumi Hamada; Taiji Tsukamoto, 2007年08月01日, The Prostate, 67, 11, 1163, 73, 研究論文（学術雑誌）
• [Prostate cancer screening at Tatebayashi City in Gunma prefecture--results of screening with PSA alone between 2003 and 2005]., Toshiyuki Nakamura; Toru Etsunaga; Yasushi Sasaki; Takashi Nitta; Yasunobu Okugi; Hiroshi Okazaki; Nobuo Katou; Takumi Yamamoto; Kazuhiro Suzuki, 2007年05月, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 98, 4, 619, 28, 研究論文（学術雑誌）
• WS2-2 前立腺癌に対する放射線外照射療法 (斜入4門照射) の有害事象 : 直腸出血を中心に(限局性前立腺癌に対する非観血的治療-各治療の有害事象とQOLへの影響を中心に, 第95回日本泌尿器科学会総会), 伊藤, 一人; 秋元, 哲夫; 山本, 巧; 石川, 仁; 中野, 隆史; 鈴木, 和浩, 2007年02月, 日本泌尿器科學會雜誌, The Japanese Journal of Urology, 98, 2, 188, 研究論文（学術雑誌）
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, 2007年, Cancer detection and prevention, 31, 2, 149, 53, 研究論文（学術雑誌）
• [Prostate biopsy]., Kazuhiro Suzuki; Kazuto Ito, 2005年02月, Nihon rinsho. Japanese journal of clinical medicine, 63, 2, 253, 9, 研究論文（学術雑誌）
• [Bladder cancer and prostate cancer in hemodialysis patients]., Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2004年06月, Nihon rinsho. Japanese journal of clinical medicine, 62 Suppl 6, 374, 7, 研究論文（学術雑誌）
• [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan]., Seiji Nakata; Nobuaki Ohtake; Yutaka Kubota; Kazuto Ito; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2004年03月, Hinyokika kiyo. Acta urologica Japonica, 50, 3, 165, 70, 研究論文（学術雑誌）
• 前立腺癌に対する外照射併用高線量率組織内照射法の短期効果と急性反応, 斎藤, 淳一; 秋元, 哲夫; 北本, 佳住; 石川, 仁; 桜井, 英幸; 中野, 隆史; 黒川, 公平; 山本, 巧; 鈴木, 和浩; 山中, 英寿, 2003年05月, The KITAKANTO medical journal, The KITAKANTO medical journal, 53, 2, 234, 研究論文（学術雑誌）
• リムパーザの登場によりmCRPCの個別化治療はどこまで進んだか, 鈴木 和浩;井上 貴博;加藤 真史;三好 康秀, 2022年04月, Prostate Journal, 9, 1, 1
• 前立腺癌の画像診断の最前線　unmet needsへの現状と展望, 鈴木 和浩;楫 靖;堀越 浩幸;渡部 直史, 2022年04月, Espoir, 5, 1, 05
• 【前立腺癌を対象にした最新の基礎研究-トランスレーショナルリサーチによる未来予想図-】前立腺癌における血中・組織ステロイドの代謝と薬剤感受性, 新井 誠二;宮澤 慶行;大津 晃;澤田 達宏;関根 芳岳;柴田 康博;鈴木 和浩, 2022年04月, Prostate Journal, 9, 1, 35
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer., Kazama Hirotaka;Kawaguchi Osamu;Seto Takeshi;Suzuki Kazuhiro;Matsuyama Hideyasu;Matsubara Nobuaki;Tajima Yuki;Fukao Taro, 2022年04月, BMC cancer, BMC cancer, 22, 1

  DOI
• リムパーザの登場によりmCRPCの個別化治療はどこまで進んだか, 鈴木 和浩;井上 貴博;加藤 真史;三好 康秀, 2022年04月, Prostate Journal, 9, 1, 1
• 【前立腺癌を対象にした最新の基礎研究-トランスレーショナルリサーチによる未来予想図-】前立腺癌における血中・組織ステロイドの代謝と薬剤感受性, 新井 誠二;宮澤 慶行;大津 晃;澤田 達宏;関根 芳岳;柴田 康博;鈴木 和浩, 2022年04月, Prostate Journal, 9, 1, 35
• Enzalutamide投与前のCRPC患者の血中テストステロン濃度と投与後QOL変化の相関, 宮澤 慶行;関根 芳岳;大津 晃;小池 秀和;鈴木 和浩, 2022年04月, 日本内分泌学会雑誌, 98, 1, 312
• 前立腺癌の画像診断の最前線　unmet needsへの現状と展望, 鈴木 和浩;楫 靖;堀越 浩幸;渡部 直史, 2022年04月, Espoir, 5, 1, 05
• 34年前に全骨盤照射施行後、生体腎移植を施行した1例, 須藤 佑太;関根 芳岳;羽鳥 基明;野村 昌史;新井 誠二;宮澤 慶行;齋藤 智美;大津 晃;岡 大祐;根井 翼;澤田 達宏;金山 あずさ;須長 理沙;杉野 陽彦;清水 孝倫;田中 俊之;町田 昌巳;林 雅道;柴田 康博;鈴木 和浩, 2022年05月, 日本透析医学会雑誌, 55, Suppl.1, 469
• 当院で発生した水道水汚染に対する人工腎臓センターの対応, 関根 芳岳;齋藤 智美;金山 あずさ;澤田 達宏;須藤 佑太;青木 雅典;岡 大祐;大津 晃;野村 恵;宮澤 慶行;新井 誠二;柴田 康博;鈴木 和浩;小松 康宏, 2022年05月, 日本透析医学会雑誌, 55, Suppl.1, 516
• 当院で水汚染時に行ったRO膜による透析用水浄化前後の亜硝酸塩濃度の考察, 宮澤 慶行;関根 芳岳;齋藤 智美;金山 あずさ;澤田 達宏;須藤 佑太;青木 雅典;岡 大祐;大津 晃;野村 恵;新井 誠二;柴田 康博;鈴木 和浩;小松 康宏, 2022年05月, 日本透析医学会雑誌, 55, Suppl.1, 674
• 本人の強い意思で保存的腎臓療法が行われた一例, 大津 晃;周東 孝浩;大澤 英史;金山 あずさ;吉原 忠寿;須藤 佑太;青木 雅典;岡 大祐;宮澤 慶行;新井 誠二;野村 昌史;関根 芳岳;小池 秀和;松井 博;柴田 康博;鈴木 和浩, 2022年05月, 日本透析医学会雑誌, 55, Suppl.1, 775
• 群馬県における前立腺がん検診の有効性評価研究(PROCEED), 関根 芳岳;藤塚 雄司;須藤 佑太;鈴木 和浩;竹澤 豊;古作 望;伊藤 一人, 2022年07月, 日本腎泌尿器疾患予防医学研究会プログラム・抄録集, 31回, 34
• 【LOH症候群】テストステロン補充療法の副作用, 周東 孝浩;鈴木 和浩, 2022年07月, 泌尿器科, 16, 1, 25
• 【泌尿器科領域の遺伝性疾患とゲノム医療の最前線】遺伝性前立腺がん, 鈴木 和浩;松井 博;宮澤 慶行;関根 芳岳;新井 誠二;小池 秀和;野村 昌史;藤塚 雄司;大竹 伸明, 2022年08月, 泌尿器科, 16, 2, 149
• タンパク翻訳阻害剤Homoharringtonineの前立腺癌細胞における抗腫瘍効果の検討, 大津 晃;新井 誠二;澤田 達宏;宮澤 慶行;関根 芳岳;鈴木 和浩, 2022年08月, 泌尿器外科, 35, 8, 860
• プレシジョンメディシンを目指した前立腺癌診療〜生検、臨床病理、遺伝子検査、リキッドバイオプシー〜　前立腺生検update, 関根 芳岳;宮澤 慶行;新井 誠二;伊藤 一人;鈴木 和浩, 2022年08月, 泌尿器外科, 35, 8, 909
• 【泌尿器科医が知っておくべき遺伝性・家族性疾患:最近のTopics】家族性前立腺癌, 鈴木 和浩;大竹 伸明;松井 博, 2015年10月, 泌尿器外科, 28, 10, 1631
• Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer, Nakayama, Hiroshi;Sekine, Yoshitaka;Oka, Daisuke;Miyazawa, Yoshiyuki;Arai, Seiji;Koike, Hidekazu;Matsui, Hiroshi;Shibata, Yasuhiro;Suzuki, Kazuhiro, 2022年, PROSTATE, PROSTATE, 82, 3, 314, 322

  DOI
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Arai, Seiji;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

  DOI
• Comparative study of RARP and carbon ion radiotherapy sexual functional changes for prostate cancer using the propensity score matching method., Miyazawa, Yoshiyuki;Oka, Daisuke;Koike, Hidekazu;Kawamura, Hidemasa;Miyasaka, Yuhei;Syuto, Takahiro;Arai, Seiji;Sekine, Yoshitaka;Matsui, Hiroshi;Ohno, Tatsuya;Suzuki, Kazuhiro, 2022年, JOURNAL OF CLINICAL ONCOLOGY, JOURNAL OF CLINICAL ONCOLOGY, 40, 6

  DOI
• Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer, Kazama, Hirotaka;Kawaguchi, Osamu;Seto, Takeshi;Suzuki, Kazuhiro;Matsuyama, Hideyasu;Matsubara, Nobuaki;Tajima, Yuki;Fukao, Taro, 2022年, BMC CANCER, BMC CANCER, 22, 1

  DOI
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study, Uemura, Hiroji;Kobayashi, Kazuki;Yokomizo, Akira;Hinotsu, Shiro;Horie, Shigeo;Kakehi, Yoshiyuki;Nonomura, Norio;Ogawa, Osamu;Oya, Mototsugu;Suzuki, Kazuhiro;Saito, Atsushi;Asakawa, Keiko;Uno, Satoshi;Naito, Seiji, 2022年, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27, 10, 1632, 1643

  DOI
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Kato, Mai;Maeno, Yuta;Miyazawa, Yoshiyuki;Fujizuka, Yuji;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2022年, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 628, 76, 83

  DOI
• Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells., Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022年, CANCER RESEARCH, CANCER RESEARCH, 82, 12
• Brefeldin A mediates integrated stress response and in combination with Navitoclax induces apoptosis in prostate cancer cells, Ohtsu, Akira;Arai, Seiji;Sawada, Tatsuhiro;Miyazawa, Yoshiyuki;Sekine, Yoshitaka;Suzuki, Kazuhiro, 2022年, CANCER RESEARCH, CANCER RESEARCH, 82, 12
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS, Miyazawa, Yoshiyuki;Nakamura, Toshiyuki;Takezawa, Yutaka;Shimizu, Nobuaki;Matsuo, Yasushige;Ogura, Haruyuki;Takei, Tomoyuki;Sekine, Yoshitaka;Arai, Seiji;Suzuki, Kazuhiro, 2023年, PROSTATE, PROSTATE, 83, 8, 759, 764

  DOI
• Summary of the clinical practice manual for late-onset hypogonadism, Ide, Hisamitsu;Akehi, Yuko;Fukuhara, Shinichiro;Ohira, Shin;Ogawa, Sumito;Kataoka, Tomoya;Kumagai, Hiroshi;Kobayashi, Ko;Komiya, Akira;Shigehara, Kazuyoshi;Syuto, Takahiro;Soh, Jintetu;Tanabe, Makito;Taniguchi, Hisanori;Chiba, Koji;Matsushita, Kazuhito;Mitsui, Yozo;Yoneyama, Takahiro;Shirakawa, Tomoya;Fujii, Yasuhisa;Kumano, Hiroaki;Ueshiba, Hajime;Amano, Toshiyasu;Sasaki, Haruaki;Maeda, Seiji;Mizokami, Atsushi;Suzuki, Kazuhiro;Horie, Shigeo, 2023年, INTERNATIONAL JOURNAL OF UROLOGY, INTERNATIONAL JOURNAL OF UROLOGY, 30, 5, 422, 430

  DOI
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer, Mizukami, Tatsuji;Kawamura, Hidemasa;Kubo, Nobuteru;Sato, Hiro;Kawahara, Masahiro;Adachi, Akiko;Matsui, Hiroshi;Suzuki, Kazuhiro;Saitoh, Jun-ichi;Nakano, Takashi;Ohno, Tatsuya, 2023年, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

  DOI
• Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report, Ohtsu, Akira;Arai, Seiji;Fujizuka, Yuji;Fukuda, Reon;Hori, Keisuke;Morimura, Yuki;Kawahara, Rintaro;Shiraishi, Takuya;Ogawa, Hiroomi;Miyazawa, Yoshiyuki;Nomura, Masashi;Sekine, Yoshitaka;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023年, BMC UROLOGY, BMC UROLOGY, 23, 1

  DOI
• The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide, Miyazawa, Yoshiyuki;Hori, Keisuke;Tsuji, Yusuke;Sekine, Yoshitaka;Arai, Seiji;Fujizuka, Yuji;Nomura, Masashi;Koike, Hidekazu;Matsui, Hiroshi;Suzuki, Kazuhiro, 2023年, INTERNATIONAL JOURNAL OF UROLOGY, INTERNATIONAL JOURNAL OF UROLOGY

  DOI
• Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan, Matsuyama, Hideyasu;Matsubara, Nobuaki;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023年, BMC CANCER, BMC CANCER, 23, 1

  DOI
• Moving beyond negative campaign for PSA-based screening for prostate cancer, Ito, Kazuto;Sekine, Yoshitaka;Suzuki, Kazuhiro;Kurosawa, Isao, 2023年, CANCER SCIENCE, CANCER SCIENCE, 114, 1536, 1536
• Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance, Matsubara, Nobuaki;Matsuyama, Hideyasu;Kazama, Hirotaka;Seto, Takeshi;Sunaga, Yoshinori;Suzuki, Kazuhiro, 2023年, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, JAPANESE JOURNAL OF CLINICAL ONCOLOGY

  DOI
• 去勢抵抗性前立腺癌　基礎と臨床　Intracrinologyからみた前立腺癌のバイオロジー, 鈴木 和浩, 2016年02月, 泌尿器科学の最近の進歩, 31, 24
• Predictive models of long-term survival outcomes following radical cystectomy., Ohtsu Akira;Arai Seiji;Fujizuka Yuji;Miyazawa Yoshiyuki;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, 2023年10月, Cancer medicine, Cancer medicine, 12, 23

  DOI
• Successful embolization of subcutaneous mesenteric varices within an ileal conduit in a patient with liver cirrhosis., Sakurai Ayaka;Ohtsu Akira;Arai Seiji;Aoki Masanori;Ikeya Miho;Tokue Hiroyuki;Hori Keisuke;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Suzuki Kazuhiro, 2023年09月, IJU case reports, IJU case reports, 6, 6

  DOI
• L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity., Rii Junryo;Sakamoto Shinichi;Mizokami Atsushi;Xu Minhui;Fujimoto Ayumi;Saito Shinpei;Koike Hidekazu;Tamura Takaaki;Arai Takayuki;Yamada Yasutaka;Goto Yusuke;Sazuka Tomokazu;Imamura Yusuke;Suzuki Kazuhiro;Kanai Yoshikatsu;Anzai Naohiko;Ichikawa Tomohiko, 2024年01月, Cancer science, Cancer science, 115, 3

  DOI
• Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching., Miyazawa Yoshiyuki;Koike Hidekazu;Oka Daisuke;Kawamura Hidemasa;Kubo Nobuteru;Miyasaka Yuhei;Onishi Masahiro;Syuto Takahiro;Sekine Yoshitaka;Matsui Hiroshi;Ohno Tatsuya;Suzuki Kazuhiro, 2024年03月, BMC cancer, BMC cancer, 24, 1

  DOI
• Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial., Yokomizo Akira;Koga Hirofumi;Ito Kazuto;Takezawa Yutaka;Komiyama Motokiyo;Nishimura Kazuo;Yonese Junji;Hashine Katsuyoshi;Masumori Naoya;Arai Gaku;Saito Shiro;Shinohara Mitsuru;Shimizu Nobuaki;Yamauchi Atsushi;Satoh Takefumi;Tochigi Tatsuo;Kobayashi Mikio;Fujimoto Hiroyuki;Kakimoto Ken-Ichi;Fukui Iwao;Tsukamoto Taiji;Nozaki Miwako;Karasawa Katsuyuki;Hasumi Masaru;Ohtani Mikinobu;Ishiyama Hiromichi;Kuwahara Masaaki;Harada Masaoki;Ohashi Yasuo;Kotake Toshihiko;Kakizoe Tadao;Suzuki Kazuhiro;Naito Seiji;Yamanaka Hidetoshi; , 2021年05月, Cancer medicine, Cancer medicine, 10, 10

  DOI
• A Prospective Study of the Relationship Between Clinical Outcomes After Enzalutamide and Serum Androgen Levels Measured via Liquid Chromatography-tandem Mass Spectrometry in Patients with Castration-resistant Prostate Cancer., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Nakamura Toshiyuki;Takezawa Yutaka;Shimizu Nobuaki;Matsuo Yasushige;Ogura Haruyuki;Takei Tomoyuki;Suzuki Kazuhiro, 2021年06月, European urology open science, European urology open science, 29

  DOI
• Carbon ion radiotherapy for prostate cancer with bladder invasion., Miyasaka Yuhei;Kawamura Hidemasa;Sato Hiro;Kubo Nobuteru;Mizukami Tatsuji;Matsui Hiroshi;Miyazawa Yoshiyuki;Ito Kazuto;Nakano Takashi;Suzuki Kazuhiro;Ohno Tatsuya, 2021年08月, BMC urology, BMC urology, 21, 1

  DOI
• Presepsin as a predictor of septic shock in patients with urinary tract infection., Sekine Yoshitaka;Kotani Kazuhiko;Oka Daisuke;Nakayama Hiroshi;Miyazawa Yoshiyuki;Syuto Takahiro;Arai Seiji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Murakami Masami;Suzuki Kazuhiro, 2021年10月, BMC urology, BMC urology, 21, 1

  DOI
• Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer., Sekine Yoshitaka;Nakayama Hiroshi;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Ito Kazuto;Suzuki Kazuhiro, 2021年10月, Oncology letters, Oncology letters, 22, 6

  DOI
• Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer., Nakayama Hiroshi;Sekine Yoshitaka;Oka Daisuke;Miyazawa Yoshiyuki;Arai Seiji;Koike Hidekazu;Matsui Hiroshi;Shibata Yasuhiro;Suzuki Kazuhiro, 2021年11月, The Prostate, The Prostate, 82, 3

  DOI
• Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study., Uemura Hiroji;Kobayashi Kazuki;Yokomizo Akira;Hinotsu Shiro;Horie Shigeo;Kakehi Yoshiyuki;Naito Seiji;Nonomura Norio;Ogawa Osamu;Oya Mototsugu;Suzuki Kazuhiro;Saito Atsushi;Uno Satoshi;Akaza Hideyuki, 2021年08月, BJUI compass, BJUI compass, 3, 1

  DOI
• Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study., Uemura Hiroji;Kobayashi Kazuki;Yokomizo Akira;Hinotsu Shiro;Horie Shigeo;Kakehi Yoshiyuki;Nonomura Norio;Ogawa Osamu;Oya Mototsugu;Suzuki Kazuhiro;Saito Atsushi;Asakawa Keiko;Uno Satoshi;Naito Seiji, 2022年08月, International journal of clinical oncology, International journal of clinical oncology, 27, 10

  DOI
• Variants in HOXB13, G132E and F127C, Are Associated With Prostate Cancer Risk in Japanese Men., Kurihara Sota;Matsui Hiroshi;Ohtake Nobuaki;Aoki Masanori;Sekine Yoshitaka;Arai Seiji;Koike Hidekazu;Suzuki Kazuhiro;Miyazawa Yoshiyuki, 2022年09月, Cancer diagnosis & prognosis, Cancer diagnosis & prognosis, 2, 5

  DOI
• Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells., Ohtsu Akira;Arai Seiji;Sawada Tatsuhiro;Kato Mai;Maeno Yuta;Miyazawa Yoshiyuki;Fujizuka Yuji;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2022年08月, Biochemical and biophysical research communications, Biochemical and biophysical research communications, 628

  DOI
• Changes in Renal Function of Patients With Prostate Cancer: Focus on Androgen Deprivation Therapy., Miyazawa Yoshiyuki;Sekine Yoshitaka;Arai Seiji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2022年11月, Cancer diagnosis & prognosis, Cancer diagnosis & prognosis, 2, 6

  DOI
• Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin., Miyazawa Yoshiyuki;Shimizu Takanori;Sekine Yoshitaka;Arai Seiji;Ohtsu Akira;Fujizuka Yuji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2022年10月, IJU case reports, IJU case reports, 6, 1

  DOI
• Summary of the clinical practice manual for late-onset hypogonadism., Ide Hisamitsu;Akehi Yuko;Fukuhara Shinichiro;Ohira Shin;Ogawa Sumito;Kataoka Tomoya;Kumagai Hiroshi;Kobayashi Ko;Komiya Akira;Shigehara Kazuyoshi;Syuto Takahiro;Soh Jintetu;Tanabe Makito;Taniguchi Hisanori;Chiba Koji;Matsushita Kazuhito;Mitsui Yozo;Yoneyama Takahiro;Shirakawa Tomoya;Fujii Yasuhisa;Kumano Hiroaki;Ueshiba Hajime;Amano Toshiyasu;Sasaki Haruaki;Maeda Seiji;Mizokami Atsushi;Suzuki Kazuhiro;Horie Shigeo, 2023年02月, International journal of urology : official journal of the Japanese Urological Association, International journal of urology : official journal of the Japanese Urological Association, 30, 5

  DOI
• A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS., Miyazawa Yoshiyuki;Nakamura Toshiyuki;Takezawa Yutaka;Shimizu Nobuaki;Matsuo Yasushige;Ogura Haruyuki;Takei Tomoyuki;Sekine Yoshitaka;Arai Seiji;Suzuki Kazuhiro, 2023年03月, The Prostate, The Prostate, 83, 8

  DOI
• Carbon-ion radiotherapy for inoperable upper tract ureteral cancer., Mizukami Tatsuji;Kawamura Hidemasa;Kubo Nobuteru;Sato Hiro;Kawahara Masahiro;Adachi Akiko;Matsui Hiroshi;Suzuki Kazuhiro;Saitoh Jun-Ichi;Nakano Takashi;Ohno Tatsuya, 2023年04月, Asia-Pacific journal of clinical oncology, Asia-Pacific journal of clinical oncology

  DOI
• Retroperitoneal urothelial carcinoma arising after bladder diverticulectomy: a case report., Ohtsu Akira;Arai Seiji;Fujizuka Yuji;Fukuda Reon;Hori Keisuke;Morimura Yuki;Kawahara Rintaro;Shiraishi Takuya;Ogawa Hiroomi;Miyazawa Yoshiyuki;Nomura Masashi;Sekine Yoshitaka;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2023年05月, BMC urology, BMC urology, 23, 1

  DOI
• The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide., Miyazawa Yoshiyuki;Hori Keisuke;Tsuji Yusuke;Sekine Yoshitaka;Arai Seiji;Fujizuka Yuji;Nomura Masashi;Koike Hidekazu;Matsui Hiroshi;Suzuki Kazuhiro, 2023年05月, International journal of urology : official journal of the Japanese Urological Association, International journal of urology : official journal of the Japanese Urological Association, 30, 10

  DOI
• Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan., Matsuyama Hideyasu;Matsubara Nobuaki;Kazama Hirotaka;Seto Takeshi;Sunaga Yoshinori;Suzuki Kazuhiro, 2023年06月, BMC cancer, BMC cancer, 23, 1

  DOI
• Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin., Katsumi Shigeaki;Araki Takuya;Yashima Hideaki;Miyazawa Yoshiyuki;Suzuki Kazuhiro;Yamamoto Koujirou, 2023年07月, Case reports in oncology, Case reports in oncology, 16, 1

  DOI

MISC

• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds., Takumi Yamamoto; Kazuto Ito; Mai Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, 2008年10月, Urology, 72, 4, 892, 7

  DOI
• Nomogram ranking as new objective evaluation method in various treatment strategies for patients with prostate cancer with various clinicopathologic backgrounds, Takumi Yamamoto; Kazuto Ito; Mal Miyakubo; Hiroyuki Takechi; Kazuhiro Suzuki; Tetsuo Akimoto; Hitoshi Ishikawa; Takashi Nakano, 2008年10月, UROLOGY, 72, 4, 892, 897

  DOI
• Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Yayoi Nagai; Michiko Hasegawa; Kahori Shinmi; Chikako Kishi; Yoshito Tsushima; Keigo Endo; Kazuhiko Okabe; Kazuhiro Suzuki; Osamu Ishikawa, 2008年, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

  DOI
• Nephrogenic Systemic Fibrosis with Multiple Calcification and Osseous Metaplasia, Yayoi Nagai; Michiko Hasegawa; Kahori Shinmi; Chikako Kishi; Yoshito Tsushima; Keigo Endo; Kazuhiko Okabe; Kazuhiro Suzuki; Osamu Ishikawa, 2008年, ACTA DERMATO-VENEREOLOGICA, 88, 6, 597, 600

  DOI
• Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan., Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, 2008年11月, Urology, 72, 5, 1111, 5

  DOI
• Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan, Hiroyuki Takechi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Masaru Ohi; Kazuhiro Suzuki, 2008年11月, UROLOGY, 72, 5, 1111, 1115

  DOI
• Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer., Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, 2008年12月, Urology, 72, 6, 1229, 33

  DOI
• Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate Cancer, Hidekazu Koike; Yoshitaka Sekine; Makoto Kamiya; Haruki Nakazato; Kazuhiro Suzuki, 2008年12月, UROLOGY, 72, 6, 1229, 1233

  DOI
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2008年03月, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

  DOI
• Polymorphisms of DNA repair genes, XRCC1 and XRCC3, and susceptibility to familial prostate cancer in a Japanese population, Tatsuya Hamano; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2008年03月, ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 4, 1, 21, 26

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Yoshitaka Sekine; Yosuke Furuya; Masahiro Nishii; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki, 2008年07月25日, Biochemical and biophysical research communications, 372, 2, 356, 61

  DOI
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population, Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008年12月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 40, 4, 947, 951

  DOI
• Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population., Hidekazu Koike; Haruki Nakazato; Nobuaki Ohtake; Hiroshi Matsui; Hironobu Okugi; Yasuhiro Shibata; Seiji Nakata; Hidetoshi Yamanaka; Kazuhiro Suzuki, 2008年, International urology and nephrology, 40, 4, 947, 51

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003., Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, 2008年07月, Urology, 72, 1, 95, 8

  DOI
• Changes in baseline PSA levels in Japanese men from 1988 to 2003, Masaru Ohi; Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Yutaka Kubota; Kazuhiro Suzuki, 2008年07月, UROLOGY, 72, 1, 95, 98

  DOI
• Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor., Haruo Kato; Yoshitaka Sekine; Yosuke Furuya; Yoshiyuki Miyazawa; Hidekazu Koike; Kazuhiro Suzuki, 2015年05月22日, Biochemical and biophysical research communications, 461, 1, 115, 21

  DOI
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial., Fred Saad; Karim Fizazi; Viorel Jinga; Eleni Efstathiou; Peter C Fong; Lowell L Hart; Robert Jones; Raymond McDermott; Manfred Wirth; Kazuhiro Suzuki; David B MacLean; Ling Wang; Hideyuki Akaza; Joel Nelson; Howard I Scher; Robert Dreicer; Iain J Webb; Ronald de Wit, 2015年03月, The Lancet. Oncology, 16, 3, 338, 48

  DOI
• Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association, Hiro-omi Kanayama; Tomoharu Fukumori; Hiroyuki Fujimoto; Hiroyuki Nakanishi; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Tsuneharu Miki; Kazumi Kamoi; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Seiji Naito, 2015年09月, INTERNATIONAL JOURNAL OF UROLOGY, 22, 9, S1, S7

  DOI
• A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer., Kazuhiro Suzuki; Seiichiro Ozono; Akito Yamaguchi; Hidekazu Koike; Hiroshi Matsui; Masao Nagata; Takatoshi Takubo; Kana Miyashita; Takafumi Matsushima; Hideyuki Akaza, 2015年02月, Cancer chemotherapy and pharmacology, 75, 2, 373, 80

  DOI
• Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life, Hitoshi Ishikawa; Hiroyuki Katoh; Takuya Kaminuma; Hidemasa Kawamura; Kazuto Ito; Hiroshi Matsui; Junko Hirato; Nobuaki Shimizu; Yutaka Takezawa; Hiroshi Tsuji; Kazuhiro Suzuki; Tatsuya Ohno; Takashi Nakano, 2015年10月, ANTICANCER RESEARCH, 35, 10, 5559, 5566
• Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan., Kazuhiro Suzuki; Mikio Namiki; Tsukasa Fujimoto; Nobuyoshi Takabayashi; Kentarou Kudou; Hideyuki Akaza, 2015年12月, Japanese journal of clinical oncology, 45, 12, 1168, 74

  DOI
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer, Masahiro Nozawa; Hirofumi Mukai; Shunji Takahashi; Hiroji Uemura; Takeo Kosaka; Yusuke Onozawa; Jun Miyazaki; Kazuhiro Suzuki; Koji Okihara; Yoichi Arai; Tomomi Kamba; Masashi Kato; Yasutomo Nakai; Hiroshi Furuse; Haruki Kume; Hisamitsu Ide; Hiroshi Kitamura; Akira Yokomizo; Takahiro Kimura; Yoshihiko Tomita; Keiji Ohno; Yoshiyuki Kakehi, 2015年10月, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 5, 1026, 1034

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells, Takeaki Nagamine; Kastuyuki Nakajima; Hisashi Takada; Yoshitaka Sekine; Kazuhiro Suzuki, 2009年06月, CYTOKINE, 46, 3, 346, 350

  DOI
• Induction of type 1 interferon receptor by zinc in U937 cells, Takeaki Nagamine; Kastuyuki Nakajima; Hisashi Takada; Yoshitaka Sekine; Kazuhiro Suzuki, 2009年06月, CYTOKINE, 46, 3, 346, 350

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells, Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W. Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, 2009年11月, BMC CANCER, 9, Nov30, 414

  DOI
• Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells., Rizky Abdulah; Ahmad Faried; Kenji Kobayashi; Chiho Yamazaki; Eka W Suradji; Kazuto Ito; Kazuhiro Suzuki; Masami Murakami; Hiroyuki Kuwano; Hiroshi Koyama, 2009年11月30日, BMC cancer, 9, Nov30, 414, 414

  DOI
• Proprostate-specific antigen: Its usefulness in the era of multiple-core prostate biopsy, Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, 2009年06月, INTERNATIONAL JOURNAL OF UROLOGY, 16, 6, 561, 565

  DOI
• Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy., Mai Miyakubo; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Masaru Ohi; Kazuhiro Suzuki, 2009年06月, International journal of urology : official journal of the Japanese Urological Association, 16, 6, 561, 5

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor, Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, 2009年07月, CANCER EPIDEMIOLOGY, 33, 1, 16, 23

  DOI
• Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor., Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Sadao Takahashi; Kazuhiro Suzuki, 2009年07月, Cancer epidemiology, 33, 1, 16, 23

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Y. Shibata; K. Suzuki; S. Arai; Y. Miyoshi; S. Umemoto; N. Masumori; N. Kamiya; T. Ichikawa; Y. Kitagawa; A. Mizokami; Y. Sugimura; N. Nonomura; H. Sakai; S. Honma; Y. Kubota, 2013年05月, ANDROLOGY, 1, 3, 505, 511

  DOI
• Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy, Y. Shibata; K. Suzuki; S. Arai; Y. Miyoshi; S. Umemoto; N. Masumori; N. Kamiya; T. Ichikawa; Y. Kitagawa; A. Mizokami; Y. Sugimura; N. Nonomura; H. Sakai; S. Honma; Y. Kubota, 2013年05月, ANDROLOGY, 1, 3, 505, 511

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2013年04月, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range, Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2013年04月, WORLD JOURNAL OF UROLOGY, 31, 2, 305, 311

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, 2013年06月, Scandinavian journal of urology, 47, 3, 236, 41

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation, Tomohiro Magari; Yasuhiro Shibata; Sew Arai; Bunzo Kashiwagi; Kazuhiro Suzuki, 2013年, SCANDINAVIAN JOURNAL OF UROLOGY, 47, 3, 236, 241

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, S. Arai; Y. Shibata; Y. Nakamura; B. Kashiwagi; T. Uei; Y. Tomaru; Y. Miyashiro; S. Honma; K. Hashimoto; Y. Sekine; K. Ito; H. Sasano; K. Suzuki, 2013年01月, ANDROLOGY, 1, 1, 169, 174

  DOI
• Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues, S. Arai; Y. Shibata; Y. Nakamura; B. Kashiwagi; T. Uei; Y. Tomaru; Y. Miyashiro; S. Honma; K. Hashimoto; Y. Sekine; K. Ito; H. Sasano; K. Suzuki, 2013年01月, ANDROLOGY, 1, 1, 169, 174

  DOI
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Seiji Naito; Yoshiyuki Kakehi; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara; Kazuto Ito, 2010年10月, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

  DOI
• Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010, Seiji Naito; Yoshiyuki Kakehi; Akihiko Okuyama; Tomoaki Imamura; Hideo Yasunaga; Hideyuki Akaza; Shiro Hinotsu; Yoichi Arai; Takushi Dokiya; Shin Egawa; Kazuhiro Suzuki; Hirofumi Koga; Naoya Masumori; Koichiro Akakura; Kiyotaka Kawashima; Koji Okihara; Kazuto Ito, 2010年10月, INTERNATIONAL JOURNAL OF UROLOGY, 17, 10, 830, 838

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, 2010年03月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, 2010年03月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• The investigation of ureteral sympathetic innervation, using semi-serial sections: why does the alpha 1-adrenergic receptor antagonist work well for ureteral stones?, Kazunari Ohki; Yosihiro Ohno; Kazuhiro Suzuki, 2010年03月, INTERNATIONAL UROLOGY AND NEPHROLOGY, 42, 1, 113, 117

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, 2010年01月, Steroids, 75, 1, 13, 9

  DOI
• New quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Bunzo Kashiwagi; Yukio Tomaru; Mikio Kobayashi; Yoko Watanabe; Seijiro Honma; Kazuhiro Suzuki, 2010年01月, STEROIDS, 75, 1, 13, 19

  DOI
• Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease., Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2010年08月, The Journal of urology, 184, 2, 738, 42

  DOI
• Association of SNP rs1447295 and Microsatellite Marker DG8S737 With Familial Prostate Cancer and High Grade Disease, Tatsuya Hamano; Hiroshi Matsui; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2010年08月, JOURNAL OF UROLOGY, 184, 2, 738, 742

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Tomohiro Magari; Kazuhiro Suzuki; Seijiro Honma, 2006年11月, Urology, 68, 5, 1127, 31

  DOI
• Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo, Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Tomohiro Magari; Kazuhiro Suzuki; Seijiro Honma, 2006年11月, UROLOGY, 68, 5, 1127, 1131

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow, Bunzo Kashiwagi; Yasuhiro Shibata; Kazunari Ohki; Seiji Arai; Seijiro Honma; Kazuhiro Suzuki, 2006年09月, UROLOGY, 68, 3, 682, 686

  DOI
• Positive effect of prostaglandin on regulation of prostatic blood flow., Bunzo Kashiwagi; Yasuhiro Shibata; Kazunari Ohki; Seiji Arai; Seijiro Honma; Kazuhiro Suzuki, 2006年09月, Urology, 68, 3, 682, 6

  DOI
• A case of emphysematous pyelonephritis in a renal allograft, S Arai; T Makino; H Okugi; M Hasumi; Y Shibata; M Hatori; K Suzuki, 2006年01月, TRANSPLANTATION, 81, 2, 296, 297, 速報，短報，研究ノート等（学術雑誌）

  DOI
• A case of emphysematous pyelonephritis in a renal allograft, S Arai; T Makino; H Okugi; M Hasumi; Y Shibata; M Hatori; K Suzuki, 2006年01月, TRANSPLANTATION, 81, 2, 296, 297, 速報，短報，研究ノート等（学術雑誌）

  DOI
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population., Hironobu Okugi; Haruki Nakazato; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2006年, Cancer detection and prevention, 30, 3, 262, 8

  DOI
• Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population, Hironobu Okugi; Haruki Nakazato; Hiroshi Matsui; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2006年, CANCER DETECTION AND PREVENTION, 30, 3, 262, 268

  DOI
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells, Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Kazuhiro Suzuki, 2007年08月, CLINICA CHIMICA ACTA, 383, 1-2, 78, 84

  DOI
• Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells., Yoshitaka Sekine; Hidekazu Koike; Takamitsu Nakano; Katsuyuki Nakajima; Kazuhiro Suzuki, 2007年08月, Clinica chimica acta; international journal of clinical chemistry, 383, 1-2, 78, 84

  DOI
• Effects of a new steroidal antiandrogen, TZP-4238(17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3,20-dione), on spontaneously developed canine benign prostatic hyperplasia, Y Takezawa; K Ito; K Suzuki; Y Fukabori; H Yamanaka; S Honma; M Mieda; N Hamataki; M Kushitani, 1995年12月, PROSTATE, 27, 6, 321, 328
• Effects of a new steroidal antiandrogen, TZP-4238(17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3,20-dione), on spontaneously developed canine benign prostatic hyperplasia, Y Takezawa; K Ito; K Suzuki; Y Fukabori; H Yamanaka; S Honma; M Mieda; N Hamataki; M Kushitani, 1995年12月, PROSTATE, 27, 6, 321, 328
• Effect of androgen concentration on seminal vesicle blood flow in rats - Establishment of new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; K Suzuki; S Honma; H Yamanaka, 2005年07月, UROLOGY, 66, 1, 218, 223

  DOI
• Effect of androgen concentration on seminal vesicle blood flow in rats - Establishment of new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; K Suzuki; S Honma; H Yamanaka, 2005年07月, UROLOGY, 66, 1, 218, 223

  DOI
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike; K Ito; Y Takezawa; T Oyama; H Yamanaka; K Suzuki, 2005年04月, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544

  DOI
• Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer, H Koike; K Ito; Y Takezawa; T Oyama; H Yamanaka; K Suzuki, 2005年04月, BRITISH JOURNAL OF CANCER, 92, 8, 1538, 1544

  DOI
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; R Suzuki; S Honma; K Suzuki, 2005年09月, JOURNAL OF ANDROLOGY, 26, 5, 586, 591

  DOI
• Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: Establishment of a new highly sensitive simultaneous androgen measurement method, B Kashiwagi; Y Shibata; Y Ono; R Suzuki; S Honma; K Suzuki, 2005年09月, JOURNAL OF ANDROLOGY, 26, 5, 586, 591

  DOI
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Yoshitatsu Fukabori; Kazuhiro Suzuki, 2005年08月, Urology, 66, 2, 455, 60

  DOI
• A comparison of interobserver reproducibility of gleason grading of prostatic carcinoma in Japan and the United States, T Oyama; WC Allsbrook; K Kurokawa; H Matsuda; A Segawa; T Sano; K Suzuki; JI Epstein, 2005年08月, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 129, 8, 1004, 1010
• A comparison of interobserver reproducibility of gleason grading of prostatic carcinoma in Japan and the United States, T Oyama; WC Allsbrook; K Kurokawa; H Matsuda; A Segawa; T Sano; K Suzuki; JI Epstein, 2005年08月, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 129, 8, 1004, 1010
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy, S. Miyamoto; K. Ito; M. Miyakubo; R. Suzuki; T. Yamamoto; K. Suzuki; K. Suzuki; H. Yamanaka, 2012年03月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 1, 75, 86

  DOI
• Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy, S. Miyamoto; K. Ito; M. Miyakubo; R. Suzuki; T. Yamamoto; K. Suzuki; K. Suzuki; H. Yamanaka, 2012年03月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 1, 75, 86

  DOI
• Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2012年11月, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

  DOI
• Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands, Masahiro Nishii; Masashi Nomura; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2012年11月, JOURNAL OF ANDROLOGY, 33, 6, 1233, 1238

  DOI
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme, M. Nomura; K. Ito; M. Miyakubo; Y. Sekine; Y. Tamura; N. Shimizu; S. Aoki; K. Suzuki, 2012年06月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 2, 202, 209

  DOI
• Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme, M. Nomura; K. Ito; M. Miyakubo; Y. Sekine; Y. Tamura; N. Shimizu; S. Aoki; K. Suzuki, 2012年06月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 2, 202, 209

  DOI
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, 2012年12月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345

  DOI
• Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer, Y. Fukuma; H. Matsui; H. Koike; Y. Sekine; I. Shechter; N. Ohtake; S. Nakata; K. Ito; K. Suzuki, 2012年12月, PROSTATE CANCER AND PROSTATIC DISEASES, 15, 4, 339, 345

  DOI
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation., Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2012年03月16日, Biochemical and biophysical research communications, 419, 3, 584, 9

  DOI
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852

  DOI
• Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, K Suzuki; H Koike; H Matsui; Y Ono; M Hasumi; H Nakazato; H Okugi; Y Sekine; K Oki; K Ito; T Yamamoto; Y Fukabori; K Kurokawa; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF CANCER, 99, 6, 846, 852

  DOI
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL, K Ito; M Ohi; T Yamamoto; S Miyamoto; K Kurokawa; Y Fukabori; K Suzuki; H Yamanaka, 2002年11月, CANCER, 95, 10, 2112, 2119

  DOI
• The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL, K Ito; M Ohi; T Yamamoto; S Miyamoto; K Kurokawa; Y Fukabori; K Suzuki; H Yamanaka, 2002年11月, CANCER, 95, 10, 2112, 2119

  DOI
• Possibility of re-screening intervals of morethan one year in men with PSA levels of 4.0 ng/ml or less, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, 2003年09月, PROSTATE, 57, 1, 8, 13

  DOI
• Possibility of re-screening intervals of morethan one year in men with PSA levels of 4.0 ng/ml or less, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, 2003年09月, PROSTATE, 57, 1, 8, 13

  DOI
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, M Hasumi; K Suzuki; H Matsui; H Koike; K Ito; H Yamanaka, 2003年10月, CANCER LETTERS, 200, 2, 187, 195

  DOI
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml, K Ito; T Yamamoto; M Ohi; K Kurokawa; K Suzuki; H Yamanaka, 2003年04月, UROLOGY, 61, 4, 760, 764

  DOI
• Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml, K Ito; T Yamamoto; M Ohi; K Kurokawa; K Suzuki; H Yamanaka, 2003年04月, UROLOGY, 61, 4, 760, 764

  DOI
• An evaluation of the Banff 97 classification after kidney transplantation, T Tanaka; M Kyo; Y Kokado; S Takahara; M Hatori; K Suzuki; M Hasumi; K Toki; N Ichimaru; A Okuyama; H Yamanaka, 2003年03月, TRANSPLANTATION PROCEEDINGS, 35, 2, 860, 861

  DOI
• An evaluation of the Banff 97 classification after kidney transplantation, T Tanaka; M Kyo; Y Kokado; S Takahara; M Hatori; K Suzuki; M Hasumi; K Toki; N Ichimaru; A Okuyama; H Yamanaka, 2003年03月, TRANSPLANTATION PROCEEDINGS, 35, 2, 860, 861

  DOI
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; N Ohtake; S Nakata; H Yamanaka, 2003年08月, BRITISH JOURNAL OF CANCER, 89, 4, 691, 696

  DOI
• Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; N Ohtake; S Nakata; H Yamanaka, 2003年08月, BRITISH JOURNAL OF CANCER, 89, 4, 691, 696

  DOI
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, 2003年06月, CANCER LETTERS, 195, 2, 177, 183

  DOI
• Association of the genetic polymorphism in cytochrome P450 (CYP) 1A1 with risk of familial prostate cancer in a Japanese population: a case-control study, K Suzuki; H Matsui; H Nakazato; H Koike; H Okugi; M Hasumi; N Ohtake; S Nakata; T Takei; M Hatori; K Ito; H Yamanaka, 2003年06月, CANCER LETTERS, 195, 2, 177, 183

  DOI
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, 2003年07月, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435

  DOI
• A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Nakazato; H Okugi; H Koike; Y Ono; K Ito; K Kurokawa; H Yamanaka, 2003年07月, JOURNAL OF BIOMEDICAL SCIENCE, 10, 4, 430, 435

  DOI
• Natural history of PSA increase with and without prostate cancer, K Ito; T Yamamato; M Ohi; H Takeuchi; K Kurokawa; K Suzuki; H Yamanaka, 2003年07月, UROLOGY, 62, 1, 64, 69

  DOI
• Natural history of PSA increase with and without prostate cancer, K Ito; T Yamamato; M Ohi; H Takeuchi; K Kurokawa; K Suzuki; H Yamanaka, 2003年07月, UROLOGY, 62, 1, 64, 69

  DOI
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, 2003年10月, CANCER, 98, 7, 1411, 1416

  DOI
• Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; B Kashiwagi; M Nishii; N Ohtake; S Nakata; K Ito; H Yamanaka, 2003年10月, CANCER, 98, 7, 1411, 1416

  DOI
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo., Yasuhiro Shibata; Bunzo Kashiwagi; Seiji Arai; Yoshitatsu Fukabori; Kazuhiro Suzuki; Seijiro Honma; Hidetoshi Yamanaka, 2004年10月, Endocrinology, 145, 10, 4507, 12

  DOI
• Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivo, Y Shibata; B Kashiwagi; S Arai; Y Fukabori; K Suzuki; S Honma; H Yamanaka, 2004年10月, ENDOCRINOLOGY, 145, 10, 4507, 4512

  DOI
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, K Ito; T Yamamoto; K Suzuki; K Kurokawa; H Yamanaka, 2004年02月, JOURNAL OF UROLOGY, 171, 2, 656, 660

  DOI
• The risk of rapid prostate specific antigen increase in men with baseline prostate specific antigen 2.0 ng/ml or less, K Ito; T Yamamoto; K Suzuki; K Kurokawa; H Yamanaka, 2004年02月, JOURNAL OF UROLOGY, 171, 2, 656, 660

  DOI
• Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer., Kazuto Ito; Takumi Yamamoto; Masaru Ohi; Hiroyuki Takechi; Kohei Kurokawa; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2004年04月10日, International journal of cancer, 109, 3, 455, 60

  DOI
• Cumulative probability of PSA increase above 4.0 NG/ML in population-based screening for prostate cancer, K Ito; T Yamamoto; M Ohi; H Takechi; K Kurokawa; K Suzuki; H Yamanaka, 2004年04月, INTERNATIONAL JOURNAL OF CANCER, 109, 3, 455, 460

  DOI
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, M Ohi; K Ito; K Suzuki; T Yamamoto; H Yamanaka, 2004年01月, EUROPEAN UROLOGY, 45, 1, 92, 97

  DOI
• Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4 ng/ml, M Ohi; K Ito; K Suzuki; T Yamamoto; H Yamanaka, 2004年01月, EUROPEAN UROLOGY, 45, 1, 92, 97

  DOI
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, Y Shibata; B Kashiwagi; Y Ono; Y Fukabori; K Suzuki; S Honma; H Yamanaka, 2004年02月, UROLOGICAL RESEARCH, 32, 1, 44, 48

  DOI
• The evaluation of rat prostate blood flow using a laser speckle flowmetry: a comparative study using the microsphere method in castrated and androgen-replenished rats, Y Shibata; B Kashiwagi; Y Ono; Y Fukabori; K Suzuki; S Honma; H Yamanaka, 2004年02月, UROLOGICAL RESEARCH, 32, 1, 44, 48

  DOI
• Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer, K Kurokawa; K Ito; T Yamamoto; H Takechi; S Miyamoto; K Suzuki; H Yamanaka, 2004年02月, UROLOGY, 63, 2, 268, 272

  DOI
• Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer., Kohei Kurokawa; Kazuto Ito; Takumi Yamamoto; Hiroyuki Takechi; Shigeto Miyamoto; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2004年02月, Urology, 63, 2, 268, 72

  DOI
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation, T Kawaguchi; T Moriyama; K Suzuki; M Hatori; T Tanaka; S Takahara; H Yamanaka, 2004年06月, TRANSPLANTATION PROCEEDINGS, 36, 5, 1293, 1296

  DOI
• Pilot study of the optimum hematocrit for patients in the predialysis stage after renal transplantation, T Kawaguchi; T Moriyama; K Suzuki; M Hatori; T Tanaka; S Takahara; H Yamanaka, 2004年06月, TRANSPLANTATION PROCEEDINGS, 36, 5, 1293, 1296

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues, Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, 2011年02月, STEROIDS, 76, 3, 301, 308

  DOI
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., Seiji Arai; Yoshimichi Miyashiro; Yasuhiro Shibata; Yukio Tomaru; Mikio Kobayashi; Seijiro Honma; Kazuhiro Suzuki, 2011年02月, Steroids, 76, 3, 301, 8

  DOI
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2011年04月, The Journal of urology, 185, 4, 1497, 503

  DOI
• Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D-3 Induced Cell Growth Inhibition in Prostate Cancer, Hidekazu Koike; Yasuyuki Morikawa; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2011年04月, JOURNAL OF UROLOGY, 185, 4, 1497, 1503

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Keiji Suzuki; Kazuhiro Suzuki, 2014年05月, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

  DOI
• Time-dependent effects of castration on the bladder function and histological changes in the bladder and blood vessels, Tomohiro Magari; Yasuhiro Shibata; Seiji Arai; Bunzo Kashiwagi; Keiji Suzuki; Kazuhiro Suzuki, 2014年05月, ASIAN JOURNAL OF ANDROLOGY, 16, 3, 457, 460

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Kazumi Kamoi, 2014年05月, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

  DOI
• Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: The first large population report from the Cancer Registration Committee of the Japanese Urological Association, Hiroyuki Fujimoto; Hiroyuki Nakanishi; Tsuneharu Miki; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Yukio Homma; Kazumi Kamoi, 2014年05月, INTERNATIONAL JOURNAL OF UROLOGY, 21, 5, 527, 534

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori, 2014年09月, INFLAMMATION RESEARCH, 63, 9, 789, 796

  DOI
• Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma, Tamotsu Ishizuka; Takeshi Hisada; Motoaki Hatori; Akio Koike; Kikuo Hanabuchi; Shinichi Matsuzaki; Yosuke Kamide; Mitsuyoshi Utsugi; Haruka Aoki; Reiko Yoshino; Noriko Yanagitani; Yasuhiko Koga; Akihiro Ono; Kyoichi Kaira; Noriaki Sunaga; Kunio Dobashi; Takahiro Tsuburai; Kazuo Akiyama; Masanobu Yamada; Kazuhiro Suzuki; Masatomo Mori, 2014年09月, INFLAMMATION RESEARCH, 63, 9, 789, 796

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Tsuneharu Miki; Kazumi Kamoi; Hiroyuki Fujimoto; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Kazuya Mikami; Yukio Homma, 2014年08月, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

  DOI
• Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association, Tsuneharu Miki; Kazumi Kamoi; Hiroyuki Fujimoto; Hiro-omi Kanayama; Chikara Ohyama; Kazuhiro Suzuki; Hiroyuki Nishiyama; Masatoshi Eto; Seiji Naito; Tomoharu Fukumori; Yoshinobu Kubota; Satoru Takahashi; Kazuya Mikami; Yukio Homma, 2014年08月, INTERNATIONAL JOURNAL OF UROLOGY, 21, 8, S1, S6

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort, Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, 2014年07月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 7, 1197, 1204

  DOI
• Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort., Teruo Inamoto; Haruhito Azuma; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Suzuki Kazuhiro; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Michiyuki Usami; Masaru Murai; Hideyuki Akaza, 2014年07月, Journal of cancer research and clinical oncology, 140, 7, 1197, 204

  DOI
• Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan., Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, 2014年10月, Japanese journal of clinical oncology, 44, 10, 969, 81

  DOI
• Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan, Mizuki Onozawa; Shiro Hinotsu; Taiji Tsukamoto; Mototsugu Oya; Osamu Ogawa; Tadaichi Kitamura; Kazuhiro Suzuki; Seiji Naito; Mikio Namiki; Kazuo Nishimura; Yoshihiko Hirao; Hideyuki Akaza, 2014年10月, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 10, 969, 981

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

  DOI
• YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Seiji Arai; Yosuke Furuya; Masashi Nomura; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Tetsunari Oyama; Kazuhiro Suzuki, 2014年10月, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer., Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, 2014年04月, Cancer chemotherapy and pharmacology, 73, 4, 703, 10

  DOI
• Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer, Hirofumi Mukai; Shunji Takahashi; Masahiro Nozawa; Yusuke Onozawa; Jun Miyazaki; Keiji Ohno; Kazuhiro Suzuki, 2014年04月, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 4, 703, 710

  DOI
• Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, 速報，短報，研究ノート等（学術雑誌）

  DOI
• Suicide attempt with an overdose of sunitinib, Seiji Arai; Hiroshi Matsui; Ryo Ohki; Yoshiyuki Miyazawa; Hidekazu Koike; Tadahiro Hashita; Yoshihiko Katsuyama; Yoshitaka Sekine; Masashi Nomura; Yasuhiro Shibata; Motoaki Hatori; Kazuto Ito; Koujirou Yamamoto; Shigeru Ohmori; Kazuhiro Suzuki, 2014年10月, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 78, 4, 933, 935, 速報，短報，研究ノート等（学術雑誌）

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama; Tomoyuki Shimabukuro; Isao Hara; Yasuo Kohjimoto; Kazuhiro Suzuki; Hidekazu Koike; Hirotsugu Uemura; Taiji Hayashi; Munehisa Ueno; Kiichiro Kodaira; Yoshihiko Tomita; Toshihiko Sakurai; Nobuaki Shimizu, 2014年10月, International journal of clinical oncology, 19, 5, 946, 54

  DOI
• Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer., Hideyasu Matsuyama; Tomoyuki Shimabukuro; Isao Hara; Yasuo Kohjimoto; Kazuhiro Suzuki; Hidekazu Koike; Hirotsugu Uemura; Taiji Hayashi; Munehisa Ueno; Kiichiro Kodaira; Yoshihiko Tomita; Toshihiko Sakurai; Nobuaki Shimizu, 2014年10月, International journal of clinical oncology, 19, 5, 946, 54

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 2014年09月26日, BMC cancer, 14, 717, 717

  DOI
• High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Satoshi Morita; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 2014年09月26日, BMC cancer, 14, 717, 717

  DOI
• Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer., Yasuhide Miyoshi; Hiroji Uemura; Susumu Umemoto; Kentaro Sakamaki; Masataka Taguri; Kazuhiro Suzuki; Yasuhiro Shibata; Naoya Masumori; Tomohiko Ichikawa; Atsushi Mizokami; Yoshiki Sugimura; Norio Nonomura; Hideki Sakai; Seijiro Honma; Masaoki Harada; Yoshinobu Kubota, 2016年03月, The Prostate, 76, 4, 376, 82

  DOI
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals, Katsuyuki Nakajima; Tsukasa Kodaira; Mihoko Kato; Kyoumi Nakazato; Yoshiharu Tokita; Hiroki Kikuchi; Hiromi Sekine; Keiji Suzuki; Takeaki Nagamine, 2010年, Clinica Chimica Acta, 411, 9-10, 758, 761

  DOI
• Development of an enzyme-linked immunosorbent assay for metallothionein-I and -II in plasma of humans and experimental animals, Katsuyuki Nakajima; Tsukasa Kodaira; Mihoko Kato; Kyoumi Nakazato; Yoshiharu Tokita; Hiroki Kikuchi; Hiromi Sekine; Keiji Suzuki; Takeaki Nagamine, 2010年, Clinica Chimica Acta, 411, 9-10, 758, 761

  DOI
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA](n) repeat with familial prostate cancer risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4941, 4946
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Koike; H Nakazato; H Okugi; M Hasumi; Y Fukabori; K Kurokawa; H Yamanaka, 2003年05月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 5, 261, 266

  DOI
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, Y Shibata; B Kashiwagi; S Arai; K Suzuki, 2005年04月, JOURNAL OF UROLOGY, 173, 4, 387, 387, 研究発表ペーパー・要旨（国際会議）

  DOI
• 日本における前立腺がん検診と予後, 鈴木 和浩, 2003年, 日本がん検診・診断学会誌, 10,No.2(192-194)
• Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, S Usui; K Suzuki; H Yamanaka; T Nakano; K Nakajima; Y Hara; M Okazaki, 2002年03月, CLINICA CHIMICA ACTA, 317, 1-2, 133, 143

  DOI
• A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine, T Tanaka; S Takahara; M Hatori; K Suzuki; JD Wang; N Ichimaru; S Suzuki; K Morozumi; A Okuyama; H Yamanaka, 2002年07月, CANCER LETTERS, 181, 2, 165, 171

  DOI
• Tumor-associated tissue eosinophilia of penile cancer, Y Ono; M Ozawa; Y Tamura; T Suzuki; K Suzuki; K Kurokawa; Y Fukabori; H Yamanaka, 2002年02月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 2, 82, 87

  DOI
• 膀胱重量算出ノモグラムを使用した下部尿路閉塞の評価, 曲 友弘; 深堀 能立; 鈴木 和浩; 山中 英寿; 小倉治之, 2004年, 泌尿器科紀要, 50,No.1(7-14)
• 男性維持透析患者における前立腺癌のスクリーニング, 羽鳥 基明; 鈴木 和浩; 柴田 康博; 伊藤 一人; 黒川 公平, 2004年, 泌尿器科外科, 17, No.12 (1251-1254)
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: An association with clinical characteristics and vascular endothelial growth factor levels, K Matsumoto; K Suzuki; H Koike; K Okamura; K Tsuchiya; T Uchida; Y Takezawa; M Kobayashi; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4953, 4958
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, K Matsumoto; K Suzuki; H Koike; M Hasumi; H Matsui; H Okugi; Y Shibata; K Ito; H Yamanaka, 2003年09月, ANTICANCER RESEARCH, 23, 5A, 3767, 3773
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, 2004年02月, INTERNATIONAL JOURNAL OF ANDROLOGY, 27, 1, 50, 56

  DOI
• 未治療進行性前立腺癌における初回LH-RH agonist投与時のflare-up予防：Diethylstilbestrol-Diphosphate, Estramustine Phosphate, Chlormadinone Acetateによる比較検討, 松井 博; 鈴木 和浩; 中里 晴樹; 黒川 公平; 柴田 康博; 蓮見 勝; 伊藤 一人; 深堀 能立; 山中 英寿, 2001年, 癌の臨床, 47,No.10(861-866)
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute gen・・・, AKIMOTO TETSUO; ITO KAZUTO; YAMAMOTO TAKUMI; SUZUKI KAZUHIRO; NAKANO TAKASHI, 2005年10月01日, Int J Radiat Oncol Biol Phys., International journal of radiation oncology, biology, physics, 63, 2, 463, 71

  DOI
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis: A case report, Kazuhisa Matsumoto; Masamichi Hayashi; Nozomu Kosaku; Yoshihiro Ono; Takumi Yamamoto; Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2003年, Kitakanto Medical Journal, 53, 1, 55, 57

  DOI
• 前立腺生検の適応, 鈴木 和浩; 伊藤 一人; 山中 英寿, 2004年, 臨床泌尿器科, 58,No.7(455-459)

  DOI
• Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8(+) T cells, TA Fehniger; K Suzuki; A Ponnappan; JB VanDeusen; MA Cooper; SM Florea; AG Freud; ML Robinson; J Durbin; MA Caligiuri, 2001年01月, JOURNAL OF EXPERIMENTAL MEDICINE, 193, 2, 219, 231

  DOI
• 膀胱癌と前立腺癌, 羽鳥 基明; 鈴木 和浩; 山中英壽, 2004年, 日本臨床, 62, 増刊号6 (374-377)
• 前立腺疾患のトピックス 前立腺癌家族内発生, 鈴木 和浩; 大竹伸明; 中田誠司; 山中 英寿, 2003年, 臨床泌尿器科, 57,No.4(310-315)

  DOI
• 前立腺癌における新しい画像診断：MR-Spectroscopy(MRS), 鈴木 和浩, 2004年, 日本がん検診・診断学会誌, 11,No.2(62-64)
• 前立腺癌検診の効用, 鈴木 和浩; 山中 英寿, 2004年, 綜合臨牀, 53,No.10(2741-2742)
• ガイドラインに基づく腎尿路疾患診療 前立腺癌, 鈴木 和浩; 羽鳥 基明, 2004年, 腎と透析, 56,No.5(758-762)
• 家族性・遺伝性前立腺がん, 鈴木 和浩; 大竹伸明; 松井 博; 中田誠司, 2004年, 泌尿器外科, 17,No.9(971-976)
• 前立腺癌の症状、治療の基礎知識, 鈴木 和浩; 村椿茂里; 諸田了子, 2004年, ウロ・ナーシング, 9,No.10(908-915)
• 進行性前立腺癌におけるFlutamideによる副腎性アンドロゲン抑制効果の臨床的検討, 中里 晴樹; 鈴木 和浩; 伊藤 一人; 深堀 能立; 黒川 公平; 山中 英寿, 2001年, 日本泌尿器科学会雑誌, 92,No.(6-12)

  DOI
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer, S Miyamoto; K Ito; K Kurokawa; K Suzuki; K Suzuki; H Yamanaka, 2006年06月, INTERNATIONAL JOURNAL OF UROLOGY, 13, 6, 767, 772

  DOI
• 前立腺生検法, 鈴木 和浩; 伊藤 一人, 2005年, 日本臨床, 63,No.2(253-259)
• Fatal leukemia in interleukin-15 transgenic mice, TA Fehniger; K Suzuki; JB VanDeusen; MA Cooper; AG Freud; MA Caligiuri, 2001年01月, BLOOD CELLS MOLECULES AND DISEASES, 27, 1, 223, 230

  DOI
• 酢酸クロルマジノン(プロスタール)を用いた症例, 鈴木 和浩; 黒川 公平; 山中 英寿, 2002年, 排尿障害プラクティス, 10,No.3(245-248)
• 初回ホルモン療法後の再燃における放射線療法の適応 PSAdoubling time(PSADT)による判定は可能か, 黒川 公平; 伊藤 一人; 鈴木 和浩; 深堀 能立; 秋元 哲夫; 三橋紀夫; 山中 英寿, 2001年, 泌尿器外科, 14,No.臨時増刊(451-453)
• CAPD導入5年後に陰嚢浮腫、陰茎浮腫を認めた1例, 上井崇智; 曲 友弘; 川口拓也; 羽鳥 基明; 鈴木 和浩; 山中 英寿, 2004年, 日本透析医学会雑誌, 37,No.3(249-252)

  DOI
• 網膜多発血栓を合併し、ヘパリン起因性血小板減少症(HIT)が強く疑われた1例, 曲 友弘; 羽鳥 基明; 蓮見 勝; 田中俊之; 松井 博; 森田崇弘; 小野芳啓; 鈴木 和浩; 山中 英寿, 2004年, 日本透析医学会雑誌, 37,No.6(1437-1442)

  DOI
• BODY MASS INDEX（BMI）の前立腺がん罹患および血清PSA値に与える影響, 山本 巧; 伊藤 一人; 武智 浩之; 鈴木 和浩, 2006年, 腎泌予防医誌, 14(1): 43-45
• 前立腺がん集団検診における年齢階層別発見がんの臨床病理学的検討―受診年齢上限の設定について―, 山本 巧; 伊藤 一人; 武智 浩之; 黒川 公平; 鈴木 和浩; 山中 英寿, 2003年, 日本がん検診・診断学会誌, 10(2):118-122
• 年齢階層別PSAを基準とした前立腺がん検診の展開―前立腺がん集団検診における導入の意義―, 山本 巧; 黒川 公平; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2003年, 日本がん検診・診断学会誌, 10(2):87-90
• 前立腺がん集団検診における年齢階層別ＰＳＡ基準値の有用性―69歳以下のＰＳＡ基準値引き下げによる効果―, 武智 浩之; 山本 巧; 伊藤 一人; 黒川 公平; 鈴木 和浩; 山中 英寿, 2003年, 日本がん検診・診断学会誌, 10(2):126-129
• Hands-free hook for endourological procedures, Y Ono; K Suzuki, 2003年10月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 10, 561, 562

  DOI
• 群馬県における前立腺癌の罹患率、臨床病期、組織学的分化度の推移, 中田誠司; 大竹伸明; 久保田裕; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2004年, 泌尿紀要, 50:165-170
• Role of androgen on blood flow and capillary structure in rat seminal vesicles, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, 2004年03月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 202, 3, 193, 201

  DOI
• 本邦における家族性前立腺癌の最新知見, 大竹伸明; 中田誠司; 深堀 能立; 鈴木 和浩; 山中 英寿, 2002年, 日本臨牀, 60,No.11(469-473)
• 古作クリニックにおけるブラッドアクセスの現状と初回内シャントと2回目内シャントの比較検討, 小野芳啓; 羽鳥 基明; 伊藤 一人; 鈴木 和浩; 山中 英寿; 古作 望; 松本和久; 林 雅道; 内田達也; 竹澤 豊; 小林 幹男; 中里 晴樹; 山本 巧, 2002年, 臨牀透析, 18,No.10(1377-1381)
• 原発性陰嚢内硬化性脂肪肉芽腫―手術的摘除例と自然消退例, 小野芳啓; 古作 望; 矢嶋久徳; 高橋 修; 深堀 能立; 鈴木 和浩; 山中 英寿; 真下正道; 関原哲夫; 猿木和久; 松本和久; 林 雅道, 2002年, Kitakanto Med J, 52,No.4(271-277)

  DOI
• 機能的解剖を応用した術中勃起神経温存評価の短期結果, 黒川 公平; 小山大輔; 山中 英寿; 鈴木 孝憲; 鈴木 和浩; 伊藤 一人; 小野芳啓; 深堀 能立; 武井智幸; 寺田直樹; 荒井陽一, 2002年, 泌尿器外科, 15,No.8(928-930)
• 尿路腫瘍(膀胱、腎盂・尿管癌)外来におけるPSAスクリーニング, 黒川 公平; 松井 博; 深堀 能立; 山中 英寿; 鈴木 和浩; 岡崎 浩; 伊藤 一人; 塩野昭彦; 羽鳥 基明; 蓮見 勝; 井上雅晴; 川口拓也, 2002年, 日本腎泌尿器疾患予防医学研究会誌, 10,No.1(29-30)
• 集合管癌(Bellini管癌)の一例, 小池 秀和; 武井智幸; 大竹伸明; 真下正道; 鈴木 和浩; 山中 英寿, 2002年, Kitakannto Med J, 52,No.4(267-270)

  DOI
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; N Terada; K Ito; D Yoshikawa; Y Arai; H Yamanaka, 2003年03月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 3, 136, 140

  DOI
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: Is it possible to identify patients likely to have good treatment outcomes?, K Kurokawa; K Ito; K Suzuki; Y Ono; T Yamamoto; T Akimoto; H Yamanaka, 2002年11月, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 32, 11, 466, 471

  DOI
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, K Suzuki; N Ohtake; S Nakata; T Takei; H Matsui; Y Ono; H Nakazato; M Hasumi; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2002年11月, ANTICANCER RESEARCH, 22, 6B, 3507, 3511
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, M Hasumi; K Suzuki; N Oya; K Ito; K Kurokawa; Y Fukabori; H Yamanaka, 2002年03月, ANTICANCER RESEARCH, 22, 2B, 1205, 1208
• 私の行っている縫合と吻合の手技―膀胱･尿道吻合, 黒川 公平; 鈴木 和浩; 山中 英寿, 2002年, 臨床泌尿器科, 56,No.13(1119-1123)

  DOI
• Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage, H Koike; K Suzuki; T Satoh; N Ohtake; T Takei; S Nakata; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4947, 4951
• 慢性腎不全に腎盂腫瘍を合併し、血液透析導入、外科手術を行った血友病Ｂの１例, 曲 友弘; 羽鳥 基明; 小野芳啓; 塩野昭彦; 清水信明; 黒川 公平; 深堀 能立; 鈴木 和浩; 山中 英寿, 2003年, 日本透析医学会雑誌, 36,No.12(1731-1736)

  DOI
• 後腹膜原発性腺外胚細胞腫瘍の一例, 河野真意; 鈴木光一; 鈴木 孝憲; 富田 光; 岡本亘平; 松井 博; 山本 巧; 中里 晴樹; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002年, Kitakanto Med J, 52,No.3(203-206)
• 前立腺特異抗原(PSA)による前立腺がん検診と精度管理, 山本 巧; 伊藤 一人; 武智 浩之; 黒川 公平; 鈴木 和浩; 山中 英寿, 2004年, 日本がん検診・診断学会誌, 11(2): 37-39
• PSA4.1～10ng/mlにおける前立腺生検法の検討 年齢/前立腺体積を考慮に入れた前立腺生検法の有用性, 伊藤 一人; 山本 巧; 大井 勝; 深堀 能立; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002年, 泌尿器外科, 15No.8(934-937)
• 膀胱平滑筋肉腫の一例, 河野真意; 松井 博; 山本 巧; 小野芳啓; 深堀 能立; 黒川 公平; 鈴木 和浩; 山中 英寿; 鈴木慶二, 2002年, Kitakanto Med J, 52,No.4(279-282)

  DOI
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/mL or less, K Ito; Y Kubota; T Yamamoto; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2001年02月, CANCER, 91, 4, 744, 751

  DOI
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride, Y Shibata; Y Fukabori; K Ito; K Suzuki; H Yamanaka, 2001年01月, JOURNAL OF UROLOGY, 165, 1, 289, 293
• Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray, H Matsui; K Suzuki; M Hasumi; H Koike; H Okugi; H Nakazato; H Yamanaka, 2003年01月, ANTICANCER RESEARCH, 23, 1A, 195, 200
• 生下時より認めていたと思われる小児精巣腫瘍の１例, 上井崇智; 加藤雄一; 三木正也; 鈴木 和浩; 山中 英寿, 2002年, 泌尿器外科, 15,No.11(1237-1240)
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, T Yamamoto; K Ito; K Suzuki; H Yamanaka; K Ebihara; A Sasaki, 2002年07月, JOURNAL OF UROLOGY, 168, 1, 190, 191, その他
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, K Kurokawa; K Suzuki; H Okazaki; K Ito; A Shiono; Y Fukabori; H Yamanaka, 2002年05月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 5, 237, 240

  DOI
• Gene expression profiles in human BPH: Utilization of laser-capture microdissection and quantitative real-time PCR, K Suzuki; H Matsui; M Hasumi; Y Ono; H Nakazato; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2001年11月, ANTICANCER RESEARCH, 21, 6A, 3861, 3864
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less, T Yamamoto; K Ito; M Ohi; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2001年12月, UROLOGY, 58, 6, 994, 998

  DOI
• 透析患者の腎尿路系腫瘍 ３前立腺癌, 鈴木和浩; 羽鳥基明, 2006年, 透析フロンティア, 16, 3, 13, 15
• 前立腺肥大症治療におけるChlormadinone acetate投与によるPSA測定値への影響（他施設共同研究）, 藤本清秀; 舛森直哉; 塚本泰司; 徳山聡; 荒井陽一; 谷川俊貴; 高橋公太; 鈴木和浩; 山中英壽; 宮永直人; 赤座英之; 加藤聡彦; 石井延久; 宮澤克人; 鈴木孝治; 小野佳成; 大島伸一; 平尾佳彦; CMA-PSA研究会, 2005年, 日本腎泌尿器疾患予防医学研究会誌, 13, 1, 89, 91
• 前立腺癌診療ガイドラインからみた前立腺癌検診, 鈴木和浩, 2006年, 総合臨床, 55, 11, 2705
• 前立腺癌, 鈴木和浩; 羽鳥基明, 2006年, 腎と透析 臨時増刊号, 464, 468
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2006年09月, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149

  DOI
• 前立腺の病気になりやすい人はいるか, 鈴木和浩; 松井博; 大竹伸明, 2005年, からだの科学, 243
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, Y Ono; K Suzuki; H Yuasa; K Kurokawa; Y Fukabori; H Yamanaka, 2003年09月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 201, 1, 29, 38

  DOI
• Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; K Ito; K Kurokawa; H Yamanaka, 2003年05月, ANTICANCER RESEARCH, 23, 3C, 2897, 2902
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, M Hasumi; K Suzuki; A Taketomi; H Matsui; T Yamamoto; K Ito; K Kurokawa; J Aoki; K Endo; H Yamanaka, 2003年09月, ANTICANCER RESEARCH, 23, 5B, 4223, 4227
• NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer, K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2001年04月, JOURNAL OF LEUKOCYTE BIOLOGY, 69, 4, 531, 537
• 新しい前立腺がん診断法と将来の方向性について, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2004年, 日本がん検診・診断学会誌, 11: 50-53
• 群馬大学医学部附属病院における維持透析患者の手術症例の検討, 羽鳥 基明; 黒川 公平; 深堀 能立; 山中 英寿; 林 雅道; 塩野昭彦; 蓮見 勝; 武井智幸; 松井 博; 川口拓也; 伊藤 一人; 鈴木 和浩, 2002年, 日本透析医学会雑誌, 35,No.11(1447-1451)

  DOI
• 嫌色素性腎癌の１例, 柏木 文蔵; 栗田 晋; 中村敏之; 加藤宣雄; 鈴木 和浩; 山中 英寿, 2002年, 泌尿器科紀要, 48,No.2(85-87)
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, K Suzuki; Y Fukabori; H Nakazato; M Hasumi; H Matsui; K Ito; K Kurokawa; H Yamanaka, 2001年06月, INTERNATIONAL JOURNAL OF ANDROLOGY, 24, 3, 183, 188

  DOI
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; K Ito; N Shimizu; Y Fukabori; H Yamanaka, 2001年05月, INTERNATIONAL JOURNAL OF UROLOGY, 8, 5, 231, 236

  DOI
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, K Ito; T Yamamoto; M Ohi; Y Kubota; Y Fukabori; K Kurokawa; K Suzuki; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 6, 316, 321

  DOI
• 内分泌外科からみた前立腺癌の臨床：前立腺癌の治療法と適応, 鈴木和浩, 2005年, 内分泌外科, 22, 4, 206, 216
• 腫瘍マーカー/泌尿器系 PSA(γ-Sm), 鈴木和浩, 2005年, Medicina, 42, 12, 539, 541
• 腎細胞癌の多発性肺転移症例に対する骨髄非破壊的同種末梢血幹細胞移植, 土岐典子; 松島孝文; 斉藤泰之; 横浜章彦; 塚本憲史; 唐沢正光; 村上博和; 鈴木和浩; 野島美久, 2006年08月, kitakanto medical journal, Kitakanto Medical Journal, 56, 3, 231, 235

  DOI
• 前立腺腫瘍マーカーの進歩と問題点：２．前立腺がんスクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 伊藤 一人; 鈴木 和浩; 山中 英寿, 2001年, 泌尿器外科, 14(臨増): 441-443
• 前立腺集団検診受診者における国際前立腺症状スコアー(I-PSS)の傾向とQOL indexとの関係, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2001年, 泌尿器外科, 14(8): 868-871
• 前立腺特異抗原値(PSA)が6.1～10.0ng/mlにおける生検陽性率に関係する因子の臨床的検討, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2001年, 腎泌予防医誌, 9(1): 66-68
• 前立腺特異抗原(PSA)値別および年齢別の遊離型PSA(fPSA)・総PSA(tPSA)比の基準値設定に関する研究, 山本 巧; 伊藤 一人; 鈴木 和浩; 山中 英寿, 2001年, 腎泌予防医誌, 9(1): 69-70
• 群馬県における前立腺がん検診の変遷・現況・将来展望, 武智浩之; 伊藤 一人; 山本 巧; 鈴木 和浩, 2003年, 泌尿器外科, 16(9),1005-1010
• 前立腺集団検診における年齢階層別PSA基準値の有用性, 山本 巧; 伊藤 一人; 大井 勝; 久保田裕; 黒川 公平; 鈴木 和浩; 山中 英寿, 2002年, 日本腎泌尿器疾患予防医学研究会誌, 10,No.1(18-19)
• Malignant fibrous histiocytoma of the right spermatic cord: A case report, Y Sekine; K Ohki; K Okamoto; M Nomura; H Tomita; N Ohtake; K Suzuki; K Kurokawa; M Mashimo; K Saruki; T Morita; H Nakazato; H Yokoo; H Yamanaka, 2001年10月, INTERNATIONAL JOURNAL OF UROLOGY, 8, 10, 581, 584

  DOI
• 前立腺癌の早期診断と治療をめぐって, 荒井陽一; 鈴木 和浩; 頴川 晋, 2004年, カレントテラピー, 22,No.9(88-94)
• 男性型脱毛症薬プロペシア錠（フィナステリド）の前立腺がん検診における内服症例と年齢をマッチさせた非内服症例の血清PSA値の比較, 宮久保真意; 伊藤一人; 山本巧; 武智浩之; 大井勝; 鈴木和浩, 2008年, 日本がん検診・診断学会雑誌, 15, 2, 125, 127
• 前立腺癌の治療Q&A, 鈴木和浩, 2005年, 泌尿器ケア 冬季増刊, 140, 153
• 前立腺癌治療後のPSA再発をいかにとらえるか 放射線療法後のPSA再発に対する治療戦略 When and How+, 鈴木和浩, 2008年, Urological View, 6, 2, 74, 80
• 前立腺癌予見因子としての血清インスリン様成長因子の意義, 山本巧; 伊藤一人; 武智浩之; 大井勝; 宮久保真意; 鈴木和浩, 2007年, 日本がん検診・診断学会雑誌, 15, 1, 93, 95
• 前立腺癌予防の可能性：脂質, 関根芳岳; 小池秀和; 鈴木和浩, 2007年, 泌尿器外科, 20, 12, 1525, 1529
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 検診 前立腺癌検診における年齢階層別PSA基準値導入の意義, 大井勝; 伊藤一人; 山本巧; 武智浩之; 鈴木和浩, 2007年, 日本臨床, 65, 10, 203, 206
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 検診 我が国における前立腺癌検診の現状と展望, 鈴木和浩, 2007年, 日本臨床, 65, 10, 187, 293
• 前立腺癌 基礎・臨床研究のアップデート 臨床研究 疫学 我が国における家族性前立腺癌の特徴, 大竹伸明; 中田誠司; 鈴木和浩; 深堀能立; 山中英壽, 2007年, 日本臨床, 65, 10, 182, 186
• 排尿障害の診断と治療, 鈴木和浩, 2007年, 高崎医学, 57, 25, 27
• 前立腺癌 男性ホルモン依存性と非依存性, 鈴木 和浩; 山中 英寿, 2002年, ホルモンと臨床, 50,No.1(83-87)
• 泌尿器科 疼痛対策 進行癌の疼痛対策 前立腺癌, 鈴木和浩; 小池秀和, 2007年, Urology view, 5, 5, 77, 82
• 多数箇所生検で発見された前立腺癌の前立腺領域別分布, 武智 浩之; 伊藤 一人; 山本 巧; 黒川 公平; 鈴木 和浩, 2005年, 日本がん検診・診断学会誌, 12: 148-150
• PSAスクリーニング導入後10年間の検診発見前立腺癌症例の臨床病理学的特徴の変化, 山本 巧; 伊藤 一人; 武智 浩之; 河野真意; 坂西理恵; 黒川 公平; 鈴木 和浩; 山中 英寿, 2005年, 泌尿器外科, 18(8):1000-1002
• 前立腺がん検診暴露率と発見がん症例の臨床的特徴の関係, 武智 浩之; 伊藤 一人; 山本 巧; 黒川 公平; 鈴木 和浩; 山中 英寿, 2005年, 泌尿器外科, 18(8): 997-999
• 群馬県における前立腺集団検診形態の変遷-18年間の総括および現況・問題点-, 伊藤 一人; 山本 巧; 鈴木 和浩; 山中 英寿, 2000年, 泌尿器外科, 13/8,997-1001
• Incidence of bladder cancer discovered by urethrocystoscopy at prostate biopsy: Extraordinary high incidence of tiny bladder cancer in elderly males, H Okazaki; K Suzuki; T Suzuki; K Kurokawa; K Ito; K Suzuki; H Yamanaka, 2004年05月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 203, 1, 31, 36

  DOI
• JUA前立腺癌診療ガイドライン 初版の読みどころと改定に向けての課題 疫学, 鈴木和浩, 2007年, 泌尿器外科, 20, 6, 737, 741
• 泌尿器悪性腫瘍 最近の診断と治療 増加する前立腺癌 家族性・遺伝性前立腺がん, 鈴木和浩, 2000年, 臨床と研究, 84, 3, 309, 314
• EBMに基づいた前立腺癌診療ガイドライン２００６年度版 要約, 守殿貞夫; 大島伸一; 平尾佳彦; 鈴木和浩; 荒井陽一; 藤元博行; 江川晋; 赤座英之; 原勲; 筧善行; 樋之津史朗; 長谷川友紀, 2007年, 日本泌尿器科学会雑誌, 98, 1, 31
• Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, K Ito; Y Fukabori; Y Shibata; K Suzuki; M Mieda; K Gotanda; S Honma; H Yamanaka, 2000年10月, EUROPEAN JOURNAL OF ENDOCRINOLOGY, 143, 4, 543, 554
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: Evaluation of mass screening populations, K Ito; Y Kubota; K Suzuki; N Shimizu; Y Fukabori; K Kurokawa; K Imai; H Yamanaka, 2000年05月, UROLOGY, 55, 5, 705, 709
• Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, Y Shibata; K Ito; K Suzuki; K Nakano; Y Fukabori; R Suzuki; Y Kawabe; S Honma; H Yamanaka, 2000年01月, PROSTATE, 42, 1, 45, 55

  DOI
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998年, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, 1997年11月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, 1996年05月, PROSTATE, 28, 5, 328, 337

  DOI
• Editorial Comment, Kazuhiro Suzuki, 2008年, Int J Urol, 2, 15, 161

  DOI
• Editorial Comment, Kazuhiro Suzuki, 2008年, Int J Urol, 15

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan - Comment, Ernesto Lopez-Corona; Maxwell Meng, 2007年10月, JOURNAL OF UROLOGY, 178, 4, 1263, 1264, その他

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, 2007年04月, JOURNAL OF UROLOGY, 177, 4, 536, 537, 研究発表ペーパー・要旨（国際会議）

  DOI
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response, TA Fehniger; MH Shah; MJ Turner; JB VanDeusen; SP Whitman; MA Cooper; K Suzuki; M Wechser; F Goodsaid; MA Caligiuri, 1999年04月, JOURNAL OF IMMUNOLOGY, 162, 8, 4511, 4520
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, 1997年11月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, 1996年05月, PROSTATE, 28, 5, 328, 337

  DOI
• IL-15 costimulates the generalized shuartzman reaction and innate immune IFN-γ production in vivo, SUZUKI KAZUHIRO, 2000年02月, J Immunol, JOURNAL OF IMMUNOLOGY, 164, 4, 1643, 1647
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998年, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, K Ito; T Yamamoto; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2000年08月, UROLOGY, 56, 2, 278, 282

  DOI
• ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA - PROSTATE SIZE AND VOLUME ARE CORRELATED WITH SERUM ESTROGEN CONCENTRATION, K SUZUKI; K ITO; Y ICHINOSE; K KUROKAWA; T SUZUKI; K IMAI; H YAMANAKA; S HONMA, 1995年03月, SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 29, 1, 65, 68
• SYNERGISTIC EFFECTS OF ESTROGEN AND ANDROGEN ON THE PROSTATE - EFFECTS OF ESTROGEN ON ANDROGEN-RECEPTORS AND ESTROGEN-RECEPTORS, BRDU UPTAKE, IMMUNOHISTOCHEMICAL STUDY OF AR, AND RESPONSES TO ANTIANDROGENS, K SUZUKI; K ITO; T SUZUKI; S HONMA; H YAMANAKA, 1995年03月, PROSTATE, 26, 3, 151, 163
• 前立腺疾患：疫学の動向、治療のトレンド、手術のポイント, 鈴木和浩, 2009年, Life Support ad Anesthesia, 16, 11, 1064
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Keigo Okamura; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2009年08月, Cancer Epidemiology, 33, 2, 137, 141

  DOI
• 前立腺癌検診の意義, 鈴木和浩, 2009年, 総合臨床, 58, 11, 2351, 352
• 進行癌に対する内分泌療法, 鈴木和浩, 2009年, Urology View, 7, 2, 10, 16
• 照射後の膀胱全摘・尿路変更に伴う腸管トラブル, 鈴木和浩, 2010年, 泌尿器外科, 23, 5, 719
• 前立腺がんと前立腺肥大症の疫学, 鈴木和浩, 2009年, 日本医師会雑誌, 138, 2, 251
• 前立腺がん検診の有効性 死亡率減少効果について, 鈴木和浩, 2008年, 泌尿器外科, 21, 12, 1585
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009年, JMAJ, 52, 6, 478
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy, K Suzuki; H Okazaki; Y Ono; K Kurokawa; T Suzuki; E Onuma; H Takanashi; Y Mamiya; H Yamanaka, 1998年10月, PROSTATE, 37, 2, 70, 76

  DOI
• 前立腺と組織内アンドロゲン ー前立腺癌の診断・治療における応用の可能性, 鈴木和浩; 柏木文蔵; 新井誠二; 柴田康博; 本間誠次郎, 2009年, 産科と婦人科, 81, 2, 200
• 去勢抵抗性前立腺がんにおける男性ホルモンの意義, 2011年, 最新医学
• 前立腺がんの病態・診断・治療, 2011年, 泌尿器ケア
• 国内外のガイドラインからみた間歇的内分泌療法の位置付けと現状, 2011年, 泌尿器外科
• 我が国における前立腺癌検診の現状と展望, 2011年, 日本臨床
• 尿路上皮癌に対するＧＣ療法施行時におけるパロノセトロンの効果：グラニセトロンとの比較検討, 2011年, 癌の臨床
• 泌尿器科領域におけるがん検診と超音波の役割, 2011年, 泌尿器科領域におけるがん検診と超音波の役割
• 透析療法における様々な疑問に答える ー４透析患者の腎尿路悪性腫瘍-前立腺癌, 2011年, 透析フロンティア
• 腎・泌尿器疾患：ＡＬＰおよびＰＳＡの異常高値をきたした64歳の男性ー進行性前立腺癌, 2012年, 検査と技術
• 進行性・去勢抵抗性前立腺癌に対するホルモン療法の現状と今後の展望ー前立腺癌のアンドロゲン依存性に関するパラダイムシフトー, 2012年, 泌尿器外科
• 去勢抵抗性前立腺癌に対するドセタキセルの役割：効果判定とその後の治療選択, 2012年, 泌尿器外科
• シロドシンによる排尿障害の治療：Urief Dose-up Study, 2012年, 泌尿器外科
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range., Kazuto Ito; Mai Miyakubo; Yoshitaka Sekine; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2013年04月, World journal of urology, 31, 2, 305, 11

  DOI
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate, Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 2012年02月01日, International Journal of Radiation Oncology Biology Physics, 82, 2, e211, e217

  DOI
• Serous borderline tumor of the paratestis in a child., 2012年, BJUI.org
• Lower urinary tract symptoms of neurological origin in urological practice., 2012年, Clin Auton Res

  DOI
• THE INFLUENCE OF CASTRATION ON BLADDER BLOOD FLOW AND FUNCTION DURING RAPID PHASE OF ANDROGEN DEPRIVATION, T. Magari; Y. Shibata; S. Arai; B. Kashiwagi; K. Suzuki, 2010年, NEUROUROLOGY AND URODYNAMICS, 29, 6, 912, 914, 研究発表ペーパー・要旨（国際会議）
• Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation, Yasuyuki Morikawa; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2012年03月16日, Biochemical and Biophysical Research Communications, 419, 3, 584, 589

  DOI
• HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Yoshitaka Sekine; Kazuhiro Suzuki; Alan T. Remaley, 2011年09月, PROSTATE, 71, 13, 1480, 1480, その他

  DOI
• HIGH FAT DIET REDUCES THE EXPRESSION OF GLUTATHIONE PEROXIDASE 3 IN MOUSE PROSTATE, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki; Alan Remaley, 2011年04月, JOURNAL OF UROLOGY, 185, 4, E293, E294, 研究発表ペーパー・要旨（国際会議）

  DOI
• 泌尿器科領域ＰＳＡスクリーニング検査がもたらすもの, 2010年, Annual Review腎臓
• "泌尿器科領域におけるトラブルシューティング(第9回) 照射後の膀胱全摘・尿路変更に伴う腸管トラブル", 2010年, 泌尿器外科
• 前立腺肥大の術式, 2010年, 日本医事新報
• 臓器部位別の治療戦略 前立腺がん, 2010年, がん治療レクチャー
• Chronic expanding hematoma in the retroperitoneal space: A case report, Takahiro Syuto; Motoaki Hatori; Nomura Masashi; Yoshitaka Sekine; Kazuhiro Suzuki, 2013年11月18日, BMC Urology, 13, 60

  DOI
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist, Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015年07月03日, Basic and Clinical Andrology, 25, 1, 7

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy, Koike, Hidekazu; Morikawa, Yasuyuki; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International, 1, 3, 113, 116

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy, Koike, Hidekazu; Matsui, Hiroshi; Morikawa, Yasuyuki; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International, 1, 2, 76, 80

  DOI
• 腎・泌尿器疾患のインフォームドコンセントと治療選択：前立腺疾患, 2010年, 腎と透析
• ＣＲＰＣの定義と発症メカニズム, 2011年, 泌尿器外科
• High-density lipoprotein and prostate cancer: An overview, Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z. Ikpot; Kazuhiro Suzuki; Alan T. Remaley, 2013年, Journal of Epidemiology, 23, 5, 313, 319

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, 2013年04月, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancer., Kazumichi Muramatsu; Hiroshi Matsui; Yoshitaka Sekine; Hidekazu Koike; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013年, Prostate international, 1, 1, 10, 5

  DOI
• Association of the genetic polymorphism of the CYP19 intron 4 [TTTA](n) repeat with familial prostate cancer risk in a Japanese population, K Suzuki; H Nakazato; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4941, 4946
• Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population, K Suzuki; H Matsui; N Ohtake; S Nakata; T Takei; H Koike; H Nakazato; H Okugi; M Hasumi; Y Fukabori; K Kurokawa; H Yamanaka, 2003年05月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 5, 261, 266

  DOI
• Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques, S Usui; K Suzuki; H Yamanaka; T Nakano; K Nakajima; Y Hara; M Okazaki, 2002年03月, CLINICA CHIMICA ACTA, 317, 1-2, 133, 143

  DOI
• A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine, T Tanaka; S Takahara; M Hatori; K Suzuki; JD Wang; N Ichimaru; S Suzuki; K Morozumi; A Okuyama; H Yamanaka, 2002年07月, CANCER LETTERS, 181, 2, 165, 171

  DOI
• Tumor-associated tissue eosinophilia of penile cancer, Y Ono; M Ozawa; Y Tamura; T Suzuki; K Suzuki; K Kurokawa; Y Fukabori; H Yamanaka, 2002年02月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 2, 82, 87

  DOI
• Prognostic significance of plasma placental growth factor levels in renal cell cancer: An association with clinical characteristics and vascular endothelial growth factor levels, K Matsumoto; K Suzuki; H Koike; K Okamura; K Tsuchiya; T Uchida; Y Takezawa; M Kobayashi; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4953, 4958
• Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia, K Matsumoto; K Suzuki; H Koike; M Hasumi; H Matsui; H Okugi; Y Shibata; K Ito; H Yamanaka, 2003年09月, ANTICANCER RESEARCH, 23, 5A, 3767, 3773
• Androgen-dependent blood flow control and morphological changes of the capillaries in rat prostate, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, 2004年02月, INTERNATIONAL JOURNAL OF ANDROLOGY, 27, 1, 50, 56

  DOI
• Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity, T Akimoto; K Ito; J Saitoh; S Noda; K Harashima; H Sakurai; Y Nakayama; T Yamamoto; K Suzuki; T Nakano; H Niibe, 2005年10月, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 63, 2, 463, 471

  DOI
• Intermittent deep coma in a hemodialysis patient with liver cirrhosis: A case report, Kazuhisa Matsumoto; Masamichi Hayashi; Nozomu Kosaku; Yoshihiro Ono; Takumi Yamamoto; Motoaki Hatori; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2003年, Kitakanto Medical Journal, 53, 1, 55, 57

  DOI
• Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8(+) T cells, TA Fehniger; K Suzuki; A Ponnappan; JB VanDeusen; MA Cooper; SM Florea; AG Freud; ML Robinson; J Durbin; MA Caligiuri, 2001年01月, JOURNAL OF EXPERIMENTAL MEDICINE, 193, 2, 219, 231

  DOI
• Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer., Shigehito Miyamoto; Kazuto Ito; Kohei Kurokawa; Kazuhiro Suzuki; Keiji Suzuki; Hidetoshi Yamanaka, 2006年06月, International journal of urology : official journal of the Japanese Urological Association, 13, 6, 767, 72

  DOI
• Fatal leukemia in interleukin-15 transgenic mice, TA Fehniger; K Suzuki; JB VanDeusen; MA Cooper; AG Freud; MA Caligiuri, 2001年01月, BLOOD CELLS MOLECULES AND DISEASES, 27, 1, 223, 230

  DOI
• Hands-free hook for endourological procedures, Y Ono; K Suzuki, 2003年10月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 10, 561, 562

  DOI
• Role of androgen on blood flow and capillary structure in rat seminal vesicles, Y Ono; K Suzuki; B Kashiwagi; Y Shibata; K Ito; Y Fukabori; H Yamanaka, 2004年03月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 202, 3, 193, 201

  DOI
• Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues, Masaru Hasumi; Kazuhiro Suzuki; Hiroshi Matsui; Hidekazu Koike; Kazuto Ito; Hidetoshi Yamanaka, 2003年10月28日, Cancer Letters, 200, 2, 187, 195

  DOI
• Preliminary results of a monitoring system to confirm the preservation of cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; N Terada; K Ito; D Yoshikawa; Y Arai; H Yamanaka, 2003年03月, INTERNATIONAL JOURNAL OF UROLOGY, 10, 3, 136, 140

  DOI
• Salvage external beam radiotherapy for local recurrence without systemic progression or prostate specific antigen recurrence of prostate cancer after initial hormonal therapy: Is it possible to identify patients likely to have good treatment outcomes?, K Kurokawa; K Ito; K Suzuki; Y Ono; T Yamamoto; T Akimoto; H Yamanaka, 2002年11月, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 32, 11, 466, 471

  DOI
• Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population, K Suzuki; N Ohtake; S Nakata; T Takei; H Matsui; Y Ono; H Nakazato; M Hasumi; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2002年11月, ANTICANCER RESEARCH, 22, 6B, 3507, 3511
• MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer, M Hasumi; K Suzuki; N Oya; K Ito; K Kurokawa; Y Fukabori; H Yamanaka, 2002年03月, ANTICANCER RESEARCH, 22, 2B, 1205, 1208
• Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage, H Koike; K Suzuki; T Satoh; N Ohtake; T Takei; S Nakata; H Yamanaka, 2003年11月, ANTICANCER RESEARCH, 23, 6D, 4947, 4951
• Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/mL or less, K Ito; Y Kubota; T Yamamoto; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2001年02月, CANCER, 91, 4, 744, 751

  DOI
• Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride, Y Shibata; Y Fukabori; K Ito; K Suzuki; H Yamanaka, 2001年01月, JOURNAL OF UROLOGY, 165, 1, 289, 293
• Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray, H Matsui; K Suzuki; M Hasumi; H Koike; H Okugi; H Nakazato; H Yamanaka, 2003年01月, ANTICANCER RESEARCH, 23, 1A, 195, 200
• Rapidly progressive malignant epithelioid angiomyolipoma of the kidney, T Yamamoto; K Ito; K Suzuki; H Yamanaka; K Ebihara; A Sasaki, 2002年07月, JOURNAL OF UROLOGY, 168, 1, 190, 191, その他
• Usefulness of PSA screening in outpatients with bladder cancer: Preliminary results, K Kurokawa; K Suzuki; H Okazaki; K Ito; A Shiono; Y Fukabori; H Yamanaka, 2002年05月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 5, 237, 240

  DOI
• Gene expression profiles in human BPH: Utilization of laser-capture microdissection and quantitative real-time PCR, K Suzuki; H Matsui; M Hasumi; Y Ono; H Nakazato; H Koike; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2001年11月, ANTICANCER RESEARCH, 21, 6A, 3861, 3864
• Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less, T Yamamoto; K Ito; M Ohi; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2001年12月, UROLOGY, 58, 6, 994, 998

  DOI
• Methylation status of insulin-like growth factor-binding protein-3 promoter in prostate cancer tissues, Hironobu Okugi; Hidekazu Koike; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2006年09月, Asia-Pacific Journal of Clinical Oncology, 2, 3, 144, 149

  DOI
• Ultrastructural changes in subepithelial capillaries and their surrounding stroma in rat prostate and seminal vesicle after castration, Y Ono; K Suzuki; H Yuasa; K Kurokawa; Y Fukabori; H Yamanaka, 2003年09月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 201, 1, 29, 38

  DOI
• Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population, H Nakazato; K Suzuki; H Matsui; H Koike; H Okugi; N Ohtake; T Takei; S Nakata; M Hasumi; K Ito; K Kurokawa; H Yamanaka, 2003年05月, ANTICANCER RESEARCH, 23, 3C, 2897, 2902
• The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer, M Hasumi; K Suzuki; A Taketomi; H Matsui; T Yamamoto; K Ito; K Kurokawa; J Aoki; K Endo; H Yamanaka, 2003年09月, ANTICANCER RESEARCH, 23, 5B, 4223, 4227
• NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer, K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka, 2001年04月, JOURNAL OF LEUKOCYTE BIOLOGY, 69, 4, 531, 537
• Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome, K Suzuki; Y Fukabori; H Nakazato; M Hasumi; H Matsui; K Ito; K Kurokawa; H Yamanaka, 2001年06月, INTERNATIONAL JOURNAL OF ANDROLOGY, 24, 3, 183, 188

  DOI
• A simple and reliable monitoring system to confirm the preservation of the cavernous nerves, K Kurokawa; T Suzuki; K Suzuki; K Ito; N Shimizu; Y Fukabori; H Yamanaka, 2001年05月, INTERNATIONAL JOURNAL OF UROLOGY, 8, 5, 231, 236

  DOI
• Usefulness of prostate-specific antigen velocity in screening for prostate cancer, K Ito; T Yamamoto; M Ohi; Y Kubota; Y Fukabori; K Kurokawa; K Suzuki; H Yamanaka, 2002年06月, INTERNATIONAL JOURNAL OF UROLOGY, 9, 6, 316, 321

  DOI
• Malignant fibrous histiocytoma of the right spermatic cord: A case report, Y Sekine; K Ohki; K Okamoto; M Nomura; H Tomita; N Ohtake; K Suzuki; K Kurokawa; M Mashimo; K Saruki; T Morita; H Nakazato; H Yokoo; H Yamanaka, 2001年10月, INTERNATIONAL JOURNAL OF UROLOGY, 8, 10, 581, 584

  DOI
• Incidence of bladder cancer discovered by urethrocystoscopy at prostate biopsy: extraordinary high incidence of tiny bladder cancer in elderly males., Hiroshi Okazaki; Koichi Suzuki; Takanori Suzuki; Kohei Kurokawa; Kazuto Ito; Kazuhiro Suzuki; Hidetoshi Yamanaka, 2004年05月, The Tohoku journal of experimental medicine, 203, 1, 31, 6

  DOI
• Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia, K Ito; Y Fukabori; Y Shibata; K Suzuki; M Mieda; K Gotanda; S Honma; H Yamanaka, 2000年10月, EUROPEAN JOURNAL OF ENDOCRINOLOGY, 143, 4, 543, 554
• Correlation of prostate-specific antigen before prostate cancer detection and clinicopathologic features: Evaluation of mass screening populations, K Ito; Y Kubota; K Suzuki; N Shimizu; Y Fukabori; K Kurokawa; K Imai; H Yamanaka, 2000年05月, UROLOGY, 55, 5, 705, 709
• Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, Y Shibata; K Ito; K Suzuki; K Nakano; Y Fukabori; R Suzuki; Y Kawabe; S Honma; H Yamanaka, 2000年01月, PROSTATE, 42, 1, 45, 55

  DOI
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998年, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, 1997年11月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, 1996年05月, PROSTATE, 28, 5, 328, 337

  DOI
• Editorial comment, Kazuhiro Suzuki, 2008年02月, International Journal of Urology, 15, 2, 161, 速報，短報，研究ノート等（学術雑誌）

  DOI
• Editorial comment, Kazuhiro Suzuki, 2008年01月, International Journal of Urology, 15, 1, 105, 速報，短報，研究ノート等（学術雑誌）

  DOI
• Lead time of prostate cancer detected in population based screening for prostate cancer in Japan., Kazuto Ito; Takumi Yamamoto; Mai Miyakubo; Hiroyuki Takechi; Masaru Ohi; Yasuhiro Shibata; Kazuhiro Suzuki, 2007年10月, The Journal of urology, 178, 4 Pt 1, 1258, 63

  DOI
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan, Yoshitaka Sekine; Kazuto Ito; Takumi Yamamoto; Haruki Nakazato; Yasuhiro Shibata; Motoaki Hatori; Kazuhiro Suzuki, 2007年04月, JOURNAL OF UROLOGY, 177, 4, 536, 537, 研究発表ペーパー・要旨（国際会議）

  DOI
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response, TA Fehniger; MH Shah; MJ Turner; JB VanDeusen; SP Whitman; MA Cooper; K Suzuki; M Wechser; F Goodsaid; MA Caligiuri, 1999年04月, JOURNAL OF IMMUNOLOGY, 162, 8, 4511, 4520
• Expression and degradation of rat androgen receptor following castration, testosterone replacement and antiandrogens administration: Analysis by Western blot and immunohistochemistry, K Suzuki; K Ito; K Kurokawa; T Suzuki; N Shimizu; Y Fukabori; S Honma; H Yamanaka, 1997年11月, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 183, 3, 159, 172

  DOI
• Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: Changes in prostate volume and histopathological findings, K Suzuki; K Ito; Y Tamura; T Suzuki; S Honma; H Yamanaka, 1996年05月, PROSTATE, 28, 5, 328, 337

  DOI
• Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-gamma production in vivo, TA Fehniger; HX Yu; MA Cooper; K Suzuki; MH Shah; MA Caligiuri, 2000年02月, JOURNAL OF IMMUNOLOGY, 164, 4, 1643, 1647
• Estimation of canine prostatic volume: Nomogram based on prostatic cubic volume, K. Suzuki; K. Ito; H. Okazaki; Y. Ono; K. Kurokawa; T. Suzuki; H. Yamanaka, 1998年, International Urology and Nephrology, 30, 6, 725, 730

  DOI
• Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer, K Ito; T Yamamoto; Y Kubota; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka, 2000年08月, UROLOGY, 56, 2, 278, 282

  DOI
• ENDOCRINE ENVIRONMENT OF BENIGN PROSTATIC HYPERPLASIA - PROSTATE SIZE AND VOLUME ARE CORRELATED WITH SERUM ESTROGEN CONCENTRATION, K SUZUKI; K ITO; Y ICHINOSE; K KUROKAWA; T SUZUKI; K IMAI; H YAMANAKA; S HONMA, 1995年03月, SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 29, 1, 65, 68
• SYNERGISTIC EFFECTS OF ESTROGEN AND ANDROGEN ON THE PROSTATE - EFFECTS OF ESTROGEN ON ANDROGEN-RECEPTORS AND ESTROGEN-RECEPTORS, BRDU UPTAKE, IMMUNOHISTOCHEMICAL STUDY OF AR, AND RESPONSES TO ANTIANDROGENS, K SUZUKI; K ITO; T SUZUKI; S HONMA; H YAMANAKA, 1995年03月, PROSTATE, 26, 3, 151, 163
• Survivin and its spliced isoform gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer., Okamura K; Koike H; Sekine Y; Matsui H; Suzuki K, 2009年, Cancer Epidemiolo, 33, 2, 137, 141

  DOI
• Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor., Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K, 2008年, Biochem Biophys Res Commun., 372, 2, 356, 361

  DOI
• Epidemiology of prostate cancer and benign prostatic hyperplasia, Kazuhiro Suzuki, 2009年, JMAJ, 52, 6, 478
• Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy, K Suzuki; H Okazaki; Y Ono; K Kurokawa; T Suzuki; E Onuma; H Takanashi; Y Mamiya; H Yamanaka, 1998年10月, PROSTATE, 37, 2, 70, 76

  DOI
• Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related induces in men with total PSA in the 2.0-10.0ng/ml range., 2012年, World J Urol

  DOI
• Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate., Masahiko Okamoto; Hitoshi Ishikawa; Takeshi Ebara; Hiroyuki Kato; Tomoaki Tamaki; Tetsuo Akimoto; Kazuto Ito; Mai Miyakubo; Takumi Yamamoto; Kazuhiro Suzuki; Takeo Takahashi; Takashi Nakano, 2012年02月01日, International journal of radiation oncology, biology, physics, 82, 2, e211-7, e217

  DOI
• Serous borderline tumor of the paratestis in a child., 2012年, BJUI.org
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, 2013年04月, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Influence of castration on bladder blood flow and function during the rapid phase of androgen deprivation., 2012年
• HDL and Sphingosine-I-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and SIP Receptors, and Promote Cell Migration and Invasion (vol 71, pg 690, 2011), Yoshitaka Sekine; Kazuhiro Suzuki; Alan T. Remaley, 2011年09月, PROSTATE, 71, 13, 1480, 1480, その他

  DOI
• HIGH FAT DIET REDUCES THE EXPRESSION OF GLUTATHIONE PEROXIDASE 3 IN MOUSE PROSTATE, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Hiroshi Matsui; Kazuhiro Suzuki; Alan Remaley, 2011年04月, JOURNAL OF UROLOGY, 185, 4, E293, E294, 研究発表ペーパー・要旨（国際会議）

  DOI
• The investigation of ureteral sympathetic innevation, using semi-serial sections: why dose the alpha1-adrenergic receptor antagonist work well for ureteral stones?, 2010年, Int Urol Nephrol

  DOI
• Chronic expanding hematoma in the retroperitoneal space: A case report, Takahiro Syuto; Motoaki Hatori; Nomura Masashi; Yoshitaka Sekine; Kazuhiro Suzuki, 2013年11月18日, BMC Urology, 13, 60

  DOI
• Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist., Yoshiyuki Miyazawa; Haruo Kato; Seiji Arai; Yosuke Furuya; Yoshitaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015年, Basic and clinical andrology, 25, 1, 7, 7

  DOI
• Chlormadinone acetate is effective for hot flush during androgen deprivation therapy., Hidekazu Koike; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013年, Prostate international, 1, 3, 113, 6

  DOI
• Simple method for preventing inguinal hernias after radical retropubic prostatectomy., Hidekazu Koike; Hiroshi Matsui; Yasuyuki Morikawa; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2013年, Prostate international, 1, 2, 76, 80

  DOI
• High-density lipoprotein and prostate cancer: an overview., Kazuhiko Kotani; Yoshitaka Sekine; Shizukiyo Ishikawa; Imoh Z Ikpot; Kazuhiro Suzuki; Alan T Remaley, 2013年09月05日, Journal of epidemiology, 23, 5, 313, 9

  DOI
• Lower urinary tract symptoms of neurological origin in urological practice, Tomohiro Magari; Yoshitatsu Fukabori; Haruyuki Ogura; Kazuhiro Suzuki, 2013年04月, Clinical Autonomic Research, 23, 2, 67, 72

  DOI
• Androgen receptor coactivator p120 subtype beta is highly expressed in prostate cancer, Muramatasu, Kazumichi; Matsui, Hiroshi; Sekine, Yoshitaka; Koike, Hidekazu; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2013年, Prostate International, 1, 1, 10-15.

  DOI
• 家族性前立腺癌の遺伝子解析と臨床応用の可能性, 松井 博; 大竹 伸明; 中田 誠司; 栗原 聰太; 小池 秀和; 鈴木 和浩, 2016年, Prostate journal, 3, 1, 53, 60
• Growing teratoma syndromeの1例, 馬場 恭子; 関根 芳岳; 栗原 聰太; 小池 秀和; 松井 博; 中里 晴樹; 柴田 康博; 伊藤 一人; 鈴木 和浩; 西井 昌弘; 真下 透; 岡村 桂吾; 平戸 純子, 2016年, 日本泌尿器科学会雑誌, 107, 2, 115, 120

  DOI
• 泌尿器疾患におけるBone Management Bone Scan Index(BSI)による骨転移の評価, 鈴木 和浩; 堀越 浩幸; 溝上 敦, 2015年10月, Prostate Journal, Prostate Journal, 2, 2, 241, 244
• DECREASING SURVIVIN BY YM155 REVERSES RAPAMYCIN RESISTANCE IN RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yoshiyuki Miyazawa; Haruo Kato; Yosuke Furuya; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015年04月, JOURNAL OF UROLOGY, 193, 4, E458, E458, 研究発表ペーパー・要旨（国際会議）
• 血中dihydrotestosteroneレベルはPSA3-10 ng/mLの男性においてGleason score 7-10の前立腺癌を予測する独立した因子である, 三好 康秀; 梅本 晋; 上村 博司; 柴田 康博; 鈴木 和浩; 窪田 吉信; 矢尾 正祐, 2015年04月, 日本泌尿器科学会総会, 日本泌尿器科学会総会, 103回, 493, 493
• 総排泄腔外反症に有棘細胞癌を合併した一例, 大津 晃; 宮尾 武士; 小池 秀和; 馬場 恭子; 青木 雅典; 栗原 聰太; 宮澤 慶行; 加藤 春雄; 周東 孝浩; 新井 誠二; 古谷 洋介; 新田 貴士; 野村 昌史; 関根 芳岳; 松井 博; 柴田 康博; 伊藤 一人; 鈴木 和浩; 牧口 貴哉; 森田 廣樹; 古作 望; 松本 和久; 富田 光; 山本 巧; 林 雅道, 2015年, 日本泌尿器科学会雑誌, 106, 4, 274, 279

  DOI
• Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels., Kohei Okamoto; Yositaka Sekine; Masashi Nomura; Hidekazu Koike; Hiroshi Matsui; Yasuhiro Shibata; Kazuto Ito; Kazuhiro Suzuki, 2015年, Basic and clinical andrology, 25, 3, 3

  DOI
• 精索静脈瘤に対する術中インドシアニングリーン蛍光血管造影下顕微鏡下低位結紮術の有用性：予備的検討, 柴田 康博; 栗原 聰太; 新井 誠二; 宮澤 慶行; 加藤 春雄; 小池 秀和; 伊藤 一人; 中村 哲也; 鈴木 和浩, 2015年, 日本泌尿器科学会雑誌, 106, 4, 293, 298

  DOI
• 前立腺癌に対する放射線療法Multi-Disciplinary Teamとしての取り組み, 鈴木 和浩; 松井 博; 河村 英将; 平戸 純子; 渋谷 圭; 谷山 奈保子; 橋本 智美; 金井 達明; 中野 隆史; 大野 達也, 2015年, 癌と化学療法, 42, 1, 32, 35
• 前立腺癌に対する重粒子線治療 ホルモン療法の役割, 鈴木 和浩; 松井 博; 河村 英将; 大野 達也, 2015年, 癌と化学療法, 42, 2, 159, 163
• <論文奨励賞受賞報告>ANDROLOGY2013.１掲載, 新井 誠二; 柴田 康博; 関根 芳岳; 伊藤 一人; 鈴木 和浩; 中村 保宏; 笹野 公伸; 柏木 文蔵; 上井 崇智; 都丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士, 2014年08月01日, The Kitakanto medical journal = 北関東医学, The Kitakanto medical journal = 北関東医学, 64, 3, 262, 262
• 日本人の去勢抵抗性前立腺癌患者におけるカバジタキセルの第I相臨床試験(TED11576), 小坂 威雄; 向井 博文; 高橋 俊二; 植村 天受; 上村 博司; 西山 博之; 鈴木 和浩; 筧 善行; 沖原 宏治; 並木 俊一; 小川 修; 加藤 真史; 大野 桂司; 中井 康友, 2014年06月, 日本癌治療学会誌, 49, 3, 1434, 1434
• 原発性性腺機能低下症患者に発生した前立腺癌 前立腺癌組織内アンドロゲン合成に関する検討, 新井 誠二; 柴田 康博; 中村 保宏; 柏木 文蔵; 上井 崇智; 登丸 行雄; 宮代 好通; 本間 誠次郎; 橋本 貢士; 関根 芳岳; 伊藤 一人; 笹野 公伸; 鈴木 和浩, 2014年05月, 泌尿器外科, 泌尿器外科, 27, 臨増, 765, 765
• 前立腺癌患者の初回内分泌療法の成績と診断時年齢 地域差と治療施設の特徴を踏まえて, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 北村 唯一; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 宇佐美 道之; 村井 勝; 赤座 英之, 2014年04月, 日本泌尿器科学会総会, 102回, 478, 478
• スニチニブ大量内服による自殺企図を来した腎癌症例における薬物動態の検討, 新井誠二; 松井博; 大木亮; 小池秀和; 柴田康博; 伊藤一人; 鈴木和浩; 坡下真大; 山本康次郎; 勝山善彦; 大森栄, 2014年02月01日, Kitakanto Medical Journal, Kitakanto Medical Journal, 64, 1, 71

  DOI
• 初回内分泌療法を施行された前立腺癌患者における治療パターンと診断時年齢の評価, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 村井 勝; 赤座 英之; J-CaP(Japan study; group of; ProstateCancer)研究会, 2013年10月, 西日本泌尿器科, 75, 増刊, 119, 119
• 前立腺癌患者の初回内分泌療法と診断時年齢, 稲元 輝生; 東 治人; 樋之津 史郎; 塚本 泰司; 大家 基嗣; 小川 修; 北村 唯一; 鈴木 和浩; 内藤 誠二; 並木 幹夫; 西村 和郎; 平尾 佳彦; 宇佐美 道之; 村井 勝; 赤座 英之, 2013年09月, 日本癌治療学会誌, 48, 3, 1498, 1498
• 前立腺癌患者の初回内分泌療法と診断時年齢の関係, 稲元輝生; 東治人; 樋之津史郎; 塚本泰司; 大家基嗣; 小川修; 北村唯一; 鈴木和浩; 内藤誠二; 並木幹夫; 西村和郎; 平尾佳彦; 宇佐美道之; 村井勝; 赤座英之, 2013年06月15日, 泌尿器外科, 泌尿器外科, 26, 6, 960, 963
• 前立腺がんの重粒子線治療はどこまでエビデンスがあるのか?, 松井 博; 加藤 弘之; 神沼 拓也; 伊藤 一人; 鈴木 和浩; 大野 達也, 2013年, 腫瘍内科, 12, 5, 515, 521
• HIGH-FAT DIET INCREASES RENAL CANCER GROWTH ACCOMPANIED BY LEPTIN INCREASE, AND SURVIVIN INHIBITION IS EFFECTIVE FOR SIMVASTATIN RESISTANT RENAL CANCER, Hidekazu Koike; Takashi Nitta; Yoshitaka Sekine; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2012年04月, JOURNAL OF UROLOGY, 187, 4, E59, E60, 研究発表ペーパー・要旨（国際会議）
• ANDROGEN PRODUCTION IN PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER PATIENTS, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, 2012年04月, JOURNAL OF UROLOGY, 187, 4, E389, E390, 研究発表ペーパー・要旨（国際会議）
• HIGH-FAT DIET INCREASED RENAL CANCER GROWTH, AND THE ANTITUMOR SENSITIZATION EFFECT DUE TO SURVIVIN INHIBITION IN SIMVASTATIN TREATMENT FOR RENAL CANCER CELLS, Hidekazu Koike; Yoshitaka Sekine; Takashi Nitta; Yosuke Furuya; Yasuyuki Morikawa; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2011年04月, JOURNAL OF UROLOGY, 185, 4, E96, E96, 研究発表ペーパー・要旨（国際会議）
• EXPRESSION OF GENES ENCODING ENZYMES INVOLVED IN ANDROGEN SYNTHESIS IN HUMAN ADIPOSE TISSUE POSSIBILITY OF ADIPOSE TISSUE AS THE THIRD ORGAN PRODUCING ACTIVE ANDROGEN IN PROSTATE CANCER PATIENTS-, Seiji Arai; Yasuhiro Shibata; Hidekazu Koike; Hiroshi Matsui; Kazuto Ito; Seijiro Honma; Kazuhiro Suzuki, 2011年04月, JOURNAL OF UROLOGY, 185, 4, E58, E58, 研究発表ペーパー・要旨（国際会議）
• NOVEL CANDIDATE GENE FOR PROSTATE CANCER (PC) SUSCEPTIBILITY, FARNECYL-DIPHOSPHATE FARNECYLTRANSFERASE 1 (FDFT1): ASSOCIATIONS OF FDFT1 GENE VARIANTS WITH PC RISK, AND FDFT1 PROTEIN FUNCTION EVALUATION IN PC CELLS, Hiroshi Matsui; Yuji Fukuma; Tatsuya Hamano; Hidekazu Koike; Yoshitaka Sekine; Nobuaki Ohtake; Seiji Nakata; Kazuhiro Suzuki, 2010年04月, JOURNAL OF UROLOGY, 183, 4, E267, E267, 研究発表ペーパー・要旨（国際会議）
• HIGH DENSITY LIPOPROTEIN INDUCES PROLIFERATION AND MIGRATION OF HUMAN PROSTATE ANDROGEN INDEPENDENT CANCER CELLS VIA ATP-BINDING CASSETTE TRANSPORTER A1 BY A CHOLESTEROL-INDEPENDENT MECHANISM, Yoshitaka Sekine; Yosuke Furuya; Hidekazu Koike; Kazuhiro Suzuki; Alan Remaley, 2010年04月, JOURNAL OF UROLOGY, 183, 4, E42, E43, 研究発表ペーパー・要旨（国際会議）
• STATIN INHIBITS THE PROLIFERATION OF HUMAN RENAL CANCER CELLS VIA DOWN-REGULATION OF THE SURVIVIN THROUGH IGF-1 SIGNALING, Hidekazu Koike; Yasuyuki Morikawa; Takashi Nitta; Yosuke Furuya; Yoshitaka Sekine; Hiroshi Matsui; Kazuhiro Suzuki, 2010年04月, JOURNAL OF UROLOGY, 183, 4, E32, E32, 研究発表ペーパー・要旨（国際会議）
• OP-170 下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討(腎腫瘍/手術1,一般演題口演,第98回日本泌尿器科学会総会), 廣野 正法; 鈴木 和浩; 伊藤 一人; 小林 幹男; 篠原 信雄; 公文 裕巳; 早川 正道; 内藤 誠二; 大圏 誠一郎; 福井 巌; 錦戸 雅春; 木村 剛; 五十嵐 辰男, 2010年02月20日, 日本泌尿器科學會雜誌, 101, 2
• 酢酸クロルマジノンによる前立腺肥大症患者の血中PSA値に与える影響, 柴田 康博; 鈴木 和浩; 平尾 佳彦; 藤本 清秀; 大橋 靖雄; 小川 良雄; 冨士 幸蔵; 七条 武志; 植村 天受; 辻 秀憲; 朴 英哲, 2010年02月, 日本泌尿器科学会雑誌, 101, 2, 305, 305
• 新しい治療：重粒子線治療の意義/位置づけ., 石川 仁; 辻 比呂志; 加藤 弘之; 中野 隆史; 伊藤 一人; 鈴木 和浩; 島崎 淳; 鎌田 正, 2010年, 泌尿器外科, 23, 8, 1057, 1059
• 下大静脈腫瘍血栓を伴う腎細胞癌症例の臨床的検討, 廣野 正法; 鈴木 和浩; 伊藤 一人; 小林 幹男; 篠原 信雄; 公文 裕巳; 早川 正道; 内藤 誠二; 大園 誠一郎; 福井 巌; 金武 洋; 近藤 幸尋, 2009年09月, 日本癌治療学会誌, 日本癌治療学会誌, 44, 2, 540, 540
• SURVIVIN IS ASSOCIATED WITH CELL PROLIFERATION AND PLAYS A ROLE IN 1A,25-DIHYDROXYVITAMIN D-3 INDUCED CELL GROWTH INHIBITION IN PROSTATE CANCER, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Seiji Arai; Yosuke Huruya; Hiroshi Matsui; Yasuhiro Shibata; Kazuhiro Suzuki, 2009年04月, JOURNAL OF UROLOGY, 181, 4, 52, 53, 研究発表ペーパー・要旨（国際会議）
• FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE 1 IS ASSOCIATED WITH THE GROWTH OF RENAL CANCER: ASSOCIATION WITH ANTICANCER EFFECT OF STATIN, Hidekazu Koike; Yoshitaka Sekine; Yasuyuki Morikawa; Yosuke Furuya; Hiroshi Matsui; Kazuhiro Suzuki, 2009年04月, JOURNAL OF UROLOGY, 181, 4, 154, 154, 研究発表ペーパー・要旨（国際会議）
• USEFULNESS OF REAL-TIME TRANSRECTAL ULTRASOUND NAVIGATION DURING HOLMIUM LASER ENUCLEATION OF THE PROSTATE, Yasuhiro Shibata; Seiji Arai; Hidekazu Koike; Motoaki Hatori; Kazuto Ito; Kazuhiro Suzuki, 2009年04月, JOURNAL OF UROLOGY, 181, 4, 764, 764, 研究発表ペーパー・要旨（国際会議）
• 高齢者の腎細胞癌に対する体腔鏡下腎摘除術の検討, 野村昌史; 小池秀和; 松井博; 柴田康博; 羽鳥基明; 伊藤一人; 小林幹男; 鈴木和浩, 2009年, The Kitakanto Medical Journal, 59, 4, 333, 336

  DOI
• Survivin and its spliced isoforms gene expression is associated with proliferation of renal cancer cells and clinical stage of renal cancer, Hidekazu Koike; Keigo Okamura; Yoshitaka Sekine; Kazuhiro Suzuki, 2008年04月, JOURNAL OF UROLOGY, 179, 4, 211, 211, 研究発表ペーパー・要旨（国際会議）
• 再燃抵抗性前立腺癌に対するドセタキセル療法の検討, 小池秀和; 中里晴樹; 新井誠二; 森川泰如; 関根芳岳; 野村昌史; 西井昌弘; 曲友弘; 松井博; 山本巧; 柴田康博; 羽鳥基明; 伊藤一人; 鈴木和浩, 2008年, 泌尿器外科, 21, 8, 1123, 1126
• 【前立腺がん放射線療法の進歩】 放射線治療の合併症・QOL評価・改善のための工夫 前立腺癌に対する外照射併用高線量率組織内照射後の急性反応 Geometrical optimizationとanatomy based inverse optimizationの比較, 秋元 哲夫; 加藤 弘之; 白井 克幸; 田巻 倫明; 原田 耕作; 山本 巧; 伊藤 一人; 鈴木 和浩; 中野 隆史, 2006年08月, 泌尿器外科, 泌尿器外科, 19, 8, 975, 979
• HER-2 gene polymorphism at codon 655 in familial prostate cancer in a Japanese population, Sekine Y; Hasumi M; Ohtake N; Nakata S; Nakazato H; Koike H; Suzuki K, 2005年, Asia-Pacific Journal of Clinical Oncology, 1, 4, 133, 137
• Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia., Kashiwagi B; Shibata Y; Ono Y; Suzuki R; Honma S; Suzuki K, 2005年, J Androl, 26, 5, 586, 591
• Genomewide linkage analysis of familial prostate cancer in the Japanese population., Matsui H; Suzuki K; Ohtake N; Nakata S; Takeuchi T; Yamanaka H; Inoue I, 2004年, J Hum Genet., 49, 1, 9, 15

  DOI
• 腎移植患者の腎機能,QOLに対する貧血管理の関与, 田中 俊之; 高原 史郎; 守山 敏樹; 羽鳥 基明; 児島 康行; 小角 幸人; 市丸 直嗣; 蓮見 勝; 川口 拓也; 鈴木 和浩; 奥山 明彦; 山中 英壽, 2003年02月, 日本泌尿器科学会雑誌, 日本泌尿器科学会雑誌, 94, 2, 204, 204
• 4. 前立腺癌に対する外照射併用高線量率組織内照射の初期経験, 秋元 哲夫; 鈴木 和浩; 山中 英壽; 北本 佳住; 桜井 英幸; 中野 隆史; 清塚 誠; 石川 仁; 三橋 紀夫; 伊藤 一人; 山本 巧, 2002年, 泌尿器外科, 15(8):944-947
• 前立腺癌に対する外照射併用高線量率組織内照射法, 秋元 哲夫; 黒川 公平; 鈴木 和浩; 山中 英寿; 北本 佳住; 桜井 英幸; 中野 隆史; 斎藤 淳一; 原島 浩一; 三橋 紀夫; 伊藤 一人; 山本 巧, 2002年, 臨床放射線, 47(12):1708-1714

書籍等出版物

• 男性生殖腺, 内科学レビュー2004、綜合医学社, 2004年
• レーザーキャプチャーマイクロダイセクションと核酸の解析, 組織細胞化学2002―ポストゲノム時代のコアテクニック、学際企画, 2002年
• 前立腺がんの確定診断, 医薬ジャーナル, 2008年
• 前立腺癌検診ガイドライン, 金原出版, 2008年
• 前立腺がん検診ガイドライン2010版, 2009年
• 前立腺癌, 今日の診断指針第6版, 2011年
• 前立腺癌診療ガイドライン2012年版 疫学, 金原出版, 2012年
• がん骨転移のバイオロジーとマネージメント：がん治療による骨量減少（ＣＴＩＢＬ）, 医薬ジャーナル, 2012年
• 去勢抵抗性前立腺がん 薬物治療UPDATE, 先端医学社, 2015年
• 癌と骨, メデイカルレビュー社, 2013年

講演・口頭発表等

• 広汎性子宮全摘術における術中膀胱神経温存法の改善, 第41回日本癌治療学会総会, 2003年
• Impact of body mass index on serum PSA levels in Japanease males, 21th Annual EAU congress, 2006年
• Positive effect of prostaglandin on regulation of prostate blood flow- Investigation of the key factor in the signaling pathway of the prostate blood flow-, 100th AUA annual meeting, 2005年
• Chronic ischemia induces abnormal growth in the ventral prostate of the rats, 100th AUA annual meeting, 2005年
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, 100th AUA annual meeting, 2005年
• Comprehensive analysis of genetic polymorphisms involved in prostate cancer developement and progression in a high risk Japanese population, 100th AUA annual meeting, 2005年
• Cnosequences of RNASEL gene in familial prostate cancer in Japan, 98th AUA annual meeting, 2003年
• Genetic polymorphism of HPC2/ELAC2 is not associated with familial prostate cancer risk in japan, 2003年
• Familial prostate cancer, the 18th international symposiumu controvesies in prostate cancer: diagnosis and treatment, 2006年
• Multigenic involvement in familial prostate cancer risk in a Japanease population, 98th AUA annual meeting, 2003年
• Effects of new steroidal aromatase inhibitor TZA-2237 on hormone induced benign prostatic hyperplasia in the canine, 10th International Congress of Endocrinology, 1996年
• A model for the number of cores per prostate biopsy based on age and prostate volume in Japanese patients., The 17th Japan-Korea Urological Congress, 2000年
• 前立腺癌スクリーニングにおけるPSA，PSA velocity (PSAV)の使用法, 第65回日本泌尿器科学会東部総会, 2000年
• Long-term screening for prostate cancer in men with initial PSA levels of 4.0ng/ml or less., Annual Meeting of The American Urological Association, 2000年
• The correlation of prostate-specific antigen prior to prostate cancer detection and clinicopathological features., The 5th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer., 2000年
• Changes in the baseline PSA in Japanese men participated in the population-based screening for prostate cancer between 1988 and 2003., ２２ｔｈ European Association of Urology Annual Meeting, 2009年
• PSA kinetics in screen detected prostate cancer in Japan., 22thEuropean Association of Urology Annual Meeting, 2007年
• The usefulness of [-5,-7]pro/free PSA ratio in the era undergoing multiple-core biopsies for men with PSA levels between 4 and 10ng/ml : Assessment using a receiver operating characteristic partial area index(pAUC-ROC) analysis., 22thEuropean Association of Urology Annual Meeting, 2007年
• The growth inhibitory effect of mushroom extract, Phellinus linteus on prostate cancer cell line in vitro and in vivo., 102th AUA Annual Meeting, 2007年
• Evaluation of adrenal androgen and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 102th AUA annual meeting, 2007年
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., 102th AUA annual meeting, 2007年
• Japanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC)：The study concept and the first analyses on compliance and contamination for the PSA test(Gunma section), 102th AUA annual meeting, 2007年
• Seasonally changes in the serum PSA levels in men participated in the population-based screening for prostate cancer in Japan., 23th EAU annual meeting, 2008年
• Japanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): The Study Concept and the First Analyses on Compliance and Contamination for the PSA test (Gunma section)., 23th EAU annual meeting, 2008年
• Impact of pretreatment factors, biopsy Gleason grade volume index and post treatment nadir PSA on cause-specific and overall survival in patients with stage IV prostate cancer., 2nd World congress on controversies in Urology, 2009年
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 24th EAU annual meeting, 2009年
• Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009年
• Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin., 24th EAU annual meeting, 2009年
• Association between common sequence variants in the farnesyl-diphosphate farnesyltransferase 1(FDFT1) gene and the prostate cancer risk in the Japanese population., 104th AUA annual meeting, 2008年
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 103th AUA annual meeting, 2008年
• HDL and sphingosine-1-phosphate activate signal transducer and activator of transcription 3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors., AACR 101st Annual Meeting 2010, 2010年
• Diagnostic significance of [-2]proPSA and volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0 ng/mL range., The 105th Annual Meeting of American Urological Association, 2010年
• Statin inhibits the proliferation of human prenal cancer cells via down-regulation of the survivin through IGF-1 signaling., The 105th Annual Meeting of American Urological Association, 2010年
• Detection of membrane androgen-binding site in living rat prostate and evaluation of its role in prostate blood flow regulation., 2010年
• Prediction of future castration resistant prostate cancer by pre-treatment prostate tissue androgen content., AUA 106th annual Meeting, 2011年
• High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism., 2010年
• Expression of genes encoding enzymes involved in androgen synthesis in human adipose tissue -possibility of adipose tissue as the third organ producing active androgen in prostate cancer patients-, 2011年
• High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011年
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., AUA 106th annual Meeting, 2011年
• Predictive impact of free PSA/total PSA (%fPSA) on the development of prostate cancer in men with baseline PSA lower than 2.0ng/mL: baseline PSA-adjusted case control study., International urology meeting 31th, 2011年
• Androgen production in periprostatic adipose tissue in prostate cancer patients., AUA 107th annual Meeting, 2012年
• High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012年
• Some techniques to achieve high enucleation efficiency when performing holmium laser enucleation of the prostate., AUA 107th annual Meeting, 2012年
• Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012年
• High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer., 27th Annual EAU Congress, 2012年
• Androgen production in periprostatic adipose tissue in prostate cancer patients., 27th Annual EAU Congress, 2012年
• Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012年
• Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012年
• Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens., 15th International Congress on Hormonal Steroids and Hormones & Cancer symposium, 2012年
• Impact of body mass index on serum PSA levels in Japanease males, 21th Annual EAU congress, 2006年
• Positive effect of prostaglandin on regulation of prostate blood flow- Investigation of the key factor in the signaling pathway of the prostate blood flow-, 100th AUA annual meeting, 2005年
• Chronic ischemia induces abnormal growth in the ventral prostate of the rats, 100th AUA annual meeting, 2005年
• Administration of extract of the mushroom phellinus linteus induces prostate enlargement with an increase in the stromal component in experimentally developed rat benign prostatic hyperplasia, 100th AUA annual meeting, 2005年
• Comprehensive analysis of genetic polymorphisms involved in prostate cancer developement and progression in a high risk Japanese population, 100th AUA annual meeting, 2005年
• Cnosequences of RNASEL gene in familial prostate cancer in Japan, 98th AUA annual meeting, 2003年
• Genetic polymorphism of HPC2/ELAC2 is not associated with familial prostate cancer risk in japan, 2003年
• Familial prostate cancer, the 18th international symposiumu controvesies in prostate cancer: diagnosis and treatment, 2006年
• Multigenic involvement in familial prostate cancer risk in a Japanease population, 98th AUA annual meeting, 2003年
• Effects of new steroidal aromatase inhibitor TZA-2237 on hormone induced benign prostatic hyperplasia in the canine, 10th International Congress of Endocrinology, 1996年
• A model for the number of cores per prostate biopsy based on age and prostate volume in Japanese patients., The 17th Japan-Korea Urological Congress, 2000年
• Long-term screening for prostate cancer in men with initial PSA levels of 4.0ng/ml or less., Annual Meeting of The American Urological Association, 2000年
• The correlation of prostate-specific antigen prior to prostate cancer detection and clinicopathological features., The 5th Seminar of the International Cooperative Study of Diagnostic Ultrasound and Prostate Cancer., 2000年
• Changes in the baseline PSA in Japanese men participated in the population-based screening for prostate cancer between 1988 and 2003., ２２ｔｈ European Association of Urology Annual Meeting, 2009年
• PSA kinetics in screen detected prostate cancer in Japan., 22thEuropean Association of Urology Annual Meeting, 2007年
• The usefulness of [-5,-7]pro/free PSA ratio in the era undergoing multiple-core biopsies for men with PSA levels between 4 and 10ng/ml : Assessment using a receiver operating characteristic partial area index(pAUC-ROC) analysis., 22thEuropean Association of Urology Annual Meeting, 2007年
• The growth inhibitory effect of mushroom extract, Phellinus linteus on prostate cancer cell line in vitro and in vivo., 102th AUA Annual Meeting, 2007年
• Evaluation of adrenal androgen and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 102th AUA annual meeting, 2007年
• Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan., 102th AUA annual meeting, 2007年
• Japanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC)：The study concept and the first analyses on compliance and contamination for the PSA test(Gunma section), 102th AUA annual meeting, 2007年
• Seasonally changes in the serum PSA levels in men participated in the population-based screening for prostate cancer in Japan., 23th EAU annual meeting, 2008年
• Japanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): The Study Concept and the First Analyses on Compliance and Contamination for the PSA test (Gunma section)., 23th EAU annual meeting, 2008年
• Impact of pretreatment factors, biopsy Gleason grade volume index and post treatment nadir PSA on cause-specific and overall survival in patients with stage IV prostate cancer., 2nd World congress on controversies in Urology, 2009年
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 24th EAU annual meeting, 2009年
• Survivin is associated with cell proliferation and plays a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer., 24th EAU annual meeting, 2009年
• Farnesyl-diphosphate farnesyltransferase 1 is associated with the growth of renal cancer: Association with anticancer effect of statin., 24th EAU annual meeting, 2009年
• Association between common sequence variants in the farnesyl-diphosphate farnesyltransferase 1(FDFT1) gene and the prostate cancer risk in the Japanese population., 104th AUA annual meeting, 2008年
• Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues., 103th AUA annual meeting, 2008年
• HDL and sphingosine-1-phosphate activate signal transducer and activator of transcription 3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors., AACR 101st Annual Meeting 2010, 2010年
• Diagnostic significance of [-2]proPSA and volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0 ng/mL range., The 105th Annual Meeting of American Urological Association, 2010年
• Statin inhibits the proliferation of human prenal cancer cells via down-regulation of the survivin through IGF-1 signaling., The 105th Annual Meeting of American Urological Association, 2010年
• Detection of membrane androgen-binding site in living rat prostate and evaluation of its role in prostate blood flow regulation., 2010年
• High density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism., 2010年
• Expression of genes encoding enzymes involved in androgen synthesis in human adipose tissue -possibility of adipose tissue as the third organ producing active androgen in prostate cancer patients-, 2011年
• High-fat diet increased renal cancer growth, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer cells., AUA 106th annual Meeting, 2011年
• Prediction of future castration resistant prostate cancer by pre-treatment prostate tissue androgen content., AUA 106th annual Meeting, 2011年
• High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate., AUA 106th annual Meeting, 2011年
• Predictive impact of free PSA/total PSA (%fPSA) on the development of prostate cancer in men with baseline PSA lower than 2.0ng/mL: baseline PSA-adjusted case control study., International urology meeting 31th, 2011年
• Androgen production in periprostatic adipose tissue in prostate cancer patients., AUA 107th annual Meeting, 2012年
• High-fat diet increases renal cancer growth accompanied by leptin increase, and survivin inhibition is effective for simvastatin resistant renal cancer., AUA 107th annual Meeting, 2012年
• Some techniques to achieve high enucleation efficiency when performing holmium laser enucleation of the prostate., AUA 107th annual Meeting, 2012年
• Simple method of preventing postradical retropubic prostatectomy inguinal hernia., 27th Annual EAU Congress, 2012年
• High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer., 27th Annual EAU Congress, 2012年
• Androgen production in periprostatic adipose tissue in prostate cancer patients., 27th Annual EAU Congress, 2012年
• Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012年
• Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy., 15th International Congress on Hormonal Steroids and Hormones & Cancer, 2012年
• Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens., 15th International Congress on Hormonal Steroids and Hormones & Cancer symposium, 2012年

産業財産権

• 特許権, 前立腺癌と良性前立腺過形成の鑑別法

受賞

• 第1回北関東医学会奨励賞, 1997年
• 前立腺がんワークショップ医学賞, 2002年

社会貢献活動情報

社会貢献活動

• 市民公開講座, 2022年, 2022年
• 前立腺シンポジウム, 2022年, 2022年, 前立腺研究財団理事および前立腺シンポジウムの運営委員長して企画・得運営担当
• 日本泌尿器科学会群馬地方会, 2022年, 2022年（対象：その他）
• 群馬県臓器移植推進会議, 2022年, 2022年

学術貢献活動

• 前立腺シンポジウム運営委員長, 学会・研究会等, 2022年, 2022年
• 前立腺研究財団, 学会・研究会等, 2022年, 2022年
• 日本泌尿器科学会代議員, 学会・研究会等, 2022年, 2022年